As filed with the Securities and Exchange Commission on April 17, 2007
Registration No. 333-135796
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM SB-2/A
POST-EFFECTIVE AMENDMENT NO. 3
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
EDGEWATER FOODS INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
NEVADA 20-3113571
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
5552 WEST ISLAND HIGHWAY, QUALICUM BEACH
BRITISH COLUMBIA, CANADA V9K 2C8
(Address of principal executive offices (zip code))
(250) 757-9811
(Registrant's telephone number, including area code)
ROBERT SAUNDERS
PRESIDENT AND CHIEF EXECUTIVE OFFICER
5552 West Island Highway, Qualicum Beach
British Columbia, Canada V9K 2C8
(Name, address and telephone number of agent for service)
Approximate date of proposed sale to the public: AS SOON AS PRACTICABLE AFTER
THE EFFECTIVE DATE OF THIS REGISTRATION STATEMENT.
If this form is filed to register securities for an offering to be made on a
continuous or delayed basis, check the following box: [X]
If this form is filed to register additional securities for an offering pursuant
to Rule 462(b) under the Securities Act, please check the following box and list
the Securities Act registration statement number of the earlier effective
registration statement for the same offering. [ __ ]
If this form is a post-effective amendment filed pursuant to Rule 462(c) under
the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ __ ]
If this form is a post-effective amendment filed pursuant to Rule 462(d) under
the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ __ ]
If delivery of the prospectus is expected to be made pursuant to Rule 434, check
the following box. [ __ ]
- ------------------------- ---------------------- ----------------------- ---------------------- ----------------------
TITLE OF EACH CLASS OF AMOUNT TO BE PROPOSED MAXIMUM PROPOSED MAXIMUM AMOUNT OF
SECURITIES TO BE REGISTERED OFFERING PRICE PER AGGREGATE OFFERING REGISTRATION FEE
REGISTERED UNIT (1) PRICE (1)
- ------------------------- ---------------------- ----------------------- ---------------------- ----------------------
Common Stock underlying 9,465,599 (2) (3) $1.40 $13,251,838.60 $1,417.95
the Preferred Stock
- ------------------------- ---------------------- ----------------------- ---------------------- ----------------------
Common Stock Underlying 21,440,020 $1.40 $30,016,028.00 $3,211.71
the Warrants
- ------------------------- ---------------------- ----------------------- ---------------------- ----------------------
Common Stock Underlying 2,868,803 $1.40 $4,016,324.20 $429.75
the Placement
Consultant Warrants
- ------------------------- ---------------------- ----------------------- ---------------------- ----------------------
Common Stock 647,860 (3) (4) $1.40 $907,004.00 $97.05
- ------------------------- ---------------------- ----------------------- ---------------------- ----------------------
Total 34,422,282 $5,156.45
- ------------------------- ---------------------- ----------------------- ---------------------- ----------------------
(1) Estimated solely for the purpose of computing the registration fee in
accordance with Rule 457(c) of the Securities Act of 1933 based upon
the average of the bid and asked price of the Registrant's common
stock as quoted on the Over-the-Counter Bulletin Board of $1.40 on
July 11, 2006.
(2) This number represents 120% of the aggregate number of shares of
common stock necessary to effect the conversion of all of our Series A
Preferred Stock currently outstanding with the investors of our 2006
private financings.
(3) An indeterminate number of additional shares of common stock shall be
issuable pursuant to Rule 416 to prevent dilution resulting from stock
splits, stock dividends or similar transactions and in such an event
the number of shares registered shall automatically be increased to
cover the additional shares in accordance with Rule 416 under the
Securities Act.
(4) Includes 22,860 shares issued as dividends to some of our Series A
Convertible Preferred shareholders; 400,000 shares issued to a lender
as consideration for extending the repayment date of a loan; and
225,000 shares issued to consultants.
Pursuant to Rule 416 of the Act, this registration statement also covers such
indeterminate additional shares of common stock as may become issuable as a
result of stock splits, stock dividends or other similar events.
THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES
AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL FILE
A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT
SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF THE
SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME
EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SECTION 8(a), MAY
DETERMINE.
ii
COPIES OF COMMUNICATIONS TO:
LOUIS E. TAUBMAN, ESQ.
LAW OFFICES OF LOUIS E. TAUBMAN, P.C.
17 State Street, 16th Floor
New York, NY 10004
(212) 732-7184
FAX: (212) 202-6380
iii
EXPLANATORY NOTE: We are filing this amendment to conform the disclosure
contained herein to our Quarterly Report on Form 10-QSB for the period ending
February 28, 2007, which we filed on April 13, 2007.
The information contained in this preliminary prospectus is not complete and may
be changed. These securities may not be sold until the Securities and Exchange
Commission declares the registration statement filed with it effective. This
preliminary prospectus is not an offer to sell these securities, and it is not
soliciting an offer to buy these securities in any state where the offer or sale
is not permitted. You should rely only on the information contained in this
preliminary prospectus. We have not authorized anyone to provide you with
information that is different.
PRELIMINARY PROSPECTUS
SUBJECT TO COMPLETION, DATED
EDGEWATER FOODS INTERNATIONAL, INC.
34,422,282 SHARES OF COMMON STOCK
The 34,422,282 shares of common stock, $.001 par value, being offered
by the selling shareholders listed on page 11. The shares of our common stock
covered by this prospectus include:
o 400,000 shares of common stock to The Bridge Financing Group (doing
business as "World Wide Mortgage Corporation") on January 31, 2006 as
consideration of their agreement to extend the due date for repayment
of our $1,500,00 bridge loan with them;
o 225,000 shares of common stock issued to the following parties
pursuant to consulting agreements with us, in consideration for
services provided to us: 100,000 shares issued to Aurelius Consulting
Group, Inc. in October 2005; 100,000 shares issued to Gallatin
Consulting, Inc. on June 27, 2005; 12,500 shares issued to Christian
Galatti on October 21, 2005 and November 11, 2005; and 12,500 shares
issued to Gary Shemano on October 21, 1005 and November 11, 2005;
o 21,440,020 shares of common stock issuable upon exercise of 21,440,020
warrants to purchase shares of our common stock to investors in our
2006 private financings;
o 9,465,599 shares of common stock issuable upon conversion of the
Series A Convertible Preferred Stock granted to investors in our 2006
private financings; this number represents 120% of the aggregate
number of shares of common stock necessary to convert the currently
outstanding 7,887,999 shares of our Series A Preferred Stock, which is
required by the transaction documents of our April 12, 2006, May 30,
2006, June 30, 2006 and July 11, 2006 private financings;
o 2,868,803 shares of common stock issuable upon exercise of three (3)
placement consultant warrants to purchase shares of our common stock
granted to the placement consultant in our April 12, 2006, May 30,
2006, June 30, 2006 and July 11, 2006 private financings;
o 22,860 shares of common stock issuable pursuant to dividends that were
issued in July 2006 and pursuant to dividends that may be paid in the
future to our Series A Preferred Shareholders.
This offering is not being underwritten.
The prices at which the selling shareholders may sell their shares will
iv
be determined by the prevailing market price for the shares or in privately
negotiated transactions. Information regarding the selling shareholders and the
times and manner in which they may offer and sell the shares under this
prospectus is provided under the "Selling Shareholders" and "Plan of
Distribution" sections in this prospectus. Edgewater will not receive any of the
proceeds from the sale of the shares under this prospectus.
Our common stock is listed on the Over the Counter Bulletin Board, also called
the OTCBB, under the trading symbol "EDWT." On April 16, 2007, the closing bid
for our common stock as reported on the OTCBB was $1.05 per share. As of April
16, 2007, Edgewater had the following amount of shares issued and outstanding:
o 23,285,291 shares of Common Stock;
o 8,010,333 shares of Series A Preferred Stock; and,
o 207 shares of Series B Preferred Stock
THIS INVESTMENT INVOLVES RISK.
SEE "RISK FACTORS"BEGINNING ON PAGE 3.
Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved the securities or determined that this
prospectus is complete or accurate. Any representation to the contrary is a
criminal offense.
------------------------------------------
The date of this Prospectus is
------------------------------------------
v
TABLE OF CONTENTS
Page
Corporate Information...................................................... vii
Prospectus Summary......................................................... 1
Risk Factors............................................................... 4
Cautionary Statement Regarding Forward Looking Statements.................. 10
Use Of Proceeds............................................................ 10
Selling Shareholders....................................................... 11
Plan of Distribution....................................................... 13
Business................................................................... 15
Description of Property.................................................... 22
Management................................................................. 26
Executive Compensation..................................................... 31
Security Ownership of Certain Beneficial Owners and Management............. 37
Certain Relationships And Related Transactions............................. 39
Description Of Securities.................................................. 39
Market for Common Equity and Related Shareholder Matters................... 44
Management's Discussion and Analysis or Plan of Operations................. 45
Changes in and Disagreements with Accountants on Accounting and 54
Financial Disclosure
Legal Proceedings.......................................................... 54
Experts.................................................................... 54
Legal Matters.............................................................. 54
Financial Statements....................................................... F-1
vi
PROSPECTUS SUMMARY
The following is a summary that highlights what we believe to be the most
important information regarding Edgewater and the securities being offered
herein. Because it is a summary, however, it may not contain all of the
information that is important to you. To understand our business and this
offering fully, you should read this entire prospectus and our financial
statements and related notes carefully. Unless the context requires otherwise,
"we," "us," "our" and similar terms refer to Edgewater.
THE COMPANY
We are the parent company of Island Scallops Ltd., a Vancouver Island
aquaculture company. Island Scallops was established in 1989 and for over 15
years has successfully operated a scallop farming and marine hatchery business.
Island Scallops is dedicated to the farming, processing and marketing of high
quality, high value marine species: scallops and sablefish. Scallop farming is
relatively new to North America and Island Scallops is the only producer of both
live-farmed Pacific scallops and live sablefish (or blackcod). Given Island
Scallops' unique hatchery technology and extensive research and development, we
believe that there is no significant competition for the farming of these marine
species in our geographic area. Island Scallops is committed to rapidly
expanding production and profits while continuing to finance the aggressive
growth of the company and maintaining a healthy respect for the marine
environment.
RECENT DEVELOPMENTS
Business
We commenced harvesting our year-class 2004 sea scallops in February
2006. We refer to the year-class of scallops based on when the scallops were
spawned. Generally, the harvest occurs approximately 22 to 24 months after
spawning of the scallops. The 2004 year-class scallop harvest started
approximately one month sooner than we originally anticipated. The early start
to the harvest was attributed to improved scallop growth rates as a result of
selective breeding and use of proprietary farming techniques. The benefits of
five years of selective breeding are starting to show benefits with the 2004
year-class, displaying a higher weight to shell ratio. We anticipated harvesting
approximately 2 million scallops between February and October 2006, however, the
results of our experimentation with ear hanging scallops as opposed to keeping
them in nets during the final portion of their growth cycle were disappointing
and resulted in greater mortality than expected, as well as sporadic growth. As
a result, and due to the labor costs of ear-hanging versus lantern-style
netting, we decided to use nets for the final grow-out stage of the 2005 crop
and subsequent classes.
In October 2006, we installed twenty new longlines at our Hindoo Creek
scallop farm in Baynes Sound (1). Each longline is 108 yds (324 feet) long and
submerged at approximately 25 ft depth. In July 2006, we received approval for
an additional 23 longlines. The October and July additions bring the tenure up
to its management plan of 67. At harvest, each new longline has the capacity to
hold 90,000 scallops in final stage grow-out nets, thereby increasing the
production of the farm to 6 million scallops. Additionally, the Deep Bay tenure
has been expanded to 32 longlines, which has the capacity to hold 2.8 million at
harvest.
After an analysis of our production results to date, we decided to
transition production to a combination of our ear-hanging method and the use of
"lantern style" nets (for our grow-out nets), the later of which will allow for
approximately 90,000 scallops per line (vs. 100,000 "ear-hung). The costs of
"lantern style" are similar to that of "ear-hanging" ($.08 per scallop in net
vs. $.075 per ear hung scallop): labor costs for the lantern method are less
because there is less handling of the scallops, however, capital costs are more
since we will need to purchase boats capable of handling additional weight per
line caused by use of nets vs. ear hanging. In conjunction with the transfer of
our 2005 scallop class from small mesh nets to the final stage lantern nets, we
also moved the 2006 crop from the pond sites (at our hatchery) to small mesh
nets on our farms; it is estimated that these animals will be ready for harvest
in the Spring of 2008.
The 2006 year-class scallop spawning season commenced in March of
2006 and was completed in April 2006. The scallop brood-stock conditioning for
these spawning began in mid-December 2005. We expect to begin harvesting the
2006 year-class scallops during the Spring of 2008, however, we could begin
harvesting portions of the class sooner if mortality rates (at various points of
the growth cycle) are significantly better than our current projection or if
growth rates are substantially higher. We anticipate that of the over 350
million larvae that were spawned during the 2006 spawning season, at least 5 to
10 million scallops could reach full maturity and thus be harvested. During the
first and second quarter of our 2007 fiscal year, we continued moving the 2006
scallop crop from the onshore ponds at our harvest facility into grow-out nets
at our tenure sites. The use of DNA based family analysis that started in 2000
and will continue through 2007, with the goal of breeding high meat yield
scallops, began showing results in the harvest of our 2004 scallop class.
Average weight per scallop increased from 150-180 grams to over 225-250 grams --
representing an increase of over 20% from the previous year. In the first
quarter of our 2007 fiscal year, we started harvesting the remaining balance of
our 2004 year class of scallops and completed transferring our 2005 year-class
scallops that were still maturing in our tenured growing sites and joint venture
locations, to final stage large grow-out nets on our farm sites.
We began harvesting our 2005 scallop class in March of 2007 and expect
to bring between 3 and 4 million scallops to market over the next twelve months.
SERIES B PREFERRED STOCK AND WARRANT FINANCINGS
On January 16, 2007, we completed a private equity financing of
$2,070,000 with two accredited investors. Net proceeds from the offering, are
approximately $1,864,400. We issued 207 shares of our Series B Preferred Stock,
par value $0.001 per share and stated value of $10,000 per share and each
investor also received one of each of the following warrants: (i) Series A
Warrant, (ii) Series B Warrant, (iii) Series C Warrant, (iv) Series J Warrant,
(v) Series D Warrant, (vi) Series E Warrant, and (vii) Series F Warrant, each to
purchase a number of shares of common stock equal to 50% of the number of shares
of common stock issuable upon conversion of the purchaser's Series B Preferred
Stock, except for the Series J Warrants, which shall entitle the investor to
purchase a number of shares of our common stock equal to 100% of the number of
shares of common stock issuable upon conversion of the purchaser's Series B
Preferred Stock. Each of the Warrants has a term of 6 years, except for the
Series J Warrants, which have a term of 1 year. Each share of the Series B
Preferred Stock is convertible into a number of fully paid and nonassessable
2
shares of our common stock equal to the quotient of the liquidation preference
amount per share ($10,000) divided by the conversion price, which initially is
$1.15 per share, subject to certain adjustments, or approximately 8,696 shares
of common for each share of converted preferred stock. In connection with the
financing, our management agreed not to sell any of our securities owned by
them, their affiliates or anyone they have influence over until the registration
statement has been effective for six months.
In connection with the January 16, 2007 financing, we paid cash
compensation to a placement consultant in the amount of $165,600 and issued him
placement consultant warrants, exercisable for a period of three years from the
date of issue. The placement consultant's warrants allow him to purchase up to
(i) 20 shares of Series B Preferred Stock, and each of the following warrants,
which are identical to the warrants issued to the investors of the financing:
(i) Series A Warrant, (ii) Series B Warrant, (iii) Series C Warrant, (iv) Series
D Warrant, (v) Series J Warrant, (vi) Series E Warrant, and (vii) Series F
Warrant, each to purchase 90,004 shares of common stock, except for the Series J
Warrants, which shall entitle the Consultant to purchase 180,008 shares of
common stock.
In connection with the January 2007 financing, we filed, as agreed to
in the corresponding Registration Rights Agreement, a registration statement
with the Securities and Exchange Commission to register for resale the shares of
our common stock into which the shares of our Series B Preferred Stock may be
converted and the shares of common stock issuable upon the exercise of the
warrants issued in such financing (Registration No. 333-140571). We are required
to keep that registration statement continuously effective under the Securities
Act for the Effectiveness Period which continues until such date as is the
earlier of the date when all of the securities covered by that registration
statement have been sold or the date on which such securities may be sold
without any restriction pursuant to Rule 144. If that registration statement
ceases to be effective prior to the expiration of the Effectiveness Period, we
will be required to pay liquidated damages equal to 2.0% of the amount invested
for each calendar month or portion thereof thereafter such date until the
registration statement is declared effective. Pursuant to the January 2007
financing, in no event shall the amount of liquidated damages payable at any
time and from time to time exceed an aggregate of 20% of the amount of the
initial investment in the Series B Preferred Stock. As of the date of this
filing, our initial registration statement for the January 2007 financing was
declared effective on February 28, 2007.
The net proceeds from the financing are to be used for capital
expenditures necessary to expand our operations into clam farming in Morocco
(any remaining proceeds may be used for working capital and general corporate
purposes). We are currently conducting due diligence on a North African based
aquaculture company that farms shellfish products in Morocco and pending the
successful completion of such inquiry, may acquire a majority ownership interest
in the company. At the date of this filing, we have not entered into any binding
agreements for the purchase of such company and may or may not do so depending
on the results of our due diligence investigation.
SERIES A PREFERRED STOCK AND WARRANT FINANCINGS
On April 12, 2006 we completed a private equity financing of $1,062,000
with 2 accredited investors. Net proceeds from the offering, were approximately
$952,040. We issued 1,888,000 shares of our Series A Preferred Stock, par value
$0.001 per share and stated value of $0.75 per share, at a purchase price of
$0.5625 per share and each investor also received one of each of the following
warrants: (i) Series A Warrant, (ii) Series B Warrant, (iii) Series C Warrant,
3
(iv) Series D Warrant, (v) Series J Warrant, (vi) Series E Warrant, (vii) Series
F Warrant, (viii) Series G Warrant, and (ix) Series H Warrant, each to purchase
a number of shares of Common Stock equal to 50% of the number of shares of
Series A Preferred Stock purchased, except for the Series J Warrants, which
entitled the investor to purchase a number of shares of our common stock equal
to 100% of the number of shares of Series A Preferred Stock purchased. As of the
date of this filing, all of these Series J Warrants issued in the April 12, 2006
financing have been exercised. We issued a total of 9,440,000 Warrants. Each of
the Warrants has a term of five (5) years, except for the Series J Warrants,
which have a term of one (1) year. Each share of the Series A Preferred Stock is
convertible into one fully paid and nonassessable share of our common stock.
In connection with the April 12, 2006 financing, our management agreed
not to sell any of our securities owned by them, their affiliates or anyone they
have influence over until this registration statement has been effective for six
months. World Wide Mortgage, to whom we borrowed the amount of CDN $1,500,000,
also entered into a lock up agreement to sell no more than 100,000 shares of our
common stock per quarter until the registration statement has been effective for
six months.
In connection with the April 12, 2006 financing, we paid cash
compensation to a placement consultant in the amount of $84,960 and issued him
188,800 warrants. Each of the placement consultant's warrants allows him to
purchase one share of our Series A Preferred Stock, and one half of each of the
Series A-H Warrants and one Series J warrant. Each of the placement consultant's
warrants to purchase the securities described above is exercisable at a price of
$0.5625 per warrant, for a period of three years.
On May 30, 2006 we completed another round of private equity financing
of $1,500,000 pursuant to a Series A Convertible Preferred Stock Purchase
Agreement dated May 30, 2006. The net proceeds from this financing were
approximately $1,380,000. We issued 2,000,000 shares of our Series A Preferred
Stock, stated value of $0.75 per share, at a purchase price of $0.75 per share
and the investor also received one of each of the following warrants: (i) Series
A Warrant, (ii) Series B Warrant, (iii) Series C Warrant, and (iv) Series D
Warrant, each to purchase a number of shares of Common Stock equal to 50% of the
number of shares of Series A Preferred Stock purchased; we issued a total of
4,000,000 Warrants. Each of the Warrants has a term of five (5) years and is
identical to the Series A-D Warrants we issued to investors pursuant to the
financing we closed on April 12, 2006.
In connection with the May 30, 2006 financing, we paid cash
compensation to a placement consultant in the amount of $120,000 and issued him
200,000 warrants. Each of the placement consultant's warrants allows him to
purchase one share of our Series A Preferred Stock, and one-half of each of the
Series A-D Warrants. Each of the placement consultant's warrants to purchase the
securities described above is exercisable at a price of $1.50 per warrant, for a
period of three years.
On June 30, 2006 and July 11, 2006 we completed two final rounds of
private equity financing accepting subscriptions in the aggregate amount of
$2,840,000 from 9 institutional and accredited investors pursuant to the May 30,
2006 Series A Convertible Preferred Stock Purchase. On June 30, 2006 and July
11, 2006, we entered into separate Joinder Agreements to each of the Series A
4
Convertible Preferred Stock Purchase Agreement and the Registration Rights
Agreement, each dated as of May 30, 2006, with each of the new investors which
added such investors as additional parties to the May 30, 2006 financing
documents. Net cash proceeds from these two rounds were approximately
$2,659,000. Pursuant to these two final financings, we issued a total of
3,786,666 shares of our Series A Preferred Stock, stated value of $0.75 per
share at a purchase price of $0.75 per share and each investor also received one
of each of the following warrants: (i) Series A Warrant, (ii) Series B Warrant,
(iii) Series C Warrant, and (iv) Series D Warrant, each to purchase a number of
shares of Common Stock equal to 50% of the number of shares of Series A
Preferred Shares purchased (subject to the rounding of factional shares); we
issued a total of 7,573,344 Warrants in these two rounds of financing. Each of
the Warrants has a term of five (5) years and is identical to the Series A-D
Warrants we issued to investors pursuant to the financings we closed on April
12, 2006 and May 30, 2006. Each share of our Series A Preferred Stock is
convertible into one fully paid and nonassessable share of our common stock.
In connection with the June 30, 2006 and July 11, 2006 financings, we
paid a total placement consultant fee of $217,000. The placement consultant
received $160,000 of his fee in securities (as described below) and $57,000 in
cash. As a result, we issued the placement consultant 213,333 shares of our
Series A Preferred Stock, and one of each of the A-D Warrants, each to purchase
106,667 shares of our Common Stock. The A-D Warrants issued to the placement
consultant are identical to the Series A-D Warrants we issued to the investors
as described above.
Pursuant to the April, May, June and July 2006 financings, we received
aggregate net proceeds of approximately $4,991,040 and we issued an aggregate of
7,887,999 shares of our Series A Preferred Stock and Warrants to purchase an
aggregate of 21,440,020 shares of our common stock.
For further information regarding the preferred stock and warrants see
"Description of Securities - Series A Preferred Stock," "Description of
Securities - Series B Preferred Stock" and "Description of Securities
- -Warrants."
Also in connection with the issuance of the shares of our Series A
Preferred Stock and Warrants issued in the April, May, June and July 2006
financings described above, we agreed to file this registration statement with
the Securities and Exchange Commission to register for resale the shares of our
common stock into which the shares of our Series A Preferred Stock may be
converted and the shares of common stock issuable upon the exercise of the
warrants. We are required to keep this registration statement continuously
effective under the Securities Act for the Effectiveness Period which continues
until such date as is the earlier of the date when all of the securities covered
by this registration statement have been sold or the date on which such
securities may be sold without any restriction pursuant to Rule 144. If the
registration statement ceases to be effective prior to the expiration of the
Effectiveness Period, we will be required to pay liquidated damages equal to
1.0% of the amount invested for each calendar month or portion thereof
thereafter such date until this registration statement is declared effective.
Pursuant to the April 12, 2006 financing, in no event shall the amount of
liquidated damages payable at any time and from time to time exceed an aggregate
of 24% of the amount of the initial investment in the Series A Preferred Stock.
Pursuant to the May 30, 2006, June 30, 2006 and July 11, 2006 financings, in no
event shall the amount of liquidated damages payable at any time and from time
to time exceed an aggregate of 10% of the amount of initial investment in the
5
Series A Preferred Stock pursuant to such rounds of financing.
RISK FACTORS
You should carefully consider the risks described below before making an
investment in EDGEWATER. All of these risks may impair our business operations.
If any of the following risks actually occurs our business, financial condition
or results of operations could be materially adversely affected. In such case,
the trading price of our common stock could decline, and you may lose all or
part of your investment.
RISKS RELATING TO AQUACULTURE
We are subject to a number of biological and environmental risks.
Our business would be adversely affected if our scallop crop is infected by
Perkinsus Quagwadi. Perkinsus affects a variety of scallops. In 1992, mortality
due to Perkinsus infection was large and mortality was high, but Island Scallops
was able to overcome this disease by breeding the remaining stock. Eight years
of successfully breeding hardy individuals resulted in the remaining populations
of scallops being Perkinsus-free. Although there is a chance that other diseases
may occur, the Island Scallops hybrid scallop has proven resistant to Perkinsus
disease for the last ten years.
Paralytic Shellfish Poisoning (PSP or Red Tide) could limit the amount of
scallops available for sale.
Paralytic Shellfish Poisoning (PSP or red tide) is another concern when farming
scallops. The adductor muscle can be processed for sale to the traditional
scallop meat market even when there is a PSP closure. On the other hand, the
live animal market is stopped by PSP toxicity. Sewage Contamination (fecal
coliform) is also monitored by the Canadian Food Inspection Agency (CFIA) to
avoid this problem. These types of contaminants do not threaten the crop, it
only causes a temporary displacement to the marketing of the product. Island
Scallops' aquaculture is not without total risk; however, the development
program over the last decade has reduced the risk of disease and increased the
historical grow-out survival rate to 95% over the past six years. Despite these
advances, however, an outbreak of PSP, even if it did not affect Island
Scallops' stock, could have a depressive effect on the shellfish market in
general, which could then adversely affect our business.
Aquaculture and scallop farming is subject to a variety of general disease
risks.
Bacteria are almost always associated with mortalities in the larval stages of
growth. Control of disease outbreaks in the hatchery consists of regular
inspection, growth rates, color and larvae is checked for proper shape. Proper
hygiene practices within the hatchery minimize problems with Bacteria. In
general, scallops are harder to handle and transport and care needs to be taken
when moving them. Scallops can develop a stress related disease that can be
6
avoided by proper handling conditions such as temperature, moisture rates and
time before getting back in the water (maximum time being 24 hours).
Boring sponges and worms can adversely impact our scallop yield.
Boring sponges and worms are organisms that make holes in the scallop's shell,
weakening it and requiring the scallop to make repairs. Secreting additional
layers of shell material to mend these holes directs energy away from growth and
maintenance of the scallop. In cases of severe infestation, the adductor muscle
may be reduced in weight by up to 50%, and the meat may be discolored.
Our business would be adversely affected if our scallop crop is infected by
flatworm.
Flatworms can be devastating, destroying all seed within 2 weeks. Island
Scallops has managed to minimize this problem and keep mortalities down by
keeping the seeds in the pond a little longer so it becomes larger, making the
time spent in the first net culture less. We then move the seeds to a larger
mesh net culture, which causes the flatworms to fall off and no longer pose a
problem. This husbandry technique alleviates the problem to a large degree.
Scallops raised in the open ocean are subject to a variety of predators that
could adversely impact crop yield.
Starfish are a major predator of scallops, particularly in bottom culture. If
the hanging techniques are far enough from the bottom, even during extreme low
tides, then this does is not problematic. Since starfish and crabs have a
free-swimming larval stage as part of their life cycle, it is possible that
these larvae can settle within the "grow-out" nets and settle there and prey on
these scallops. However, with proper husbandry techniques these effects can be
minimized.
Our business would be adversely affected if a majority of our scallop crop
experiences fouling.
Fouling is caused by settlement and growth of several organisms such as
macroalgae, bryozoans, barnacles and mussels on the nets. Heavy fouling of
culture nets and scallops impedes growth of the scallops. Since most fouling
occurs in shallower waters, hanging scallops at deeper depths can reduce
fouling. If culture systems are managed properly, fouling is not a problem.
Aquaculture can be subject to a variety of growing conditions that can adversely
affect product growth and development.
Certain growing conditions and sea conditions can affect the quality and
quantity of scallops produced, decreasing the supply of our products and
negatively impacting profitability. Extreme wave actions tend to make scallops
seasick. In cases of extreme seasickness, scallops stop feeding and growth is
reduced. This may create mortality by weakening the scallops and making them
susceptible to other problems and diseases. Currently, the water leases owned by
Island Scallops are located in areas where this will prove to be less
problematic. Additionally, if other environmental conditions are unfavorable,
growing conditions in the ocean can greatly inhibit scallop growth. Generally
this risk is mitigated by year-to-year variations in growing conditions.
However, we cannot guarantee that we will not be negatively affected, at least
in the short term, if we experience poor growing conditions.
7
Increased mortality rates would adversely impact our business.
In general, increased mortality rates in juveniles are due to improper feeding
and hatchery husbandry. Once scallops are introduced to the ocean, increased
mortality rates are caused by the above factors as well as fluctuations in
salinity and currents. Given the location of Island Scallops' current farming
areas, the salinity and currents should not be problematic. Mortality rates can
also increase due to overcrowding problems. In cases of extreme overcrowding
scallops actually bite each other and their shells become damaged.
If we are unable to expand our tenures, our projected production may be delayed.
To increase our production capacity, we must expand our tenures. However,
expanding tenures requires government approval, which can be a timely and costly
process. Two of our tenures, Hindoo Creek and Deep Bay, have been approved for
expansion. Our Denman tenure must be re-zoned before expansion thereof will be
approved and our Bowser bottom lease Management Plan must be reconfigured before
expansion of that area is approved. Although we are confident that such approval
will be granted after issues raised by local residents and fisherman, such as
the use of surface floats for our longlines have been addressed, there is no
guarantee that it will be granted. In the future, we will seek expansion of our
other tenures, which also may not be granted. If we do not receive expansion
approval for our Denman tenure and Bowser bottom lease, it will delay our
proposed expansion.
BUSINESS RISKS
We will require additional capital to fund our current business plan.
Our success is dependent on future financings. The aquaculture or marine farming
industry is a capital-intensive business, which requires substantial capital
expenditures to develop and acquire farms and to improve or expand current
production. Further, the farming of marine life and acquisition of additional
farms may require substantial amounts of working capital. We project the need
for significant capital spending and increased working capital requirements over
the next several years. There can be no assurance that we will be able to secure
such financing on terms, which are acceptable, if at all. The failure to secure
future financing with favorable terms could have a material adverse effect on
our business and operations.
We are dependent on certain key existing and future personnel.
Our success will depend, to a large degree, upon the efforts and abilities of
our officers and key management employees such as Mr. Saunders, Mr. Bruce Evans
and Ms. Patti Greenham. The loss of the services of one or more of these or
other key employees could have a material adverse effect on our operations. We
currently maintain key man life insurance on Mr. Saunders for a value of
$1,000,000. We also have an employment agreement with Mr. Saunders. We do not
maintain key man insurance for, nor do we currently have employment agreements
with, any of our other key employees. In addition, as our business plan is
implemented, we will need to recruit and retain additional management and key
8
employees in virtually all phases of our operations. Key employees will require
a strong background in the marine aquaculture industry. We cannot assure that we
will be able to successfully attract and retain key personnel.
The fact that our directors and officers own approximately 43% of our capital
stock and 61% of our voting capital stock may decrease your influence on
shareholder decisions.
Our executive officers and directors, in the aggregate, beneficially own
approximately 43% of our capital stock and 61% of our voting capital stock. As a
result, our officers and directors, will have the ability to influence our
management and affairs and the outcome of matters submitted to shareholders for
approval, including the election and removal of directors, amendments to our
bylaws and any merger, consolidation or sale of all or substantially all of our
assets.
Our acquisitions and potential future acquisitions involve a number of risks.
Our potential future acquisitions involve risks associated with assimilating
these operations into our company; integrating, retaining and motivating key
personnel; integrating and managing geographically-dispersed operations
integrating the technology and infrastructures of disparate entities; and risks
inherent in the husbandry and farming of marine species.
We may have difficulty competing with larger and better-financed companies in
our sector.
In general, the aquaculture industry is intensely competitive and highly
fragmented. Many of our competitors have greater financial, technical, marketing
and public relations resources than we presently have. Our sales may be harmed
to the extent we are not able to compete successfully against such seafood
producers.
Contamination of our seafood would harm our business.
Because our products are designed for human consumption, our business is subject
to certain hazards and liabilities related to food products, such as
contamination. A discovery of contamination in any of our products, through
tampering or otherwise, could result in a recall of our products. Any such
recall would significantly damage our reputation for product quality, which we
believe is one of our principal competitive assets, and could seriously harm our
business and sales. Although we maintain insurance to protect against such
risks, we may not be able to maintain such insurance on acceptable terms and
such insurance may not be adequate to cover any resulting liability.
We may experience barriers to conducting business due to potential government
regulations.
There are no hatchery/producer competitors in the scallop farming business in
British Columbia. The United States will not allow the farming of the species
farmed by Island Scallops in their waters, as this species is considered an
"exotic". It is unlikely that the Canadian government would decide to regulate
this species like the United States does (as the Canadian government developed
the technology) however if it does, this would have a material adverse affect on
our business.
Our business may be adversely affected price by volatility.
9
If market prices for Island Scallops' products decrease, we will incur a loss of
profits. However, our operational costs will increase because we will have to
produce the same quantity to meet the current demand, which will decrease profit
margin. This form of price volatility would be detrimental for our business.
Foreign exchange rates risks, political stability risk, and/or the imposition of
adverse trade regulations could harm our business.
We conduct some of our business in foreign currencies. Our profitability depends
in part on revenues received in United States dollars as a result of sales into
the United States. A decline in the value of the United States dollar against
the Canadian dollar would adversely affect earnings from sales in the United
States. As part of our plans to acquire other businesses we may expand our
operations to other countries, operate those businesses in foreign currencies,
and export goods from those countries. Thus far, we have not engaged in any
financial hedging activities to offset the risk of exchange rate fluctuations.
We may in the future, on an as-needed basis, engage in limited financial hedging
activities to offset the risk of exchange rate fluctuations. There is a risk
that a shift in certain foreign exchange rates or the imposition of unforeseen
and adverse political instability and/or trade regulations could adversely
impact the costs of these items and the liquidity of our assets, and have an
adverse impact on our operating results. In addition, the imposition of
unforeseen and adverse trade regulations could have an adverse effect on our
exported seafood operations. We expect the volume of international transactions
to increase, which may increase our exposure to future exchange rate
fluctuations.
RISKS RELATING TO THE OFFERING
There may not be sufficient liquidity in the market for our securities in order
for investors to sell their securities.
There is currently only a limited public market for our common stock, which is
listed on the Over-the-Counter Bulletin Board, and there can be no assurance
that a trading market will develop further or be maintained in the future.
During the month of July 2006, our common stock traded an average of
approximately 318 shares per day. As of April 16, 2007, the closing bid price of
our common stock was $1.05 per share. As of April 16, 2007, we had approximately
55 shareholders of record of our common stock, 14 shareholders of record of our
Series A Preferred Stock and 2 shareholders of record of our Series B Preferred
Stock, not including shares held in street name. In addition, during the past
two years our common stock has had a trading range with a low price of $0.51 per
share and a high price of $1.95 per share.
The market price of our common stock may be volatile.
The market price of our common stock has been and will likely continue to be
highly volatile, as is the stock market in general, and the market for OTC
Bulletin Board quoted stocks in particular. Some of the factors that may
materially affect the market price of our common stock are beyond our control,
such as changes in financial estimates by industry and securities analysts,
conditions or trends in the industry in which we operate or sales of our common
stock. These factors may materially adversely affect the market price of our
common stock, regardless of our performance. In addition, the public stock
10
markets have experienced extreme price and trading volume volatility. This
volatility has significantly affected the market prices of securities of many
companies for reasons frequently unrelated to the operating performance of the
specific companies. These broad market fluctuations may adversely affect the
market price of our common stock.
The outstanding warrants may adversely affect us in the future and cause
dilution to existing shareholders.
There are currently 29,243,568 warrants outstanding. The terms of these warrants
expire as early as 2007 and as late as 2013. The exercise price of these
warrants range from $0.5625 to $2.75 per share, subject to adjustment in certain
circumstances. Exercise of the warrants may cause dilution in the interests of
other shareholders as a result of the additional common stock that would be
issued upon exercise. In addition, sales of the shares of our common stock
issuable upon exercise of the warrants could have a depressive effect on the
price of our stock, particularly if there is not a coinciding increase in demand
by purchasers of our common stock. Further, the terms on which we may obtain
additional financing during the period any of the warrants remain outstanding
may be adversely affected by the existence of these warrants as well.
The SEC has adopted regulations which generally define a "penny stock" to be an
equity security that has a market price of less than $5.00 per share or an
exercise price of less than $5.00 per share, subject to specific exemptions. The
market price of our common stock is less than $5.00 per share and, therefore, it
may be designated as a "penny stock" according to SEC rules. This designation
requires any broker or dealer selling these securities to disclose certain
information concerning the transaction, obtain a written agreement from the
purchaser and determine that the purchaser is reasonably suitable to purchase
the securities. These rules may restrict the ability of brokers or dealers to
sell our common stock and may affect the ability of investors to sell their
shares.
CAUTIONARY STATEMENT REGARDING
FORWARD-LOOKING INFORMATION
From time to time, we may make written statements that are
"forward-looking," including statements contained in this prospectus and other
filings with the Securities and Exchange Commission, reports to our stockholders
and news releases. All statements that express expectations, estimates,
forecasts or projections are forward-looking statements. In addition, other
written or oral statements which constitute forward-looking statements may be
made by us or on our behalf. Words such as "expects," "anticipates," "intends,"
"plans," "believes," "seeks," "estimates," "projects," "forecasts," "may,"
"should," variations of such words and similar expressions are intended to
identify such forward-looking statements. These statements are not guarantees of
future performance and involve risks, uncertainties and assumptions which are
difficult to predict. Therefore, actual outcomes and results may differ
materially from what is expressed or forecasted in or suggested by such
forward-looking statements. We undertake no obligation to update publicly any
forward-looking statements, whether as a result of new information, future
events or otherwise. Important factors on which such statements are based are
assumptions concerning uncertainties, including but not limited to uncertainties
associated with the following:
11
(a) volatility or decline of our stock price;
(b) potential fluctuation in quarterly results;
(c) our failure to earn revenues or profits;
(d) inadequate capital and barriers to raising the additional capital
or to obtaining the financing needed to implement its business
plans;
(e) inadequate capital to continue business;
(f) changes in demand for our products and services;
(g) rapid and significant changes in markets;
(h) litigation with or legal claims and allegations by outside parties;
or
(i) insufficient revenues to cover operating costs.
There is no assurance that we will be profitable, we may not be able to
successfully develop, manage or market our products and services, we may not be
able to attract or retain qualified executives and technology personnel, our
products and services may become obsolete, government regulation may hinder our
business, additional dilution in outstanding stock ownership may be incurred due
to the issuance of more shares, warrants and stock options, or the exercise of
warrants and stock options, and other risks inherent in the our businesses.
We undertake no obligation to publicly revise these forward-looking
statements to reflect events or circumstances that arise after the date hereof.
Readers should carefully review the factors described in other documents we file
from time to time with the Securities and Exchange Commission, including the
Quarterly Reports on Form 10-QSB and Annual Report on Form 10-KSB and any
Current Reports on Form 8-K filed by us. All forward-looking statements
attributable to us are expressly qualified in their entirety by the cautionary
statement above.
USE OF PROCEEDS
We have registered these shares because of registration rights granted to the
investors in our recent private equity financing and the other selling
shareholders. We will not receive any proceeds upon the conversion of the
preferred shares into shares of our common stock, however, we received net
proceeds of approximately $4,990,000 from the initial sale of the preferred
shares and we could receive up to approximately $34,350,000, net of fees and
expenses, from the exercise of the warrants when and if exercised.
The net proceeds from the sale of the Series A Preferred Stock and any proceeds
received form the exercise of the warrants have been and will be used as set
forth in the table below.
The following table represents estimates only. The actual amounts may vary from
these estimates.
12
Use of Funds Funds Received from Sale Funds Received from
- ----------- of Preferred Shares Sale of Preferred
---------------- Shares and Exercise
of the Warrants
---------------
Working Capital $3,540,000 $34,350,000
Repayment of Bridge Loan $1,450,000 -
Total $4,990,000 $34,350,000
- ---------------
SELLING SHAREHOLDERS
The following table sets forth certain information concerning the
resale of the shares of common stock by the selling shareholders (the "Selling
Shareholders"). None of the Selling Shareholders nor any of their affiliates has
held any position or office with, been employed by or otherwise has had any
material relationship with us or our affiliates during the three years prior to
the date of this prospectus. Unless otherwise indicated below, none of the
Selling Shareholders are broker-dealers or affiliates of a broker-dealer within
the meaning of Section 3 of the Securities Exchange Act.
The Selling Shareholders may offer all or some portion of the shares of
the common stock or the shares of common stock issuable upon conversion of the
Series A Preferred Stock and/or exercise of the warrants. Accordingly, no
estimate can be given as to the amount or percentage of our common stock that
will be held by the Selling Shareholders upon termination of sales pursuant to
this prospectus. In addition, the Selling Shareholder identified below may have
sold, transferred or disposed of all or a portion of their shares since the date
on which they provided the information regarding their holdings in transactions
exempt from the registration requirements of the Securities Act. The amount of
shares owned and offered hereby by the Selling Shareholders are calculated
assuming a conversion ratio of one share of common stock for each share of
Series A Preferred Stock, which conversion price is subject to adjustment under
certain circumstances and a number of fully paid and nonassessable shares of our
common stock equal to the quotient of the liquidation preference amount per
share ($10,000) divided by the conversion price, which initially is $1.15 per
share, subject to certain adjustments, or approximately 8,696 shares of common
for each share of converted Series B Preferred Stock. See "Description of
Securities." Individual beneficial ownership of the Selling Shareholders also
includes shares of common stock that a person has the right to acquire within 60
days from April 16, 2007. See "Description of Securities -Warrants."
As of April 16, 2007, there were 23,285,291 shares of our common stock
outstanding, 8,010,333 shares of our Series A Preferred Stock outstanding and
207 shares of our Series B Preferred Stock outstanding, which are treated on as
13
converted basis for the purposes of computing the percentage of outstanding
securities owned by the Selling Shareholders. Unless otherwise indicated, the
Selling Shareholders have the sole power to direct the voting and investment
over the shares owned by them. We will not receive any proceeds from the resale
of the common stock by the Selling Shareholders. We estimate that our costs and
expenses of registering the shares listed herein for resale will be
approximately $10,000.
Unless otherwise indicated, all of the Selling Shareholders received
their shares pursuant to the April, May, June or July 2006 financings, which are
described above in Recent Developments, Series A Preferred Stock and Warrant
Financings.
OWNERSHIP OF COMMON STOCK BY SELLING SHAREHOLDERS
-------------------------------------------------
NAME OF SELLING NUMBER OF SHARES NUMBER OF NUMBER OF PERCENTAGE OF
STOCKHOLDER PRIORTO THE OFFERING SHARESOFFERED SHARES TO BE THE OWNERSHIP
HEREBY OWNED AFTER AFTER THE
THE OFFERING OFFERING
(1)(2)(3)
-------------------------------------------------------------------------------------------------------------------
Vision Opportunity 28,392,553(4) 20,913,853 (4) 7,478,700 (2) (4) 24.27% (3)
Master Fund, Ltd.
Michael Ross 732,635(5) 732,635 (5) 0 (2) *
IRA FBO, Michael P. 200,003 (16) 200,003 (16) 0 (2) *
Ross, Pershing LLC as
Custodian
Nite Capital, LP 1,005,958 (6) 1,005,958 (6) 0 (2) *
IRA FBO, Richard M. 402,384 (7) 402,384 (7) 0 (2) *
Ross, Pershing LLC as
Custodian
Irene S. Ross 2005 GS 402,384 (8) 402,384 (8) 0 (2) *
Trust
Lenore Rabin-Koster 201,195 (9) 201,195 (9) 0 (2) *
Jack Halpern 804,484 (10) 804,484 (10) 0 (2) *
Judith S. Brauner 201,124 (11) 201,124 (11) 0 (2) *
Union Bancaire Privee 5,544,139 (12) 4,022,407 (12) 1,521,732(2) (12) 4.94%
Bridge Financing Group 800,000 400,000 (13) 400,000 1.39%
(doing business as
"World Wide Mortgage
Corporation")
Aurelius Consulting 90,000 90,000 (14) 0 (2) *
Group, Inc.
Gallatin Consulting, 100,000 100,000 (15) 0 (2) *
Inc.
Gary Shemano 12,500 12,500 (17) 0 (2) *
Christian Galatti 12,500 12,500 (17) 0 (2) *
Lauren Stock 4,020 (18) 4,020 (18) 0 (2) *
Ijaz Malik 200,768 (19) 200,768 (19) 0 (2) *
Providence Consulting, 1,670,107 (20) 1,670,107 (20) 0 (2) *
LLC
Niel Kleinman 1,276,920 (21) 1,276,920 (21) 0 (2) *
14
Pai's International 893,945 (22) 0 893,945 (22) 2.90%
Trade, Inc.
Shu Ching and Chi Pai 320,004 (23) 320,004 (23) 0
* Less than 1% ownership of our common stock following the offering.
1) All Percentages have been rounded up to the nearest one hundredth of
one percent.
2) Since we do not have the ability to control how many, if any, of their
shares each of the selling shareholders listed above will sell, we have
assumed that the selling shareholders will sell all of the shares
offered herein for purposes of determining how many shares they will
own after the Offering and their percentage of ownership following the
offering.
3) The number of shares offered by this prospectus will vary from time to
time based upon several factors including the amount of Series A
Preferred Stock the holder intends to convert and the amount of
warrants that may be exercised. See "Prospectus Summary - Recent
Developments - Financing." Based upon the terms of the both the Series
A Preferred Stock and the warrants, holders may not convert the Series
A Preferred Stock and/or exercise the warrants, if on any date, such
holder would be deemed the beneficial owner of more than 9.99% of the
then outstanding shares of our common stock. Additionally, the shares
of Preferred Stock are subject to certain anti-dilution provisions,
which would be triggered if we were to sell securities at a price below
the price at which we sold the Series A Preferred Stock.
4) The person having voting, dispositive or investment powers over Vision
Opportunity Master Fund, Ltd, is Adam Benowitz, Authorized Agent. This
amount includes 1,800,000 shares of common stock pursuant to the
exercise of some of the Warrants they received in the April 2006
financing, 5,133,333 shares of common stock issuable upon conversion of
Vision's Series A Convertible Preferred Stock, 13,866,668 shares of
common stock issuable upon exercise of Vision's Warrants Vision
received in the April, May, June and July 2006 financings, 22,107
shares of common stock Vision received as dividends on June 30, 2006,
and 91,745 shares of common stock Vision received as dividends on
December 31, 2006. Although not being offered hereby, this number
includes 1,495,740 shares of common stock issuable conversion of
Vision's Series B Convertible Preferred Stock and 5,982,960 shares of
common stock issuable upon exercise of Vision's Warrants that it
received in the January 16, 2007 financing, all of which are registered
in our Registration Statement on Form SB-2 File No. 333-140571.
5) This amount includes 88,000 shares of common stock pursuant to the
exercise of some of the Warrants he received in the April 2006
financing, 141,333 shares of common stock issuable upon conversion of
his Series A Convertible Preferred Stock, 485,668 shares of common
stock issuable upon exercise of his Warrants received in the April,
May, June and July 2006 financings and 753 shares of common stock he
received as dividends on June 30, 2006. This amount also includes an
additional 13,333 shares of common stock issuable upon conversion of
13,333 shares of Series A Convertible Preferred Stock, 26,664 shares of
common stock issuable upon exercise of 26,664 Warrants Mr. Ross
received from Chi Pai, and 3,885 shares of common stock Mr. Ross
received as dividends on December 31, 2006.
6) The person having voting, dispositive or investment powers over Nite
Capital is Keith Goodman, Authorized Agent. This amount includes
333,333 shares of common stock issuable upon conversion of Nite's
Series A Convertible Preferred Stock, 666,668 shares of common stock
issuable upon exercise of the warrants Nite received in the April, May,
June and July 2006 financings, and 5,957 shares of common stock Nite
received as dividends on December 31, 2006.
7) This amount includes 133,333 shares of common stock issuable upon
conversion of his Series A Convertible Preferred Stock, 266,668 shares
of common stock issuable upon exercise of the warrants he received in
the April, May, June and July 2006 financings, and 2,383 shares of
common stock he received as dividends on December 31, 2006.
8) This amount includes 133,333 shares of common stock issuable upon
conversion of her Series A Convertible Preferred Stock, 266,668 shares
of common stock issuable upon exercise of the Warrants she received in
the April, May, June and July 2006 financings, and 2,383 shares of
common stock she received as dividends on December 31, 2006.
9) This amount includes 66,667 shares of common stock issuable upon
conversion of her Series A Convertible Preferred Stock, 133,336 shares
of common stock issuable upon exercise of the warrants she received in
15
the April, May, June and July 2006 financings, and 1,192 shares of
common stock she received as dividends on December 31, 2006.
10) This amount includes 266,667 shares of common stock issuable upon
conversion of his Series A Convertible Preferred Stock, 533,336 shares
of common stock issuable upon exercise of the warrants he received in
the April, May, June and July 2006 financings, and 4,481 shares of
common stock he received as dividends on December 31, 2006.
11) This amount includes 66,667 shares of common stock issuable upon
conversion of her Series A Convertible Preferred Stock, 133,336 shares
of common stock issuable upon exercise of the warrants she received in
the April, May, June and July 2006 financings, and 1,121 shares of
common stock she received as dividends on December 31, 2006.
12) The persons having voting, dispositive or investment powers over Union
Bancaire Privee are Olivier Constantin and Franco Rossi, Authorized
Agents. This amount includes 1,333,333 shares of common stock issuable
upon conversion of Union's Series A Convertible Preferred Stock,
2,666,668 shares of common stock issuable upon exercise of the warrants
it received in the April, May, June and July 2006 financings, and
22,406 shares of common stock it received as dividends on December 31,
2006. Although not being offered hereby, this number includes 304,347
shares of common stock issuable conversion of Union's Series B
Convertible Preferred Stock and 1,217,385 shares of common stock
issuable upon exercise of Union's Warrants that it received in the
January 16, 2007 financing, all of which are registered in our
Registration Statement on Form SB-2 File No. 333-140571.
13) The person having voting, dispositive or investment powers over The
Bridge Financing Group is Randy Howarth, Authorized Agent. The Bridge
Financing Group received shares of our common stock as consideration
for agreeing to extend the due date to April 15, 2006 for us to repay
our CDN $1,500,000 loan pursuant to the bridge loan agreement dated
November 9, 2004 and amended on April 15, 2005 between us and the
Bridge Financing Group.
14) The person having voting, dispositive or investment powers over
Aurelius Consulting Group, Inc. is David Gentry, Authorized Agent. In
October 2005, we engaged Aurelius Consulting to provide marketing and
investor relations services for an initial term of one year. Aurelius
is entitled to receive 25,000 shares of our restricted common stock per
quarter during the term of its agreement, in consideration for their
services.
15) The person having voting, dispositive or investment powers over
Gallatin Consulting, Inc. is Thomas Bostic Smith, Authorized Agent. In
June 2005, we engaged Gallatin Consulting, Inc. to provide investor
relations services for an initial term of one year. Gallatin is
entitled to receive 100,000 of our restricted common stock in
consideration for their services, although the shares shall vest
quarterly on a 25,000 shares per quarter basis.
16) This amount includes 66,667 shares of common stock issuable upon
conversion of his Series A Convertible Preferred Stock and 133,335
shares of common stock issuable upon exercise of his Warrants received
in the April, May, June and July 2006 financings.
17) At October 21, 2005 and November 11, 2005, our board approved the
issuance of a total of 25,000 shares of our common stock to The Shemano
Group, LLC for preparing a research report for the Company. Mr. Shemano
and Mr. Gallati are the President and CEO of The Shemano Group, which
is a registered Broker-Dealer; however, as indicated herein, the shares
were issued in the ordinary course of business and at the time of
issuance, neither shareholder had any agreements or understandings,
directly or indirectly, with any party to distribute the shares.
18) This amount includes 1,333 shares of common stock issuable upon
conversion of her Series A Convertible Preferred Stock, 2,664 shares of
common stock issuable upon exercise of her Warrants received from Chi
Pai, and 23 shares of common stock she received as dividends on
December 31, 2006.
19) This amount includes 66,666 shares of common stock, 133,332 shares of
common stock issuable upon exercise of his Warrants received from Chi
Pai, and 770 shares of common stock he received as dividends on
December 31, 2006.
20) The person having voting, dispositive or investment powers over
Providence Consulting, LLC is Chi Pai, Authorized Agent. This amount
includes 64,666 shares of common stock; 130,001 shares of common stock
issuable upon conversion of their Series A Convertible Preferred Stock;
130,676 shares of common stock issuable upon exercise of their Warrants
received from Chi Pai; 258,664 shares of common stock issuable upon
exercise of the April 2006 financing Warrants that Providence received
as a result of exercising some of their placement consultant warrants
received from Chi Pai; 1,085,002 shares of common stock issuable upon
exercise of their placement consultant warrants received from Chi Pai;
and 1,098 shares of common stock Providence received as dividends on
December 31, 2006.
21) This amount includes 70,800 shares of common stock; 137,466 shares of
common stock issuable upon conversion of his Series A Convertible
Preferred Stock, 133,332 shares of common stock issuable upon exercise
of his Warrant received from Chi Pai; 283,200 shares of common stock
issuable upon exercise of the April 2006 financing Warrants that he
received as a result of exercising some of the placement consultant
warrants he received from Chi Pai; 651,001 shares of common stock
issuable upon exercise of the placement consultant warrants he received
from Chi Pai; and 1,121 shares of common stock he received as dividends
on December 31, 2006.
22) The person having voting, dispositive or investment powers over Pai's
International Trade, Inc. is Sam Pai, Authorized Agent. Although not
being offered hereby, this number includes 173,913 shares of common
stock issuable upon conversion of Mr. Pai's Series B Convertible
Preferred Stock and 720,032 shares of common stock issuable upon
exercise of Mr. Pai's Warrants, all of which are only issuable upon
exercise of the placement consultant warrant that Mr. Pai received in
the January 16, 2007 financing. All of Mr. Pai's foregoing securities
are registered in our Registration Statement on Form SB-2 File No.
333-140571.
23) This amount includes 53,334 shares of common stock; 53,334 shares of
common stock issuable upon conversion of their Series A Convertible
Preferred Stock; and, 213,336 shares of common stock issuable upon
exercise of the April 2006 financing Warrants that Shu Ching and Chi
Pai received from Providence Consulting, Inc.
PLAN OF DISTRIBUTION
We are registering the shares of common stock on behalf of the Selling
Shareholders. The selling security holders and any of their pledgees, donees,
assignees and successors-in-interest may, from time to time, sell any or all of
their shares of common stock being offered under this prospectus on any stock
exchange, market or trading facility on which shares of our common stock are
traded or in private transactions. These sales may be at fixed or negotiated
prices. The selling security holders may use any one or more of the following
methods when disposing of shares:
o ordinary brokerage transactions and transactions in which the
broker-dealer solicits purchasers;
o block trades in which the broker-dealer will attempt to sell the
shares as agent but may position and resell a portion of the block as
principal to facilitate the transaction;
o purchases by a broker-dealer as principal and resales by the
broker-dealer for its account;
o an exchange distribution in accordance with the rules of the
applicable exchange; o privately negotiated transactions;
o to cover short sales made after the date that the registration
statement of which this prospectus is a part is declared effective by
the Commission;
o broker-dealers may agree with the selling security holders to sell a
specified number of such shares at a stipulated price per share;
o a combination of any of these methods of sale; and
o any other method permitted pursuant to applicable law.
The shares may also be sold under Rule 144 under the Securities Act of
1933, as amended if available, rather than under this prospectus. The selling
17
security holders have the sole and absolute discretion not to accept any
purchase offer or make any sale of shares if they deem the purchase price to be
unsatisfactory at any particular time.
The selling security holders may pledge their shares to their brokers
under the margin provisions of customer agreements. If a selling security holder
defaults on a margin loan, the broker may, from time to time, offer and sell the
pledged shares.
Broker-dealers engaged by the selling security holders may arrange for
other broker-dealers to participate in sales. Broker-dealers may receive
commissions or discounts from the selling security holders (or, if any
broker-dealer acts as agent for the purchaser of shares, from the purchaser) in
amounts to be negotiated, which commissions as to a particular broker or dealer
may be in excess of customary commissions to the extent permitted by applicable
law.
If sales of shares offered under this prospectus are made to
broker-dealers as principals, we would be required to file a post-effective
amendment to the registration statement of which this prospectus is a part. In
the post-effective amendment, we would be required to disclose the names of any
participating broker-dealers and the compensation arrangements relating to such
sales.
The selling security holders and any broker-dealers or agents that are
involved in selling the shares offered under this prospectus may be deemed to be
"underwriters" within the meaning of the Securities Act in connection with these
sales. Commissions received by these broker-dealers or agents and any profit on
the resale of the shares purchased by them may be deemed to be underwriting
commissions or discounts under the Securities Act. Any broker-dealers or agents
that are deemed to be underwriters may not sell shares offered under this
prospectus unless and until we set forth the names of the underwriters and the
material details of their underwriting arrangements in a supplement to this
prospectus or, if required, in a replacement prospectus included in a
post-effective amendment to the registration statement of which this prospectus
is a part.
The selling security holders and any other persons participating in the
sale or distribution of the shares offered under this prospectus will be subject
to applicable provisions of the Exchange Act, and the rules and regulations
under that act, including Regulation M. These provisions may restrict activities
of, and limit the timing of purchases and sales of any of the shares by, the
selling security holders or any other person. Furthermore, under Regulation M,
persons engaged in a distribution of securities are prohibited from
simultaneously engaging in market making and other activities with respect to
those securities for a specified period of time prior to the commencement of
such distributions, subject to specified exceptions or exemptions. All of these
limitations may affect the marketability of the shares.
If any of the shares of common stock offered for sale pursuant to this
prospectus are transferred other than pursuant to a sale under this prospectus,
then subsequent holders could not use this prospectus until a post-effective
amendment or prospectus supplement is filed, naming such holders. We offer no
assurance as to whether any of the selling security holders will sell all or any
portion of the shares offered under this prospectus.
We have agreed to pay all fees and expenses we incur incident to the
registration of the shares being offered under this prospectus. However, each
selling security holder and purchaser is responsible for paying any discounts,
commissions and similar selling expenses they incur.
18
We and the selling security holders have agreed to indemnify one
another against certain losses, damages and liabilities arising in connection
with this prospectus, including liabilities under the Securities Act.
BUSINESS
OVERVIEW
We were incorporated under the laws of the State of Nevada on June 12,
2000, with the name Heritage Management Corporation. In August 2005, we entered
into a share exchange agreement with Edgewater Foods International, Inc., the
parent company of Island Scallops Ltd. an aquaculture company located in
Vancouver Island, British Columbia. As a result of the Share Exchange, Edgewater
became our wholly owned subsidiary and Edgewater's shareholders became the
owners of the majority of our voting stock. Pursuant to the terms of the Share
Exchange Agreement, Edgewater's officers and directors have been appointed as
our officers and Directors. Additionally, we changed our name from Heritage
Management, Inc. to Edgewater Foods International, Inc.
Our wholly owned subsidiary, Edgewater Foods International Inc., a
Nevada Corporation, is the parent company of Island Scallops Ltd., a Vancouver
Island aquaculture company. Island Scallops was established in 1989 and for over
15 years has successfully operated a scallop farming and marine hatchery
business. Island Scallops is dedicated to the farming, processing and marketing
of high quality, high value marine species: scallops and sablefish. Scallop
farming is relatively new to North America and Island Scallops is the only
producer of both live-farmed Pacific scallops and live sablefish (or blackcod).
Given Island Scallops' unique hatchery technology and extensive research and
development, we believe that there is currently no significant competition for
these marine species. Island Scallops is committed to rapidly expanding
production and profits while continuing to finance the aggressive growth of the
company and maintaining a healthy respect for the marine environment.
Edgewater acquired Island Scallops in June 2005 through a tax free
share exchange. Island Scallops was established in 1989 to commercialize
Canadian government research on scallop aquaculture. Island Scallops' hatchery
operations have diversified to produce other species of shellfish such as
mussels, clams, geoducks and oysters. Island Scallops has also investigated the
culture of halibut, spot prawn, sea urchin and abalone. Island Scallops is the
first hatchery to successfully produce sablefish juveniles for commercial
grow-out.
Currently, Island Scallops' primary product is farmed pacific scallops
for sale in the west coast of North America. Island Scallops offers a variety of
other products and services to the industry including aquaculture equipment,
consulting, research and development, and custom processing and marketing.
Internationally, Island Scallops has collaborated with both Japanese and
Moroccan fisheries interests.
General Fisheries Market Overview
The worldwide market for farmed marine species continues to grow.
According to a personal communication from the National Marine Fisheries
Service, Fisheries Statistics Division, Silver Spring, MD, in British Columbia
alone, farming production increased from US$44.56 million in 1988 to US$190.24
million in 1998. Although significant growth occurred in salmon farming and
19
little or no growth occurred in shellfish (oyster) farming, recent problems
within the salmon industry are causing some salmon farming interests to turn
towards shellfish. Island Scallops can only benefit from this recent trend
towards shellfish, as training farmers in correct husbandry would only add
another revenue stream.
The majority of the world's current scallop production comes from three
species of scallops: the Japanese scallop, the sea scallop and the king scallop.
The Chinese scallop is also selling well, but FDA inspections of China
facilities found that the conditions and hygiene were issues as hatcheries were
highly polluted. There has also been a fishery boom on the east coast of Canada
and the United States with the Digby or sea scallop.
In the United States, consumption of scallops exceeded 64 million
pounds in 2002. Various communications between Island Scallops personnel and the
National Marine Fisheries Service, Fisheries Statistics Division, Silver Spring,
MD and analysis of data from the Fisheries Statistics & Economics Division of
the National Marine Fisheries Service (NMFS) website for annual landings of
commercial fisheries (http://www.st.nmfs.noaa.gov/st1/commercial/index.html),
tell us that this represented a per capita consumption of 0.22 pounds, with a
dollar value of US$342 million. After shrimp, scallops represent one of the most
popular shellfish products in the United States. In general, per capita
consumption of seafood in the United States has remained steady over the last
six years ranging from 15.2 to 16.2 pounds per annum. Based upon Robert
Saunders', our chairman and president, communications with the National Marine
Fisheries Service, Fisheries Statistics Division of Silver Spring, MD, and
personal observations, given consumers' growing preoccupation with healthier
foods and the increasing availability of seafood (due to the recent successes in
aqua farming and improved distribution channels), we expect per capita
consumption to continue to increase.
Shifts in North American shellfish market trends from shucked to live
in shell products can be seen in the oyster markets. Within the last 5 years, we
have seen a significant trend away from shucked oyster meat to live in the shell
product in the Pacific Northwest due to the demand for fresh high quality
products. We believe that once a live in the shell product is readily available
within the scallop market, a shift from frozen scallop meat to fresh in shell
product will also occur.
KEY CORPORATE OBJECTIVES
Our key business development objectives over the next 30 months are to
expand scallop and sablefish production using both existing and new
infrastructure at our facilities in Qualicum Beach, Canada, that we anticipate
will enable us to reach annual sales of approximately US$19.2 million and
earnings of approximately US$8.6 million by the end of 2009 on scallop sales
alone. This significant expansion will be accomplished by implementing the
following five initiatives:
o Capitalize on the high demand for sablefish in foreign markets by
entering into the blackcod market in the next 2 to 3 years.
o Expand current distribution by establishing new strategic
relationships with 10-15 American fisheries importers in Seattle,
Portland, San Francisco, San Jose, and Los Angeles in 2007.
20
o We expect to begin harvesting the 2006 year-class scallops during the
spring of 2008; however, we could begin harvesting portions of the
class sooner if mortality rates (at various points of the growth
cycle) are significantly lower than our current projection or if
growth rates are substantially higher. We anticipate that at least 5
to 10 million scallops could reach full maturity and thus be
harvested.
o We anticipate that in 2007, we will plant 100 million scallop seed and
rapidly increase farm production with a projected minimum 2007 scallop
class of at least 30-50 million, which we expect to begin to harvest
in early 2009.
o We expect to produce more than 200 million scallop seeds in 2008, with
a projected 2008 scallop class of at least 100 million scallops at
various sizes.
MARKETING AND DISTRIBUTION
Our marketing and distribution strategy for Island Scallops is focused
on developing and maintaining long-term relationships with distribution channel
members. Island Scallops also strives to differentiate its products to achieve
consistent supply and quality. Island Scallops believes the scallop market
effectively functions as a commodity market and therefore, relationships with
distributors are important. To develop these relationships, Island Scallops has
identified key purchasing criteria for the distributors: price, quality and
consistent farmed supply. In the short term, Island Scallops intends to adopt a
pricing policy equal to the market wholesale prices. In other words, we do not
intend to set any promotional or premium prices for either the whole or shucked
product, but instead intend to sell our products at the market rate. This would
mean Island Scallops' products would compete on other factors, such as supply
and consistent quality.
Over the long term, for the reasons noted below, Island Scallops wants
to differentiate its products so that it can command premium prices. Freshness
is an important factor for scallops since whole scallops only have a shelf life
of approximately 7 days while shucked scallops remain fresh for up to 20 days.
Due to this short shelf life, distributors try to offer the freshest products.
Island Scallops believes it is in a favorable position to supply fresh products
to United States brokers/distributors, especially those located on the west
coast where demand for the product is strong. Currently, these
brokers/distributors are supplied for the most part with east coast North
American scallops, which have several transportation-related delivery delays
that decrease freshness.
Supply is another key factor where Island Scallops has a distinct
advantage. Based on our planned increase in scallop production, we believe that
Island Scallops will have a large quantity of scallops for sale. Therefore, a
distributor would not have to deal with numerous suppliers, which costs
additional time and money. This makes Island Scallops an attractive source for
scallops, since we believe that we will be able to satisfy the demand of
distributors, which will save them time and money.
21
Island Scallops has also developed a unique live holding system for use
with our distribution model. This system allows Island Scallops to deliver live
product directly to seafood suppliers and individual restaurants.
PRODUCTS
Current Products
Island Scallops currently focuses exclusively on aquaculture products
and is not involved in wild fisheries. All seafood products are produced in
private hatcheries and grown on ocean farm sites. Currently, the Pacific Scallop
is the only product that Island Scallops produces, grows, processes and markets.
Island Scallops has, however, produced a variety of other shellfish species
including the Pacific oyster, European flat oyster, Manila clam, eastern blue
mussel, Mediterranean mussel, rock scallop, geoduck clam and sea urchin, which
in the past we have sold to third party shellfish farmers. Additionally, our
hatchery has produced and is capable of producing a variety of shellfish seed
(for grow-out and sale by our companies) including mussel, oysters and geoduck
as well as scallop seed.
Island Scallops has been a leader in marine hatchery technology for the
past 17 years. Island Scallops has developed proprietary hatchery techniques for
a number of marine species, most notably the hybridizing of the Pacific Scallop
and becoming the first company to produce commercial quantities of sablefish
juveniles. Both of these breakthroughs have required many years of research and
considerable investment. In the case of sablefish, which is a cold-water fish
that spawns at depths of 800 - 2400 ft, a variety of techniques were required to
successfully mature, spawn, incubate and rear the larvae. In addition, there
were technical difficulties associated with egg and yolk sac incubation (as well
as larvae rearing and weaning) that were resolved using proprietary technology
developed at Island Scallops. Island Scallops was only able to reach its goal of
commercially farming sablefish with over 8 years of dedicated research and
capital investment of approximately US$2.4 million. We intend to begin
significant further commercialization of sablefish in the next two to three
years, provided we are able to finance the expansion of this product which we
estimate will require at least $5.0 million of capital.
SCALLOP OVERVIEW
Island Scallops' main product is the "Pacific Scallop", which is a
hybrid of the imported Japanese scallop and the local weathervane scallop.
Between 1993 and 1999, Island Scallops developed this new scallop using Japanese
scallops that were imported under quarantine in the early 1990's. This unique
scallop is marketed as the Pacific scallop and is the largest scallop in the
world, reaching sizes of 15 cm and 500 grams. The scallop species farmed by
Island Scallops, has a proven record of being disease resistant, with a 95%
survival rate during the grow-out phase. We have the necessary farming
infrastructure to significantly increase our scallop production to a minimum of
15 million scallops annually beginning with the 2006 scallop class, which will
begin its harvest during the spring of 2008, and up to 25 million scallops
annually by the fall of 2007. Given the high worldwide demand for scallops,
Island Scallops is poised to rapidly expand production and significantly
increase revenues and earnings.
The Pacific Scallop is sold live in four sizes: medium, large, extra
large and jumbo. Pricing ranges from a low of US$3.95 per pound to $4.20 per
22
pound for the larger sized scallops; these prices represent an average increase
of approximately $0.55 per pound since last year. Previously, Island Scallops
also produced shucked meats with or without roe. However, due to the large
demand and high value for live scallops, meat product was discontinued and the
focus switched to the sale of live scallops.
The basis for our anticipated scallop farming production increase stems
from a combination of our tenure expansion, our recent financing, improved
grow-out techniques and our transition to a combination of "lantern-style"
netting and ear-hanging methods. Scallops culture utilizes two styles of small
cages referred to as "pearl nets and lantern nets." Pearl nets are shaped like a
pyramid with a 35 by 35 cm square base and grow small scallops from 2-3 mm to
10mm. The 10-mm scallops are grown in cylindrical nets called lantern nets and
are 60 cm in diameter and 1.2 meters deep containing 12 layers. Once the
scallops reach 5cm they can be grown out in lantern nets. Our Hindoo Creek and
Deep Bay tenures have been approved for expansion and once expansion of our
Denman tenure is approved, which we believe will occur by our next fiscal year,
we will be able to increase capacity to approximately 15,000,000 animals.
Thereafter, we intend to further expand our Bowser tenure in 2007, which would
supply us with the capacity to produce additional 30-50 million animals at
harvest.
As the only hatchery/producer of cultured scallops on the west coast of
North America, Island Scallops has the ability to supply fresh scallops (of a
predictable quality and quantity) throughout the year. Although the supply of
scallops has fluctuated in the past, consumer demand has always absorbed the
available supply. A primary factor for increased consumption is the increasing
health consciousness among consumers. Scallops are low in saturated fats and
cholesterol and high in protein. All parts of the scallop body are edible;
however, different parts tend to be consumed in different regions of the world.
In North America, the adductor muscle is traditionally the only part eaten, with
the rest of the body discarded. In Europe, Australia and Tasmania, the adductor
muscle is usually marketed and eaten with the gonad attached. Japan utilizes the
whole animal, where most of the product is cooked in the shell prior to sale.
Marketed scallops generally take the following product forms:
o Whole-live (shelf life of seven days);
o Whole dried;
o Eviscerated whole;
o Shucked fresh (shelf life of about 15-20 days);
o Shucked frozen (shelf life of about a year); and
o Value added forms (smoked, breaded, canned).
The shucked product form is the most significant form for North
American markets. A whole-live product form is the most desirable from the
aquaculturist's point of view, as processing costs are minimal. Island Scallops
has developed a market for whole live scallops, which exceeds 5,000 lbs. per
week into Vancouver. Our initial expansion plan envisions four major cities on
the west coast (Seattle, Portland, San Francisco and Los Angeles) to consume
2,500 lbs. per week per city based on the successful Vancouver model.
Island Scallops currently distributes through specialty wholesalers
with particular expertise in selling to restaurants and has developed a market
for whole live scallops that exceeds 5,000 lbs. per week into Vancouver.
Vancouver wholesalers include but are not limited to Albion Fisheries, Tri-Star
23
Seafood Supply, Pacific Rim Shellfish, Sea World Fisheries and Teamway
Fisheries. As we expand our distribution, we will continue to focus on specialty
wholesalers with strong ties to major restaurants.
The most predominant scallop production in North America comes from the
offshore fishery located on the Georgia Band on the east coast. Large American
and Canadian fishing companies dominate the fishery. The majority of their
product is shucked aboard ship then supplied to primarily frozen to seafood
processors onshore. The processors then distribute the product to various
restaurants, retail outlets and seafood brokers.
Sablefish (Blackcod) Overview
Sablefish (Anoplopoma fimbria), often called blackcod although not a
member of the cod family, is an elongate fish with two dorsal fins and an anal
fin similar to and opposite the second dorsal fin. Adults are black or greenish
gray; usually with slightly paler blotches or chainlike pattern on the upper
back. At 30-61 cm in size they are often greenish with faint stripes on the
back.
Sablefish inhabit shelf and slope waters in depths of greater than
1,500 meters, from Baja California to the Aleutian Islands and the Bering Sea.
The larger populations of sablefish are centered in northern British Columbia
and the Gulf of Alaska. Adults favor mud bottoms and feed on benthic
invertebrates, squid and numerous fish species. In turn, they are prey for
halibut, lingcod, hagfishes and marine mammals such as sea lions. In addition,
killer whales have been known to take sablefish from long line gear as it is
being retrieved.
Sablefish spawn from January to March along the continental shelf at
depths of 250 to 750 meters. Fecundity ranges from 60,000-200,000 eggs up to one
million eggs for a 102-cm fish. Larval sablefish are found in surface waters
over the shelf and slope in April and May. Juveniles are highly migratory with
significant movement from nursery areas in northern B.C. to the Gulf of Alaska
and the Bering Sea. Sablefish move to deeper waters as they mature. Growth is
rapid with sizes at maturity reaching 52-61 cm for five-year-old males and 58-71
cm for five-to-seven year old females. Sablefish growth appears to be rapid for
the first three-to-five years and slow asymptotically thereafter. Annual natural
mortality of adults has been estimated to be about 10 percent.
Island Scallops plans to raise sablefish onshore using shallow ponds or
above ground tanks. This system has been successful in Texas for the culture of
catfish. Tests have shown that sablefish prove to be very hardy when grown in
ponds and have the added advantage of causing sablefish to be parasite free.
Wild sablefish carry a parasite that does not allow the fish to be eaten raw.
With adequate funding, Island Scallops has already demonstrated the feasibility
of onshore sablefish farming and plans to develop a new blackcod facility that
could produce at least 500,000 sablefish as early as 2007, with production
planned to increase by at least 500,000 annually by 2008 and beyond.
Over the past eight years, Island Scallops has also developed
proprietary hatchery technology for the production of sablefish juveniles. We
believe that sablefish will be the next species, after salmon, for successful
large-scale commercial farming. Sablefish, which is a premium-quality whitefish
with a delicate texture and moderate flavor, is an ideal substitute for Chilean
sea bass (currently over-fished in all oceans). To date, Island Scallops has
24
marketed a limited number of live sablefish into the Vancouver market. Initial
response was excellent for a small 1-kilogram live sablefish (~$11/kg). To
capitalize on Island Scallops' breakthrough sablefish hatchery technology, in
the next two to three years, we plan to construct a new sablefish hatchery
consisting of the following:
o An expanded Brood Stock facility with larger capacity to hold the
various families of selected strains of sablefish. This new facility
will incorporate a new state-of-the-art water treatment system.
o An improved incubation and larval rearing facility incorporating
proprietary improvements in tank design and seawater systems.
o An upgraded zooplankton culture facility with improved handling and
enrichment techniques.
o An expanded and improved juvenile rearing facility incorporating
proprietary recirculation system designs.
As part of this expansion, we also intend to construct a new onshore
tank farm consisting of large and small ponds and tanks complete with associated
recirculation systems. This onshore facility will be used to augment the
juvenile rearing area and will house and grow juvenile fish.
At the present time, worldwide "non-farming" sablefish catches are
struggling to meet the worldwide demand according to DFOWeb, NPFMCWeb and
Pacific Fishery Management Council Website. Currently, there are only two
hatchery facilities: Island Scallops Ltd. and Sablefish Hatcheries Inc. that
have produced sablefish juveniles. Current production is only approximately
100,000 juveniles per year. Based on our analysis of present market conditions,
increasing worldwide hatchery production tenfold (to roughly 1 million 3 kilo
sablefish) would fill less than 10% of the current world demand shortfall. If
Island Scallops' new sablefish facilities are able to reach a production of 3
million sablefish annually, this will only fill less than 30% of the current
overall shortfall. The economic potential for sablefish is therefore
considerable. Given these market conditions and opportunities, Island Scallops
is determined to enter the market for sablefish in a significant manner with the
next two to three years.
Other Products
In the past Island Scallops has sold a variety of shellfish larvae and
seed to both international and local customers. Sales included two species of
mussels, manila clams, geoduck clams, oysters, abalone and sea urchins. Island
Scallops has established suppliers of aquaculture equipment in Japan and China
and supplies nets, ropes, floats, and processing equipment into the British
Columbia industry. Currently, Island Scallops is focused almost exclusively on
expansion of scallop sales and development of its sablefish operation with a
goal of further commercialization of sablefish in two to three years.
DESCRIPTION OF PROPERTY
For the fiscal year ended August 31, 2006, our U.S. corporate office
25
was located at 400 Professional Drive, Suite 310, Gaithersburg, Maryland 20878.
This space was provided on a rent free basis by one of our shareholders.
Island Scallops' main office and hatcheries are located on the east
side of Vancouver Island in the town of Qualicum Bay at 5552 West Island
Highway, Qualicum Beach, British Columbia, Canada V9K 2C8. The shellfish
hatchery and processing facilities are housed in a 930 square meter building. A
600 square meter sablefish hatchery is also located at this site. Corporate
scallop farms are situated along the east and west coasts of Vancouver Island.
These facilities represent the largest private marine research hatchery and the
first fully integrated shellfish producer in Canada.
Island Scallops has a total of seven farm sites (including two joint
ventures) for scallops. Five of these farm sites are located at Island Scallops
held tenures (shellfish tenures are government-granted rights that allow use of
offshore waters to cultivate shellfish). Three of these scallop farms are
located in Baynes Sound, 25 minutes north of the main facility. These farms
sites total approximately 200 acres and can currently accommodate more than 8
million scallops. Approximately 30% of the farm area is currently being farmed.
As part of our expansion plans, we are currently adding additional main lines
and plan to increase our capacity at these tenures to more than 24 million
scallops in the near future. An additional bottom tenure of 926 acres is located
10 minutes north of the main facility (at Bowser) and is capable of producing at
least 30 million scallops annually. The final farm site on the west coast of
Vancouver Island near Tofino is capable of producing at least three million
scallops, although that site is currently under-developed. Baynes Sound, the
marine waterway situated between eastern Vancouver Island and the western shore
of Denman Island, is considered the most productive and highly utilized
shellfish growing area in coastal British Columbia. The area supports extensive
beach culture (manila clams and oysters) as well as deepwater culture that
produces oysters, scallops and some mussels.
- ---------------------------- -------------------------- -------------------------- --------------------------
Common Site Name Lands File No. ACRES Type
- ---------------------------- -------------------------- -------------------------- --------------------------
Denman 1406063 38.64 Deepwater
- ---------------------------- -------------------------- -------------------------- --------------------------
Hindoo Creek 1406664 123.32 Deepwater
- ---------------------------- -------------------------- -------------------------- --------------------------
Deep Bay 1406711 43 Deepwater
- ---------------------------- -------------------------- -------------------------- --------------------------
Tofino 1406061 9.6 Deepwater
- ---------------------------- -------------------------- -------------------------- --------------------------
Bowser 1407517 926 Bottom lease
- ---------------------------- -------------------------- -------------------------- --------------------------
The three Baynes Sound tenures (Denman, Hindoo Creek and Deep Bay) and
the Tofino tenure offer unique features, which will add additional value to
these properties. These include the split of tenures between east and west
shores of Baynes Sound as well as the east and west coast of Vancouver Island,
allowing continual accessibility to shellfish despite managed closures (harvest
restrictions) due to incidental water quality or Paralytic Shellfish Poisoning
(PSP or red tide). The seasonal closures caused by short-term bacteriological
contamination related to rainfall and upland bacterial sources, are limited to
the western shore of the Baynes Sound and thus to only two of the three tenures
retained by Island Scallops. The result of having operating tenures on both
sides of the Baynes Sound ensures that product can be continually harvested
despite closures that may occur within this management area. The expanded
tenures should easily accommodate our increasing scallop harvest in 2009 and
beyond. At their current size and with the introduction of sufficient main
26
lines, our tenures have the capacity to accommodate approximately 13-15 million
scallops without any increase in their footprints.
Expansion of our Deep Bay and Hindoo Creek farms has been approved and
such approval does not need to be renewed for twenty years. An amended tenure
agreement has been signed with the government of BC to expand the Denman Island
site. The biggest hurdle to completing the Denman expansion process is the
re-zoning application, which must be approved before we can use the expanded
tenure. At the Bowser tenure, we are waiting for approval to convert the method
of farming from bottom to off-bottom culture in one-third of the tenure area.
Once approved, this will allow us to accommodate about 25 million scallops.
Island Scallops' location is a distinct advantage for producing marine
species. The waters off British Columbia are pristine and unspoiled by large
populations or major industries. The close proximity to major western cities
allows us to effectively put our products into the hands of the consumer within
24 hours.
The source of our raw material comes from our own hatchery brood stock.
In the case of the Pacific Scallop, we have been selectively breeding this
species for superior growth and survival for the past 15 years. The breeding
program has produced a vigorous, rapid growing, disease resistant scallop with
exceptional meat yield. In the case of sablefish we have been selecting fast
growing fish for the past 5 years, these display a high degree of domestication.
The spawning season has been extended for both of these species allowing for
juvenile production almost year round. This ability to hold seed stock and
select superior strains gives Island Scallops an advantage in the industry. It
also allows Island Scallops to tailor its production to varying seasonal and
market demands.
COMPETITION
Fisheries Industry in General
Island Scallops is in the farmed seafood business. The main
concentration of marine farming in British Columbia has traditionally been in
the salmon sector. The salmon farming business has developed into a mature
industry dominated by Norwegian farmers. The rest of the British Columbia marine
farming sector is in the shellfish industry, mainly in oysters and Manila clams
and more recently mussels. This sector is rapidly expanding and it accounted for
approximately US$16 million in British Columbia in 2002, according to the
British Columbia Shellfish Growers Association website. Given Island Scallops'
expertise and significant research and development experience, we believe that
there is little or no direct competition in the production of farmed scallops or
farmed sablefish.
Scallops
There are no significant direct competitors in the scallop farming
business in British Columbia. The United States will not allow farming this
species in their waters, as this species is considered "exotic". Although
scallop farming is a very significant industry in Japan and China, only frozen
shucked scallops are currently sold into North America from these countries.
Recent examination by the United States and Canadian Food Inspection authorities
of the growing waters in China resulted in reduced exporting due to high levels
of pollution.
27
Island Scallops is the only hatchery, outside of China, that has
successfully produced the Japanese scallop, and the only company that has
successfully, hybridized the weathervane and the Japanese scallop. Island
Scallops is uniquely positioned as the sole producer of live Pacific Scallops in
North America. There currently are no other hatcheries in North America that we
are aware of that are capable of producing this unique breed. Although a large
commercial scallop fishery exists on the east coast of North America, the
majority of the scallops are shucked at sea with only limited quantities sold
live. These scallops are sold as "Digby" or "Sea" scallops. A number of
companies have attempted to grow the bay scallop and the sea scallop on the east
coast, but these companies have only achieved limited success.
The primary British Columbia participants in scallop farming are Island
Scallops joint venture farmers or independent scallop farmers, which receive
their supply of seed scallops solely from Island Scallops. These farmers tend to
be chronically underfinanced and production from these growers usually totals
less than 1,000,000 scallops per year. Island Scallops is uniquely positioned to
rapidly expand these farms (up to six farms) under an exclusive farming and
marketing contract. Three joint venture farmers are currently farming scallops
and receive free scallop seed, technology and support for a 12% royalty on the
harvest and exclusive marketing of their product through Island Scallops.
Due to its large size and small count per pound, the sea scallop is the
prime competitor in the United States market. The fishery for this scallop is
located primarily on the North American east coast, in particular Georges Bank
off New England and the Maritime provinces. This is a limited opportunity
fishery, with actual fishing time being dictated by sea and other environmental
conditions.
Sablefish
Island Scallops is currently only one of two hatcheries to produce
quantities of juvenile sablefish. These fish were sold to five commercial salmon
farming facilities and the fish have been marketed successfully. Little demand
for a new species has materialized. Although hatcheries have been constructed in
British Columbia, neither has successfully produced large quantities of
sablefish. The farming of sablefish is still in its infancy and only limited
production has occurred.
This limited production is not a matter of biological barriers but
rather a lack of interest by the major producers to venture into a new marine
species. Alaska sablefish fishermen have expressed interest in farming sablefish
and the Sablefish Association of Alaska has voted unanimously to start farming
sablefish in southern Alaska. Island Scallops has been in discussion with this
association and has been told that due to "anti-aquaculture" policy in Alaska,
it is very unlikely that any farming will occur in the near future.
Washington State contains two parties interested in sablefish farming.
The first is the Makah Tribe and the second is a private company, which is
trying to obtain farming permits in Port Angeles. These parties have made
inquiries to Island Scallops for juvenile sablefish. However, to date, no orders
have been placed.
28
RESEARCH AND DEVELOPMENT
Due to changes in Canadian Federal Government's Research and
Development tax credits (SRED) program, which prevents any part of the research
to be combined with commercial production, no Research and Development claims
were made in fiscal 2004 and 2005. Research did continue on the genetic
selection of superior strains of scallops, as did developments in the culture
process for both marine algae and developments in re-circulation systems. In the
near future Island Scallops plans to conduct research and development under a
separate company called RKS Laboratories Ltd., which has no commercial
production and whose primary goal is the genetic improvement in breeds of the
Pacific Scallops and other marine species. We believe that this will allow the
continued support from the SRED program.
EMPLOYEES
At April 16, 2007, we have 26 full-time employees and 2 temporary
employees. We anticipate hiring between 10 and 15 temporary workers during the
upcoming spring and summer growing seasons.
None of our current employees is represented by a labor union and we
consider our relationships with our employees to be good.
REGULATORY ENVIRONMENT
Effect of Government Regulation
There are a limited number of regulations that restrict the fishing,
distributing or purchase of scallops in Canada and the United States. Therefore,
the country of origin makes little difference for the pricing or demand of
scallops.
A limitation to market supply is paralytic shellfish poisoning (PSP) or
"red tide". PSP is a toxin generated by plankton (scallops' food) at particular
times of the year. The toxin is passed to the scallop when plankton is digested,
but the toxin does not harm the shellfish. However, the shellfish containing the
toxin can be harmful to humans who consume it. Although only a limited number of
human deaths caused by red-tide poisoning have been reported, the public
announcement of red tide has a devastating effect on most shellfish sales. The
exception is scallop meat, because the adductor muscle of the scallop does not
concentrate the toxin; shucked scallops are safe to eat at any time of the year.
Nevertheless, public perception could still influence demand over short periods
of time. To monitor for PSP, the federal Fisheries Inspection Branch constantly
monitors samples of shellfish production and wild shellfish populations.
Tenure Expansion and Compliance with Environmental Laws
Our planned tenure expansions will require that we undergo an
environmental screening from Transports Canada pursuant to Canadian
Environmental Assessment Act, which includes a review of factors such as the
29
environmental effects of the planned expansions, including the environmental
effects of malfunctions or accidents that may occur in connection with the
planned expansions and any cumulative environmental effects that are likely to
result from such planned expansions; the significance of such environmental
effects and any comments from the public that are received in accordance with
the CEA Act and applicable regulations; and measures that are technically and
economically feasible and that would mitigate any significant adverse
environmental effects of the planned expansions.
Our Deep Bay and Hindo Creek tenures have received final CEA Act
approval, which lasts for twenty years and which allows us to expand these 2
tenures. We still need CEA Act approval and re-zoning approval for our Denman
tenure and approval of our Management Plan, along with a satisfactory
environmental assesment of our Bowser bottom lease. Please see our risk factor,
If we are unable to expand our tenures, our projected production may be delayed.
MANAGEMENT
DIRECTORS AND EXECUTIVE OFFICERS
The following table and text set forth the names and ages of all
directors and executive officers as of April 16, 2007. The Board of Directors is
comprised of only one class. All of the directors will serve until the next
annual meeting of shareholders and until their successors are elected and
qualified, or until their earlier death, retirement, resignation or removal. To
date we have not had an annual meeting. Dr. Kristina Miller, our Chief
Scientific Advisor is the wife of Robert Saunders, our Chairman, CEO and
President; otherwise, there are no family relationships among our directors and
executive officers. Also provided herein are brief descriptions of the business
experience of each director, executive officer and advisor during the past five
years and an indication of directorships held by each director in other
companies subject to the reporting requirements under the Federal securities
laws.
NAME AGE POSITION
- ---- --- --------
Robert Saunders 53 Chairman, CEO and President
Douglas C. MacLellan 51 Vice Chairman
Mark H. Elenowitz 36 Director
Robert L. Rooks 51 Director
Ian Fraser 45 Director
Michael Boswell 37 Director, Acting Chief Accounting Officer
Darryl Horton 57 Director
Victor Bolton 52 Director
ROBERT SAUNDERS, CHAIRMAN, CEO AND PRESIDENT. Mr. Saunders has directed all
research and development efforts at Island Scallops since its establishment.
After studying for his B.Sc. at the University of British Columbia in the early
1970's, Mr. Saunders has worked exclusively in the aquaculture research and
development field. His efforts have primarily involved designing and
implementing innovative culture technology and methods for new aquaculture
species in British Columbia. Mr. Saunders has direct experience with managing
30
projects similar to the type proposed, such as developing the hatchery
technology for producing the Japanese scallop and the development of sablefish
aquaculture.
DOUGLAS C. MACLELLAN, VICE-CHAIRMAN. Since May 1992, Mr. MacLellan has been
President and Chief Executive Officer of the MacLellan Group, Inc., a privately
held business incubator and financial advisory firm. Mr. MacLellan is currently
a member of the board of directors and chairman of the audit committee of AMDL,
Inc. (AMEX: ADL), a publicly held biotechnology firm. From 2002 until September
2005, Mr. MacLellan was Vice Chairman and a Director of AXM Pharma, Inc. (AMEX;
AXJ). From March 1998 through October 2000, Mr. MacLellan was the co-founder and
a significant shareholder of Wireless Electronique, Ltd., a China-based
telecommunications company having joint venture operations with China Unicom
(NASDAQ: CHU) in Yunnan, Inner Mongolia and Ningxia provinces. He is also a
co-founder and, since May 1997, has been a director of Datalex Corporation, a
Canadian-based legacy software solution provider. From November 1996 to March
1998, Mr. MacLellan was co-Chairman and an Investment Committee member of the
Strategic East European Fund. From November 1995 to March 1998, Mr. MacLellan
was President, Chief Executive Officer and a Director of PortaCom Wireless,
Inc., a company engaged as a developer and operator of cellular and wireless
telecommunications ventures in selected developing world markets. Mr. MacLellan
is a former member of the board of directors and co-founder of FirstCom
Corporation (NASDAQ: FCLX), an international telecommunications company that
operates a competitive access fiber and satellite network in Latin America,
which became AT&T Latin America (NASDAQ: ATTL) in August 2000. During 1996, he
was also the Vice-Chairman of Asia American Telecommunications (now Metromedia
China Corporation), a majority-owned subsidiary of Metromedia International
Group, Inc. (AMEX: MMG). Mr. MacLellan was educated at the University of
Southern California in economics and finance, with advanced training in
classical economic theory.
MARK H. ELENOWITZ, DIRECTOR. Mr. Elenowitz is a co-founder and managing director
of the TriPoint family of companies. He is responsible for the overall corporate
development of the firm and assisting Tripoint's clients with high-level
financial services and general business development. From December 2002 to
September 2005, Mr. Elenowitz was a board member of AXM Pharma formerly (AMEX:
AXJ). From September 2001 to March 2002, Mr. Elenowitz was a Director and
President of Image World Media, Inc., an international media company
specializing in the production and distribution of various media content for
worldwide distribution across multiple media platforms, such as traditional
television, film and the Internet. From February 1998 to October 2001, Mr.
Elenowitz was Co-Chairman and Managing Director of GroupNow!, Inc., a financial
consulting firm. In this role he was responsible for the company's overall
corporate development and corporate finance. Mr. Elenowitz integrates a strong,
successful entrepreneurial background with extensive financial services and
capital markets experience. He is also the senior managing director of Investor
Communications Company, LLC (ICC), a national investor relations firm he founded
in 1996. Through ICC, Mr. Elenowitz has developed ongoing relationships with
other investment banking firms, market makers, and analysts. Mr. Elenowitz has
worked with over 30 publicly traded companies providing financial consulting and
strategic planning services. Previously, Mr. Elenowitz held Series 7 and 63
licenses as a broker, and held a Series 24 license (Branch Manager) at regional
brokerage firm and also served as Vice President of Sales at NYSE member firm.
Mr. Elenowitz is the recipient of several entrepreneurial awards. He is a
graduate of the University of Maryland School of Business and Management, with a
Bachelor of Science in Finance.
31
DR. ROBERT L. ROOKS, DIRECTOR. Dr. Robert L. Rooks has been Chief of Staff of
All Care Animal Referral Center (ACARC) in Fountain Valley, California, since
1990. ACARC is the largest strictly referral veterinary center in the United
States. Dr. Rooks has a staff of over 20 veterinarians in the areas of surgery,
critical care, internal medicine, oncology, dentistry, radiology and neurology.
Their services include 24-hour critical care/emergency service, MRI and CT
scans, color-flow Doppler ultrasounds, hyperbaric oxygen therapy, a complete
orthopedic program including total hip replacements and joint reconstruction,
cobalt radiation therapy, a complete neuro-diagnostic service, a kidney
transplant program and a physical rehabilitation department and much more. He is
the published author of over 100 journals, magazine and newspaper articles. Dr.
Rooks is also the author of the book "Canine Orthopedics" published in 1997 by
Howell Bookhouse. Dr. Rooks completed his undergraduate studies at Iowa State
University in 1978. He graduated from the College of Veterinary Medicine at Iowa
State. Dr. Rooks received his Masters Degree as well as completed his surgical
residency at the University of Illinois in 1981. He is a Diplomat of both the
American College of Veterinary Surgeons and the American College of Veterinary
Practitioner.
IAN FRASER, DIRECTOR. Since 1997, Mr. Ian Fraser has been President of Fraser
Yacht Sales Ltd., a successful Yacht Brokerage located in Vancouver, B.C. Prior
to establishing Fraser Yacht Sales Ltd., Mr. Fraser gained experience in sales
and marketing both nationally and internationally as a yacht broker for two top
brokerage houses in Vancouver. Previously, Mr. Fraser was worked as an
advertising sales executive with Naylor communications from 1988 to 1990 and
learned valuable communication skills while working with numerous trades
including the Truck Logger's association, the I.W.A of America, and the B.C.
Construction industry. He also operated as a commercial fisherman on the West
coast working on commercial salmon fishing boats for the B.C. Packer Corporation
over a 4 year period and gained valuable knowledge of the coastline of Vancouver
Island and along the mainland from Victoria to the Queen Charlotte Islands. Mr.
Fraser also acquired sea time and commercial shipping skills while working on
the deck department of the B.C. Ferry Corporation based out of Horseshoe Bay
during his early professional career and during the summer months while
attending school in the early 1980s. Mr. Fraser also competes internationally on
ocean racing yachts and has crossed the Pacific and sailed up and down the coast
to Mexico on numerous occasions while racing and delivering racing yachts as
captain. Mr. Fraser studied Business Administration at Simon Fraser University
and Capilano College graduating with a diploma in Business Administration.
MICHAEL BOSWELL, DIRECTOR AND ACTING CHIEF ACCOUNTING OFFICER. Mr. Boswell is a
co-founder and member in TriPoint Capital Advisors, LLC, a boutique merchant
bank focused on small and mid-sized growth companies and a co founder of the
TriPoint family of companies. Mr. Boswell provides high-level financial services
to start-up businesses and small to mid-sized companies. Prior to the founding
of TriPoint, Mr. Boswell had a number of executive positions focusing on
business development and management consulting. Mr. Boswell also spent eight
years as a senior analyst and/or senior engineer for various branches of the
United States Government. He earned a MBA from John Hopkins University and a BS
degree in Mechanical Engineering from University of Maryland.
DARRYL HORTON, DIRECTOR. Mr. Horton has been a businessman successfully involved
in numerous construction and development projects for the past 35 years. He is
the President, Manager and a Partner of Abbotsford Development Corporation and
32
is currently managing a development project in Abbotsford, British Columbia
called Eagle Mountain. Eagle Mountain is an upscale, master planned community of
single family homes, town homes and commercial properties covering approximately
60 acres that is expected to be valued, upon completion, in excess of 200
million dollars. Prior to Eagle Mountain, Mr. Horton managed, owned and marketed
numerous other residential and commercial projects including the construction of
a 30 million dollar multi-function residential Intermediate Care Facility in
LaJolla California. For 15 years Mr. Horton was a partner in a general
contracting company that did various contracts with an average volume of about
25 million per year. In the 1970's, Mr. Horton was the Vice president of
Community Builders, the largest single family developer in British Columbia. Mr.
Horton is also the director of several other building and development companies
in British Columbia.
VICTOR BOLTON, DIRECTOR. Mr. Bolton founded a Mechanical contracting firm after
graduating from college and evolved that firm into all aspects of the
construction industry including building and raw land developing as well as
extensive property management. Retiring from this business in 2000, Mr. Bolton
now focuses time and energy towards the food manufacturing field.
Significant Employees
The following are employees who are not executive officers, but who are expected
to make significant contributions to our business:
BRUCE EVANS, FARM MANAGER. Mr. Bruce Evans has been involved in shellfish
production since 1985. He successfully established an oyster business, employing
methods of long-line and beach culture production. That business is still in
operation today, producing 7,000 gals of shucked oysters annually and employing
3 full time people and 4 part time people. He moved to Island Scallops in 1989.
Mr. Evans was responsible for securing the leases from the Provincial government
for this scallop grow-out project. He built the established long-line systems
that currently produce scallops for Island Scallops. Mr. Evans worked with a
Japanese scallop farmer for two years in B.C. and spent a month working on
highly acclaimed scallop farms in Japan. Mr. Evans has BS in Marine Biology from
the University of Victoria.
DR. KRISTINA M. MILLER, CHIEF SCIENTIFIC ADVISOR. Dr. Miller is currently Head
of the Molecular Genetics Section in the Pacific Region for the Department of
Fisheries and Oceans, Canada (DFO). She has been a research scientist at DFO
since obtaining her PhD in Biological Sciences from Stanford University in 1992.
The Molecular Genetics section she oversees contains a staff of 26, including
scientists, biologists, computer analysts and research technicians. Dr. Miller
conducts research on the genetic composition, adaptation, immunity and
physiology of wild and domesticated fish and shellfish species using both
molecular and genomic approaches. She has been a leader in the development of
molecular technologies to aid in the conservation and management of aquatic
resources. In the past 10 years, she has published over 40 scientific
peer-reviewed journal manuscripts, and her group has been the focus of numerous
magazine and newspaper articles. Dr. Miller brings a strong scientific component
to the management of Edgewater Foods, and she will serve as Chief Scientific
Advisor. In addition to her PhD, Dr. Miller received a BSc in Zoology from
University of California, Davis in 1983, an MSc in Biology from University of
British Columbia in 1986. Dr. Miller is Robert Saunders, our Chairman, CEO and
President's wife.
33
AUDIT COMMITTEE AND FINANCIAL EXPERT
We have an Audit Committee as specified in Section 3(a)(58)(A) of the
Securities Exchange Act of 1934, as amended, composed of Douglas MacLellan
(Chair), Robert Rooks and Ian Fraser. The Audit Committee focuses its efforts on
assisting our Board of Directors to fulfill its oversight responsibilities with
respect to our:
o Quarterly and annual consolidated financial statements and financial
information filed with the Securities and Exchange Commission;
o System of internal controls;
o Financial accounting principles and policies;
o Internal and external audit processes; and
o Regulatory compliance programs.
The committee meets periodically with management to consider the
adequacy of our internal controls and financial reporting process. It also
discusses these matters with our independent auditors and with appropriate
financial personnel that we employ. The committee reviews our financial
statements and discusses them with management and our independent auditors
before those financial statements are filed with the Securities and Exchange
Commission.
The committee has the sole authority to retain and dismiss our
independent auditors and periodically reviews their performance and independence
from management. The independent auditors have unrestricted access and report
directly to the committee.
AUDIT COMMITTEE FINANCIAL EXPERT
Douglas MacLellan is our Audit Committee Financial Expert, as that term
is defined in Item 401 of Regulation S-B and the Board has determined that Mr.
MacLellan is independent, as that term is used in Item 7(d)(3)(iv) of Schedule
14A under the Exchange Act. Mr. MacLellan's qualifications as an audit committee
financial expert are described in his biography above.
EXECUTIVE COMPENSATION
Summary Compensation Table
34
------------------------------ ------------
ANNUAL COMPENSATION Awards Payouts
- ---------------------------------------------------------------- ------------------------------ ------------
(a) (b) (c) (d) (e) (f) (g) (h) (i)
Name Other Securities LTIP All Other
and Annual Restricted Under- Payouts Compensation
Principal Compen- Stock lying ($) ($)
Position Year Salary($) Bonus($) sation Awards Options/
($) ($) SARs(#)
- ---------------- -------- ---------- -------------- ------------ --------------- -------------- ------------ ---------------------
Robert 2006 60,000 150,000 0 0 0 0 0
Saunders,
Chairman,
President
and CEO(1)
- ---------------- -------- ---------- -------------- ------------ --------------- -------------- ------------ ---------------------
Robert 2005 10,000 0 0 0 0 0 0
Saunders,
Chairman,
President
and CEO
- ---------------- -------- ---------- -------------- ------------ --------------- -------------- ------------ ---------------------
Robert 2004 0 0 0 0 0 0 0
Saunders,
Chairman,
President
and CEO
- ---------------- -------- ---------- -------------- ------------ --------------- -------------- ------------ ---------------------
Michael 2006 0 0 0 0 0 0 0
Boswell,
Acting Chief
Account
Officer (2)
- ---------------- -------- ---------- -------------- ------------ --------------- -------------- ------------ ---------------------
Michael 2005 0 0 0 0 0 0 0
Boswell,
President and
Acting Chief
Account
Officer
- ---------------- -------- ---------- -------------- ------------ --------------- -------------- ------------ ---------------------
Michael
Boswell 2004 0 0 0 0 0 0 0
- ---------------- -------- ---------- -------------- ------------ --------------- -------------- ------------ ---------------------
(1) In June 2005, we entered into an employment agreement with Mr. Robert
Saunders as our Chairman and President effective on June 29, 2005.
Subsequently in August 2005, Mr. Saunders was appointed CEO by our
35
Board of Directors. Mr. Saunders will serve at the pleasure of the
Board of Director's. For serving as President, Mr. Saunders'
compensation will be US $60,000 per annum. Additionally, we agreed to
grant Mr. Saunders a signing bonus of US $150,000 to be paid on
closing of at least US $3,500,000 in third party financing and
increase his compensation to $120,000 per annum if we receive at least
US $5,000,000 in outside funding. The Board recently approved the
Compensation Committee's recommendation to reduce Mr. Saunders'
compensation to $5,000 per month until our cash flow position
improves, at which time the Committee will reconvene and recommend to
the Board that Mr. Saunders' compensation increase back to $10,000 per
month. Although we have yet to reach a final agreement on payment
terms, we paid Mr. Saunders $50,000 towards the signing bonus in
September of 2006.
(2) Mr. Boswell served as our President from March to June 2005, at which
time Mr. Saunders replaced Mr. Boswell as President. Mr. Boswell has
served as our Acting Chief Accounting Officer since August 2005. Mr.
Boswell indirectly owns a minority interest in TriPoint Capital
Advisors, LLC, a significant shareholder and party with which we
maintain a consulting agreement. The Board recently approved the
Compensation Committee's recommendation to pay TriPoint $15,000 per
month, which includes fees for Mr. Boswell's services as our Acting
Chief Accounting during 2005, however TriPoint agreed to reduce such
fee to $7,000 per month until our cash flow position improves, at
which time the Committee will reconvene and recommend a return to
$15,000 per month. In addition, TriPoint has agreed not to accept any
additional fees, other than expenses, until we are sufficiently funded
to carry out our business and operations. Although Mr. Boswell did not
work for us in any capacity until 2005, we are required to include our
last three fiscal years in the above table. According to the above
reasons, Mr. Boswell did not receive any compensation in 2003, 2004 or
2005.
OPTION/SAR IN LAST FISCAL YEAR
The Board of Directors and holders of a majority of our outstanding
securities acting by consent have adopted the Edgewater Foods International 2005
Equity Incentive Plan. The Equity Plan is intended to further the growth and
financial success of Edgewater by providing additional incentives to directors,
executives and selected employees of and consultants to Edgewater so that such
participants may acquire or increase their proprietary interest in Edgewater.
The term "Corporation" shall include any parent corporation or subsidiary
corporation of Edgewater as those terms are defined in Section 424(e) and (f) of
the Internal Revenue Code of 1986, as amended. Stock options granted under the
Plan may be either "Incentive Stock Options", as defined in Code section 422 and
any regulations promulgated under that Section, or "Nonstatutory Options" at the
discretion of our Board of Directors and as reflected in the respective written
stock option agreements granted pursuant to this Equity Plan. Stock Appreciation
Rights, Restricted Stock, Restricted Stock Unit, Performance Awards, Dividend
Equivalents, or Other Stock-Based Awards may also be granted under the Equity
Plan. The Board believes that the Equity Plan will maintain the flexibility that
Edgewater needs to keep pace with its competitors and effectively recruit,
motivate, and retain the caliber of employees, directors and consultants
essential for achievement of our success.
Individuals eligible to receive awards under the Equity Plan include
36
officers, directors, employees of and consultants to Edgewater and its
affiliates. The number of shares available under the Equity Plan shall be
5,000,000 shares of our common stock, as well as the following: As of January 1
of each year, commencing with the year 2006 and ending with the year 2008, the
aggregate number of Shares available for granting Awards under the Equity Plan
shall automatically increase by a number of Shares equal to the lesser of (x) 5%
of the total number of Shares then outstanding or (y) 1,000,000. The Board may
distribute those shares in whatever form of award they so choose within the
Equity Plan's guidelines. There are no restrictions on the amount of any one
type of award that may be granted under the Equity Plan.
As of August 31, 2006, our Board of Directors granted 282,000 options
to employees, directors and consultants under the Equity Plan. No awards have
been given to any of the named executive officers. As of April 16, 2007, there
are 6 Directors, 2 executive officers, 10 consultants and approximately 25
employees other than executive officers, who are eligible to receive awards
under the Equity Plan.
The Board may delegate a Committee to administer the Equity Plan. The
Committee shall not consist of fewer than two members, each of whom is a member
of the Board and all of whom are disinterested persons, as contemplated by Rule
16b-3 promulgated under the Securities Exchange Act of 1934, as amended and each
of whom is an outside director for purposes of Section 162(m) of the Code,
acting in accordance with the provisions of Section 3.
Currently, we do not have any definitive plans for granting further
awards under the Equity Plan and no determination has been made as to the number
of awards to be granted, or the number or identity of recipients of awards.
AMENDING THE PLAN
The Board may amend, alter, suspend, discontinue, or terminate the
Equity Plan, including, without limitation, any amendment, alteration,
suspension, discontinuation, or termination that would impair the rights of any
Participant, or any other holder or beneficiary of any Award theretofore
granted, without the consent of any share owner, Participant, other holder or
beneficiary of an Award, or other Person. The Board may also waive any
conditions or rights under, amend any terms of, or amend, alter, suspend,
discontinue, or terminate, any Awards theretofore granted, prospectively or
retroactively, without the consent of any Participant, other holder or
beneficiary of an Award. Except as provided in the following sentence, the Board
is authorized to make adjustments in the terms and conditions of, and the
criteria included in, Awards in recognition of unusual or nonrecurring events
affecting the Company, any Affiliate, or the financial statements of the Company
or any Affiliate, or of changes in applicable laws, regulations, or accounting
principles, whenever the Board determines that such adjustments are appropriate
in order to prevent dilution or enlargement of the benefits or potential
benefits to be made available under the Equity Plan. In the case of any Award
that is intended to qualify as performance-based compensation for purposes of
Section 162(m) of the Code, the Board will not have authority to adjust the
Award in any manner that would cause the Award to fail to meet the requirements
of Section 162(m).
OPTIONS AND RIGHTS
Options and Stock Appreciation Rights may be granted under the Equity
37
Plan. The exercise price of options granted shall be determined by the Board or
the Committee; provided, however, that such exercise price per Share under any
Incentive Stock Option shall not be less than 100% (110% in the case of a
"10-percent shareholder as such term is used in Section 422(c)(5) of the Code)
of the Fair Market Value of a Share on the date of grant of such Incentive Stock
Option. The Board or Committee shall fix the term of each Option, provided that
no Incentive Stock Option shall have a term greater than 10 years (5 years in
the case of a "10-percent shareholder" as such term is used in Section 422(c)(5)
of the Code).
A Stock Appreciation Right granted under the Equity Plan shall confer
on the holder thereof a right to receive, upon exercise thereof, the excess of
(1) the Fair Market Value of one Share on the date of exercise or, if the Board
or Committee shall so determine in the case of any such right other than one
related to any Incentive Stock Option, at any time during a specified period
before or after the date of exercise over (2) the grant price of the right as
specified by the Board or Committee. Subject to the terms of the Plan, the grant
price, term, methods of exercise, methods of settlement, and any other terms and
conditions of any Stock Appreciation Right shall be as determined by the Board
or the Committee. The Board and the Committee may impose such conditions or
restrictions on the exercise of any Stock Appreciation Right as it may deem
appropriate.
FEDERAL INCOME TAX CONSEQUENCES
The current federal income tax consequences of grants under the Equity
Plan are generally described below. This description of tax consequences is not
a complete description, and is based on the Internal Revenue Code as presently
in effect, which is subject to change, and is not intended to be a complete
description of the federal income tax aspects of options and stock awards under
the Equity Plan. Accordingly, the discussion does not deal with all federal
income tax consequences that may be relevant to a particular recipient, or any
foreign, state or local tax considerations. Accordingly, potential recipients
are urged to consult their own tax advisors as to the specific federal, foreign,
state and local tax consequences to them as a result of receiving an Award under
the Equity Plan.
Nonqualified Stock Options
A recipient will not be subject to federal income tax upon the grant of
a nonqualified stock option. Upon the exercise of a nonqualified stock option,
the recipient will recognize ordinary compensation income in an amount equal to
the excess, if any, of the then fair market value of the shares acquired over
the exercise price. We will generally be able to take a deduction with respect
to this compensation income for federal income tax purposes. The recipient's tax
basis in the shares acquired will equal the exercise price plus the amount
taxable as compensation to the recipient. Upon a sale of the shares acquired
upon exercise, any gain or loss is generally long-term or short-term capital
gain or loss, depending on how long the shares are held. The required holding
period for long-term capital gain is presently more than one year. The
recipient's holding period for shares acquired upon exercise will begin on the
date of exercise.
Incentive Stock Options
A recipient who receives incentive stock options generally incurs no
federal income tax liability at the time of grant or upon exercise of the
options. However, the spread will be an item of tax preference, which may give
38
rise to alternative minimum tax liability at the time of exercise. If the
recipient/optionee does not dispose of the shares before the date that is two
years from the date of grant and one year from the date of exercise, the
difference between the exercise price and the amount realized upon disposition
of the shares will constitute long-term capital gain or loss, as the case may
be. Assuming both holding periods are satisfied, no deduction will be allowable
to us for federal income tax purposes in connection with the option. If, within
two years of the date of grant or within one year from the date of exercise, the
holder of shares acquired upon exercise of an incentive stock option disposes of
the shares, the recipient/optionee will generally realize ordinary compensation
income at the time of the disposition equal to the difference between the
exercise price and the lesser of the fair market value of the stock on the date
of exercise or the amount realized on the disposition. The amount realized upon
such a disposition will generally be deductible by us for federal income tax
purposes.
Stock Awards
If a recipient receives an unrestricted stock award, he/she will
recognize compensation income upon the grant of the stock award. If a recipient
receives a restricted stock award, he/she normally will not recognize taxable
income upon receipt of the stock award until the stock is transferable by the
recipient or no longer subject to a substantial risk of forfeiture, whichever
occurs earlier. When the stock is either transferable or no longer subject to a
substantial risk of forfeiture, the recipient will recognize compensation income
in an amount equal to the fair market value of the shares (less any amount paid
for such shares) at that time. A recipient may, however, elect to recognize
ordinary compensation income in the year the stock award is granted in an amount
equal to the fair market value of the shares (less any amount paid for the
shares) at that time, determined without regard to the restrictions. We will
generally be entitled to a corresponding deduction at the same time, and in the
same amount, as the recipient recognizes compensation income with respect to a
stock award. Any gain or loss recognized by the recipient upon subsequent
disposition of the shares will be capital gain or loss.
Tax Deductibility under Section 162(m)
Section 162(m) of the Internal Revenue Code disallows a public
company's deductions for employee compensation exceeding $1,000,000 per year for
the chief executive officer and the four other most highly compensated executive
officers. Section 162(m) contains an exception for performance-based
compensation that meets specific requirements. The Equity Plan is intended to
permit all options to qualify as performance-based compensation at the Board of
Directors or Committee's discretion. If an Award is to qualify as such, it shall
clearly state so in the award agreement.
Withholding
We have the right to deduct any taxes required to be withheld with
respect to grants under the Equity Plan. We may require that the participant pay
to us the amount of any required withholding. The Compensation Committee may
permit the participant to elect to have withheld from the shares issuable to him
or her with respect to an option or restricted stock the number of shares with a
value equal to the required tax withholding amount.
Aggregated Option/Sar Exercised And Fiscal Year-End Option/Sar Value Table
39
None of our named executive officers exercised options or SARs during
the last fiscal year.
Long Term Incentive Plans
No Long Term Incentive awards were granted in the last fiscal year.
BOARD OF DIRECTORS
Our directors who are employees do not receive any compensation from us
for services rendered as directors. The Board has created three classes of fees
for outside directors: (1) outside directors who are "independent," as defined
in the Exchange Act will be paid a director fee of $500 per meeting, whether
telephonic or in person - no fees for written consents in lieu of board meetings
will be given; (2) outside directors who are not "independent" will not receive
any fees at this time, but once our cash flow position improves, the
Compensation Committee will reconvene and make recommendations for such
directors; (3) the Vice Chairman will receive $3,000 per month, which includes
$1,500 per month for his role as Chairman of our Audit Committee. Additionally,
although we do not currently provide stock based compensation to our outside
directors, in the future we may grant outside directors incentive-based stock
compensation.
BOARD COMMITTEES
We currently have six committees appointed by our Board of Directors:
o Audit Committee, which is comprised of Douglas MacLellan (Chair),
Robert Rooks and Ian Fraser. The Board has determined that all of
these members are independent, as that term is defined in Section
121(A) of the American Stock Exchange's Listing Standards.
o Finance Committee, which is comprised of Mark Elenowitz (Chair),
Douglas MacLellan and Robert Saunders.
o Compensation Committee, which is comprised of Ian Fraser (Chair), Mark
Elenowitz and Doug MacLellan.
o Disclosure Committee, which is comprised of Douglas MacLellan (Chair),
Robert Saunders and Michael Boswell.
o Nominating Committee, which is comprised of Robert Saunders (Chair),
Douglas MacLellan and Robert Rooks. The Board has determined that Mr.
Rooks and Mr. MacLellan are independent, as that term is defined in
Section 121(A) of the American Stock Exchange's Listing Standards.
o Sarbanes-Oxley Steering Committee, which is comprised of Robert
Saunders, Michael Boswell and Lisa Vernon.
EMPLOYMENT AGREEMENTS
40
In June 2005, we entered into an employment agreement with Robert Saunders, our
Chairman, CEO and President. Mr. Saunders will serve at the pleasure of the
Board of Directors. Pursuant to his employment agreement, Mr. Saunders'
compensation will be $60,000 (USD) per annum for his services as our President.
Following the receipt of at least $5,000,000 (USD) min outside funding, Mr.
Saunders will receive an additional $10,000 per month for his services as
Chairman and, thereafter, $20,000 per month provided that we achieve gross
revenues of at least $20,000,000 (USD) for our most recent fiscal year and
continuing as long as we maintain gross revenues of at least $20,000,000 (USD)
for each successive fiscal year. If we fail to achieve gross revenue of
$20,000,000 (USD) in a successive fiscal year, Mr. Saunders compensation as
Chairman shall be reduced to $10,000 (USD) per month. Additionally, we agreed to
grant Mr. Saunders a signing bonus of $150,000 (USD) to be paid upon the closing
of at least $3,500,000 in new third party financing. In August 2006, our Board
approved the following revisions to Mr. Saunders' compensation: reduce Mr.
Saunders' compensation from $10,000 to $5,000 per month until our cash flow
position improves, at which time the Compensation Committee will recommend that
Mr. Saunders' compensation increase back to $10,000 per month. We are discussing
possible restructuring/payment terms regarding the $65,000 deferred compensation
from fiscal year 2006 that was to be paid to Mr. Saunders upon the closing of at
least US$3,500,000 in outside funding. Although we have yet to reach a final
agreement on payment terms, we paid Mr. Saunders $50,000 towards the bonus in
September of 2006.
SECURITY OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT
As used in this section, the term beneficial ownership with respect to a
security is defined by Rule 13d-3 under the Securities Exchange Act of 1934, as
amended, as consisting of sole or shared voting power (including the power to
vote or direct the vote) and/or sole or shared investment power (including the
power to dispose of or direct the disposition of) with respect to the security
through any contract, arrangement, understanding, relationship or otherwise,
subject to community property laws where applicable.
As of April 16, 2007, we had a total of 23,285,291 shares of common stock,
8,010,333 shares of Series A Preferred Stock and 207 shares of Series B
Preferred Stock issued and outstanding, which are our only issued and
outstanding voting equity securities. However, neither class of our preferred
stock has any voting rights except with respect to specified transactions that
may affect the rights, preferences, privileges or voting power of such class and
except as otherwise required by Nevada law. (For further information regarding
the preferred stock see "Description of Securities - Series A Preferred Stock"
and "Description of Securities - Series B Preferred Stock") At the date of this
Prospectus, each share of our Series A Preferred Stock is convertible into one
share of common stock and each share of our Series B Preferred Stock is
convertible into a number of fully paid and nonassessable shares of our common
stock equal to the quotient of the liquidation preference amount per share
($10,000) divided by the conversion price, which initially is $1.15 per share,
subject to certain adjustments, or approximately 8,696 shares of common for each
share of converted Series B Preferred Stock.
The following table sets forth, as of April 16, 2007: (a) the names and
addresses of each beneficial owner of more than five percent (5%) of our common
stock and preferred stock (taken together as one class) known to us, the number
of shares of common stock and preferred stock beneficially owned by each such
person, and the percent of our common stock and preferred stock so owned; and
(b) the names and addresses of each director and executive officer, the number
41
of shares our common stock and preferred stock beneficially owned, and the
percentage of our common stock and preferred stock so owned, by each such
person, and by all of our directors and executive officers as a group. Each
person has sole voting and investment power with respect to the shares of our
common stock and preferred stock, except as otherwise indicated. Beneficial
ownership consists of a direct interest in the shares of common stock and
preferred stock, except as otherwise indicated.
Amount and Nature of Percentage
Name and Address Beneficial Ownership Of Voting of
Securities (1)
Robert Saunders 9,900,000 29.91%
Chairman, President and CEO
5552 West Island Highway
Qualicum Beach, British Columbia
Canada V9K 2C8
Douglas C. MacLellan 1,040,000 3.14%
Vice Chairman
8324 Delgany Avenue
Playa del Ray, CA 90293
Mark Elenowitz 1,238,000 (2) 3.74%
Director
400 Professional Drive
Suite 310
Gaithersburg, MD 20879
Dr. Robert Rooks 300,000 0.91%
Director
912 Pine Avenue
Huntington Beach, CA 90293
Ian Fraser 800,000 (3) 2.42%
Director
3056 West 2nd Avenue
Vancouver, British Columbia
Canada V6T 1E9
Michael Boswell
Director and 938,000 (4) 2.83%
Acting Chief Accounting Officer
400 Professional Drive
Suite 310
Gaithersburg, MD 20879
Victor Bolton 0 0.0%
345-916 W. Broadway
Vancouver, BC V5Z 1K7
Darryl Horton 0 0.0%
33568 Eagle Mountain Drive
Abbortsford, BC V3G 2X7
42
Amount and Nature of Percentage
Name and Address Beneficial Ownership Of Voting of
Securities (1)
Vision Opportunity Master Fund, Ltd. 3,306,242 (5) 9.99%
20 West 55th St., 5th Floor
New York, NY 10019
All directors and officers as a group 14,216,000 42.95%
(8) persons)
- ----------------
(1) All Percentages have been rounded up to the nearest one hundredth of
one percent.
(2) Mr. Elenowitz is a one hundred (100%) percent shareholder of MHE,
Inc., which owns 18,000 shares of our voting stock. Additionally, MHE,
Inc. is a forty percent (40%) member of TriPoint Capital Advisors,
LLC, which owns 3,000,000 shares of our voting stock. Mr. Elenowitz
owns 20,000 shares of our voting stock directly. Therefore, Mr.
Elenowitz beneficially owns 1,240,000 shares of our voting stock.
(3) Mr. Fraser is a 100% shareholder of One Way Grill Limited, which owns
800,000 shares of our voting stock. Therefore, Mr. Fraser beneficially
owns 800,000 shares of our voting stock.
(4) Mr. Boswell and his wife jointly own Invision, LLC, which owns 38,000
shares of our voting stock. Additionally, Invision, LLC is a thirty
percent (30%) member of TriPoint Capital Advisors, LLC, which owns
3,000,000 shares of our voting stock. Therefore, Mr. Boswell
beneficially owns 938,000 shares of our voting stock.
(5) Vision owns 5,133,333 shares of our Series A Preferred Stock,
1,495,740 shares of our Series B Preferred Stock, 22,107 shares of
common stock received as dividends on June 30, 2006 and 91,745 shares
of common stock as dividends on December 31, 2006. However, based upon
the terms of the preferred stock, Vision may not convert its preferred
stock if on any date, it would be deemed the beneficial owner of more
than 9.99% of the then outstanding shares of our common stock. In
addition to the shares listed in the table, Vision holds warrants to
purchase up to 21,649,628 shares of our common stock, but based upon
the terms of these warrants, Vision cannot exercise them if on any
date, it would be deemed the beneficial owner of more than 9.99% of
the then outstanding shares of our common stock. However, Vision can
elect to waive the cap upon 61 days notice to us.
CHANGES IN CONTROL
On August 15, 2005, we completed a Share Exchange with Edgewater Foods
International, Inc., the parent company of Island Scallops Ltd. an aquaculture
company located in Vancouver Island, British Columbia. As a result of the Share
Exchange, Edgewater became our wholly owned subsidiary. The shareholders of
Edgewater now own the majority of our voting stock. To accomplish the Share
Exchange, we issued an aggregate of 19,000,000 shares of our common stock in
exchange for all of the issued and outstanding capital stock of Edgewater from
the shareholders of Edgewater. The shares issued to the Edgewater Shareholders
were issued to 17 accredited investors pursuant to a claim of exemption under
Section 4(2) of the Securities Act of 1933, as amended for issuances not
involving a public offering. Additionally, as a condition of the Share Exchange,
E. Lee Murdoch, our controlling shareholder prior to the Share Exchange, agreed
to cancel 2,300,000 shares of our common stock upon close of the Share Exchange.
43
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
Dr. Kristina Miller, our Chief Scientific Advisor is Robert Saunders,
our Chairman, CEO and President's wife.
We are party to a consulting agreement with TriPoint Capital Advisors,
LLC, a company in which Mark Elenowitz, a director and one of our significant
shareholders, indirectly owns a 40% interest. Michael Boswell, our acting Chief
Accounting Officer and one of our directors, indirectly owns a 30% interest in
TriPoint. Louis Taubman, our outside corporate and securities counsel also
indirectly owns an interest (30%) in TriPoint. Our Board recently approved the
Compensation Committee's recommendation of a flat rate $15,000 per month fee,
which shall be reduced to $7,500 per month until our cash flow position
improves, for the legal services Louis Taubman provides us. The Board also
approved the recommendation of a flat rate $15,000 per month fee, which shall be
reduced to $7,000 per month until our cash flow position improves, for the
financial advisory services and Acting CFO type services TriPoint and Michael
Boswell, respectively, provide us. Additionally, our corporate offices in
Gaithersburg, Maryland are currently provided by Tripoint Holdings, LLC, the
parent company of Tripoint, at no cost to us.
Island Scallops, our wholly owned subsidiary, recently transferred 100%
ownership of RKS Laboratories, Inc. to Robert Saunders, our Chairman, CEO and
President. RKS is a Vancouver research and development that is working towards
developing superior strains of scallops (developed by Island Scallops and known
as the Pacific Scallop) with beneficial traits such as higher meat yield and
rapid growth. Island Scallops agreed to transfer its ownership of RKS in
consideration for the grant to Island Scallops by RKS and Robert Saunders of a
right of first refusal to commercialize any intellectual property developed by
RKS. Island Scallops has the right to acquire or use any intellectual property
from RKS at RKS' cost, in perpetuity or until such time as RKS shall cease to
exist. Between June and November 2006, Island Scallops agreed to loan RKS a
total of approximately $56,000 under five non-interest bearing notes that are
secured by all of RKS' assets and are due at various dates beginning on June 15,
2007 and ending on November 31, 2007.
DESCRIPTION OF SECURITIES
Our authorized capital consists of 100,000,000 shares of common stock,
$.001 par value per share, and 10,000,000 shares of preferred stock, $.001 par
value per share. As of April 16, 2007, there were outstanding 23,285,291 shares
of our common stock outstanding, 8,010,0333 shares of our Series A Preferred
Stock and 207 shares of our Series B Preferred Stock.
COMMON STOCK
The holders of common stock are entitled to one vote for each share
held of record on all matters to be voted on by stockholders. The holders of
common stock are entitled to receive such dividends, if any, as may be declared
from time to time by the Board of Directors, in its discretion, from funds
legally available therefore. Upon liquidation or dissolution, the holders of our
44
common stock are entitled to receive, pro rata, assets remaining available for
distribution to stockholders. The common stock has no cumulative voting,
preemptive or subscription rights and is not subject to any future calls. There
are no conversion rights or redemption or sinking fund provisions applicable to
the shares of common stock. All the outstanding shares of common stock are fully
paid and nonassessable. There are no provisions in our Articles of Organization
or Bylaws that would delay, defer or prevent a change in control.
PREFERRED STOCK
Our Board of Directors will be authorized, without further action by
the shareholders, to issue, from time to time, up to 10,000,000 shares of
preferred stock in one or more classes or series. Similarly, our Board of
Directors will be authorized to fix or alter the designations, powers,
preferences, and the number of shares which constitute each such class or series
of preferred stock. Such designations, powers or preferences may include,
without limitation, dividend rights (and whether dividends are cumulative),
conversion rights, if any, voting rights (including the number of votes, if any,
per share), redemption rights (including sinking fund provisions, if any), and
liquidation preferences of any unissued shares or wholly unissued series of
preferred stock. As of the date of this filing, we have designated 8,000,000
shares of our authorized preferred stock as Series A Convertible Preferred Stock
and 220 shares of our authorized preferred stock as Series B Convertible
Preferred Stock.
Series A Preferred Stock
Our Board of Directors of has designated 8,000,000 shares of our
authorized preferred stock as Series A Convertible Preferred Stock. The
principal terms of the preferred stock are as follows:
Voting. Except with respect to specified transactions that may affect
the rights, preferences, privileges or voting power of the Series A Preferred
Stock and except as otherwise required by Nevada law, the Series A Preferred
Stock has no voting rights. We shall not affect such specified transactions,
which include authorizing, creating, issuing or increasing the authorized or
issued amount of any class or series of stock, ranking pari passu or senior to
the Series A Preferred Stock, with respect to the distribution of assets on
liquidation, dissolution or winding up, without the affirmative vote or consent
of the holders of at least 75% of the shares of the Series A Preferred Stock
outstanding at the time, given in person or by proxy, either in writing or at a
meeting, in which the holders of the Series A Preferred Stock vote separately as
a class. The common stock into which the Series A Preferred Stock is convertible
shall, upon issuance, have all of the same voting rights as other issued and
outstanding common stock and none of the rights of the Series A Preferred Stock.
Dividends. The holders of record of shares of Series A Preferred Stock
are entitled to receive, out of any assets at the time legally available
therefor and when and as declared by the Board of Directors, dividends at the
rate of 8% per annum in shares of our common stock. The number of shares of
common stock to be issued to the holder shall be an amount equal to 90% of the
quotient of (i) the dividend payment divided by (ii) the average of the daily
volume weighted average price (VWAP) of our common stock for such date on the
OTC Bulletin Board for the 20 trading days immediately preceding the date the
dividend payment is due, but in no event less than $0.65. Dividends on the
Series A Preferred Stock are cumulative, accrue and are payable semi-annually.
Dividends on the Series A Preferred Stock are prior and in preference to any
45
declaration or payment of any distribution on any outstanding shares of junior
stock. So long as any shares of Series A Preferred Stock are outstanding, we
will not declare, pay or set apart for payment any dividend or make any
distribution on any junior stock (other than dividends or distributions payable
in additional shares of junior stock), unless at the time of such dividend or
distribution we shall have paid all accrued and unpaid dividends on the
outstanding shares of Series A Preferred Stock.
Conversion. At any time on or after the issuance date, the holder of
any such shares of Series A Preferred Stock may, at the holder's option, elect
to convert all or any portion of the shares of the Series A Preferred Stock held
by such person into a number of fully paid and nonassessable shares of common
stock equal to the quotient of (i) the liquidation preference amount ($0.75) of
the shares of Series A Preferred Stock being converted plus any accrued but
unpaid dividends divided by (ii) the conversion price, which initially is $0.75
per share, subject to certain adjustments.
If within 3 business days of our receipt of an executed copy of a
conversion notice the transfer agent shall fail to issue and deliver to a holder
the number of shares of common stock to which such holder is entitled upon such
holder's conversion of the Series A Preferred Stock or to issue a new preferred
stock certificate representing the number of shares of Series A Preferred Stock
to which such holder is entitled, we shall pay additional damages to such holder
on each business day after such 3rd business day that such conversion is not
timely effected in an amount equal 0.5% of the product of (A) the sum of the
number of shares of common stock not issued to the holder on a timely basis and
to which such holder is entitled and, in the event we failed to deliver a
preferred stock certificate to the holder on a timely basis, the number of
shares of common stock issuable upon conversion of the shares of Series A
Preferred Stock represented by such certificate, as of the last possible date
which we could have issued such certificate to such holder timely and (B) the
closing bid price of our common stock on the last possible date which we could
have issued such common stock and such certificate, as the case may be, to such
holder timely. If we fail to pay those additional damages within 5 business days
of the date incurred, then such payment shall bear interest at the rate of 2.0%
per month (pro rated for partial months) until such payments are made.
The conversion price of the Series A Preferred Stock may be adjusted in
the event of (i) combination, stock split, or reclassification of the common
stock; (ii) capital reorganization; (iii) distribution of dividends; or (iv) the
issuance or sale of additional shares of common stock or common stock
equivalents.
Liquidation. In the event of the liquidation, dissolution or winding up
of our affairs, whether voluntary or involuntary, the holders of shares of
Series A Preferred Stock then outstanding shall be entitled to receive, out of
our assets available for distribution to its stockholders, an amount equal to
$0.75 per share or the liquidation preference amount, of the Series A Preferred
Stock plus any accrued and unpaid dividends before any payment shall be made or
any assets distributed to the holders of the common stock or any other junior
stock. If our assets are not sufficient to pay in full the liquidation
preference amount plus any accrued and unpaid dividends payable to the holders
of outstanding shares of the Series A Preferred Stock and any series of
preferred stock or any other class of stock ranking pari passu, as to rights on
liquidation, dissolution or winding up, with the Series A Preferred Stock, then
all of said assets will be distributed among the holders of the Series A
46
Preferred Stock and the other classes of stock ranking pari passu with the
Series A Preferred Stock, if any, ratably in accordance with the respective
amounts that would be payable on such shares if all amounts payable thereon were
paid in full. The liquidation payment with respect to each outstanding
fractional share of Series A Preferred Stock shall be equal to a ratably
proportionate amount of the liquidation payment with respect to each outstanding
share of Series A Preferred Stock. All payments pursuant thereto, shall be in
cash, property (valued at its fair market value as determined by an independent
appraiser reasonably acceptable to the holders of a majority of the Series A
Preferred Stock) or a combination thereof; provided, however, that no cash shall
be paid to holders of junior stock unless each holder of the outstanding shares
of Series A Preferred Stock has been paid in cash the full Liquidation
Preference Amount plus any accrued and unpaid dividends to which such holder is
entitled as provided herein. After payment of the full liquidation preference
amount plus any accrued and unpaid dividends to which each holder is entitled,
such holders of shares of Series A Preferred Stock will not be entitled to any
further participation as such in any distribution of our assets.
Series B Preferred Stock
Our Board of Directors of has designated 220 shares of our authorized
preferred stock as Series B Convertible Preferred Stock. The principal terms of
the preferred stock are as follows:
Voting. Except with respect to specified transactions that may affect
the rights, preferences, privileges or voting power of the Series B Preferred
Stock and except as otherwise required by Nevada law, the Series B Preferred
Stock has no voting rights. We shall not affect such specified transactions,
which include authorizing, creating, issuing or increasing the authorized or
issued amount of any class or series of stock, ranking pari passu or senior to
the Series B Preferred Stock, with respect to the distribution of assets on
liquidation, dissolution or winding up, without the affirmative vote or consent
of the holders of at least 75% of the shares of the Series B Preferred Stock
outstanding at the time, given in person or by proxy, either in writing or at a
meeting, in which the holders of the Series B Preferred Stock vote separately as
a class. The common stock into which the Series B Preferred Stock is convertible
shall, upon issuance, have all of the same voting rights as other issued and
outstanding common stock and none of the rights of the Series B Preferred Stock.
Dividends. The holders of record of shares of Series B Preferred Stock
are entitled to receive, out of any assets at the time legally available
therefor and when and as declared by the Board of Directors, dividends at the
rate of 6% per annum in shares of our common stock. The number of shares of
common stock to be issued to the holder shall be an amount equal to 90% of the
quotient of (i) the dividend payment divided by (ii) the average of the daily
volume weighted average price (VWAP) of our common stock for such date on the
OTC Bulletin Board for the 20 trading days immediately preceding the date the
dividend payment is due, but in no event less than $0.65. Dividends on the
Series B Preferred Stock are cumulative, accrue and are payable semi-annually.
Dividends on the Series B Preferred Stock are prior and in preference to any
declaration or payment of any distribution on any outstanding shares of junior
stock. So long as any shares of Series B Preferred Stock are outstanding, we
will not declare, pay or set apart for payment any dividend or make any
distribution on any junior stock (other than dividends or distributions payable
in additional shares of junior stock), unless at the time of such dividend or
distribution we shall have paid all accrued and unpaid dividends on the
outstanding shares of Series B Preferred Stock.
47
Voluntary Conversion. At any time on or after the issuance date, the
holder of any such shares of Series B Preferred Stock may, at the holder's
option, elect to convert all or any portion of the shares of the Series B
Preferred Stock held by such person into a number of fully paid and
nonassessable shares of common stock equal to the quotient of (i) the
liquidation preference amount ($10,000.00) of the shares of Series B Preferred
Stock being converted plus any accrued but unpaid dividends divided by (ii) the
conversion price, which initially is $1.15 per share, subject to certain
adjustments.
If within 3 business days of our receipt of an executed copy of a
conversion notice the transfer agent shall fail to issue and deliver to a holder
the number of shares of common stock to which such holder is entitled upon such
holder's conversion of the Series B Preferred Stock or to issue a new preferred
stock certificate representing the number of shares of Series B Preferred Stock
to which such holder is entitled, we shall pay additional damages to such holder
on each business day after such 3rd business day that such conversion is not
timely effected in an amount equal 0.5% of the product of (A) the sum of the
number of shares of common stock not issued to the holder on a timely basis and
to which such holder is entitled and, in the event we failed to deliver a
preferred stock certificate to the holder on a timely basis, the number of
shares of common stock issuable upon conversion of the shares of Series B
Preferred Stock represented by such certificate, as of the last possible date
which we could have issued such certificate to such holder timely and (B) the
closing bid price of our common stock on the last possible date which we could
have issued such common stock and such certificate, as the case may be, to such
holder timely. If we fail to pay those additional damages within 5 business days
of the date incurred, then such payment shall bear interest at the rate of 2.0%
per month (pro rated for partial months) until such payments are made.
Mandatory Conversion. Any and all outstanding shares of Series B
Preferred Stock on January 16, 2012 shall automatically and without any action
on the part of the holder thereof, convert into a number of fully paid and
nonassessable shares of common stock equal to the quotient of (i) the
Liquidation Preference Amount of the number of shares of Series B Preferred
Stock being converted on such date divided by (ii) the conversion price, which
initially is $1.15 per share, subject to certain adjustments. Such mandatory
conversion shall only take place however, if (i) the registration statement
providing for the resale of shares of the common stock issuable upon conversion
of the Series B Preferred Stock is effective and has been effective, without
lapse or suspension of any kind, for a period 60 consecutive calendar days, or
the shares of common stock into which the Series B Preferred Stock can be
converted may be offered for sale to the public pursuant to Rule 144(k) ("Rule
144(k)") under the Securities Act of 1933, as amended, (ii) trading in the
common stock shall not have been suspended by the Securities and Exchange
Commission or the OTC Bulletin Board (or other exchange or market on which the
common stock is trading), and (iii) we are in material compliance with the terms
and conditions of the Certificate of Designation of the Rights and Preferences
of the Series B Preferred Stock and other transaction documents creating same.
Notwithstanding the foregoing, the Mandatory Conversion Date will be extended if
certain events occur, including events such as a lapse in the effectiveness of
the registration statement registering the Series B Preferred Stock or the
delisting of such stock from the then current principal exchange on which such
security is traded.
The conversion price of the Series B Preferred Stock may be adjusted in
the event of (i) combination, stock split, or reclassification of the common
48
stock; (ii) capital reorganization; (iii) distribution of dividends; or (iv) the
issuance or sale of additional shares of common stock or common stock
equivalents.
Liquidation. In the event of the liquidation, dissolution or winding up
of our affairs, whether voluntary or involuntary, the holders of shares of
Series B Preferred Stock then outstanding shall be entitled to receive, out of
our assets available for distribution to its stockholders, an amount equal to
$10,000 per share or the liquidation preference amount, of the Series B
Preferred Stock plus any accrued and unpaid dividends before any payment shall
be made or any assets distributed to the holders of the common stock or any
other junior stock. If our assets are not sufficient to pay in full the
liquidation preference amount plus any accrued and unpaid dividends payable to
the holders of outstanding shares of the Series B Preferred Stock and any series
of preferred stock or any other class of stock ranking pari passu, as to rights
on liquidation, dissolution or winding up, with the Series B Preferred Stock,
then all of said assets will be distributed among the holders of the Series B
Preferred Stock and the other classes of stock ranking pari passu with the
Series B Preferred Stock, if any, ratably in accordance with the respective
amounts that would be payable on such shares if all amounts payable thereon were
paid in full. The liquidation payment with respect to each outstanding
fractional share of Series B Preferred Stock shall be equal to a ratably
proportionate amount of the liquidation payment with respect to each outstanding
share of Series B Preferred Stock. All payments pursuant thereto, shall be in
cash, property (valued at its fair market value as determined by an independent
appraiser reasonably acceptable to the holders of a majority of the Series B
Preferred Stock) or a combination thereof; provided, however, that no cash shall
be paid to holders of junior stock unless each holder of the outstanding shares
of Series B Preferred Stock has been paid in cash the full Liquidation
Preference Amount plus any accrued and unpaid dividends to which such holder is
entitled as provided herein. After payment of the full liquidation preference
amount plus any accrued and unpaid dividends to which each holder is entitled,
such holders of shares of Series B Preferred Stock will not be entitled to any
further participation as such in any distribution of our assets.
WARRANTS
2006 Series A-D and E-H Warrants
Each A-D Warrant allows its holder to purchase one share of common
stock for $1.15, $1.35, $1.85, $2.25 respectively, subject to adjustment, until
five years after the date of issuance. The E-H Warrants have the same pricing
and term as the A-D Warrants, however the E-H Warrants may only be exercised
once the holder exercises his/her Series J Warrant, which have all now been
exercised. As of April 16, 2007 there were 20,307,220 2006 Warrants outstanding.
In the event that our registration statement is not effective, as
required by the registration rights agreement between us and investors, holders
would also be permitted exercise the warrants through a cashless exercise using
the following formula:
X = Y - (A)(Y)
-----
B
Where X = the number of restricted shares of common stock to be issued
to the holder.
49
Y = the number of shares of common stock purchasable
upon exercise of all of the Warrants or, if only a
portion of the Warrant is being exercised, the
portion of the Warrant being exercised.
A = the exercise price of the Warrant.
B = the closing bid price of one share of our common
stock.
The exercise price of the 2006 Warrants and the number of shares of
common stock purchasable upon exercise of the 2006 Warrants are subject to
adjustment upon the occurrence of certain events. Such events include
recapitalizations or consolidations, combinations of our common stock, dividends
payable in our common stock, and the issuance of rights to purchase additional
shares of our common stock or to receive other securities convertible into
additional shares of common stock.
Pursuant to the terms of the 2006 Warrants, we shall not effect the
exercise of any Warrants, and no person who is a holder of any 2006 Warrant
shall have the right to exercise his/her 2006 Warrants, to the extent that after
giving effect to such exercise, such person would beneficially own in excess of
9.99% of the then outstanding shares of our common stock. However, the holder is
entitled to waive this cap upon 61 days notice to us.
No fractional shares of common stock issuable upon exercise of the 2006
Warrants will be issued in connection with any exercise, but in lieu of such
fractional shares, we shall round the number of shares to be issued upon
exercise up to the nearest whole number of shares.
The 2006 Warrants expire at the close of business on the fifth
anniversary of the date of issuance.
2007 Series A-C and D-F Warrants
Each 2007 A-C Warrant allows its holder to purchase one share of common
stock for $1.41, $2.30, $2.60 respectively, subject to adjustment, until six
years after the date of issuance. Each 2007 D-F Warrant allows its holder to
purchase one share of common stock for $1.56, $2.45, $2.75 respectively, subject
to adjustment, until six years after the date of issuance. However the D-F
Warrants may only be exercised once the holder exercises his/her Series J
Warrant, which is described below. As of April 16, 2007 there were 5,400,258 of
these Warrants outstanding.
In the event that our registration statement is not effective, as
required by the registration rights agreement between us and investors, holders
would also be permitted exercise the 2007 Warrants through a cashless exercise
using the following formula:
X = Y - (A)(Y)
------
B
Where X = the number of restricted shares of common stock to be issued
to the holder.
50
Y = the number of shares of common stock purchasable
upon exercise of all of the 2007 Warrants or, if only
a portion of the 2007 Warrant is being exercised, the
portion of the 2007 Warrant being exercised.
A = the exercise price of the 2007 Warrant.
B = the closing bid price of one share of our common
stock.
The exercise price of the 2007 Warrants and the number of shares of
common stock purchasable upon exercise of the 2007 Warrants are subject to
adjustment upon the occurrence of certain events. Such events include
recapitalizations or consolidations, combinations of our common stock, dividends
payable in our common stock, and the issuance of rights to purchase additional
shares of our common stock or to receive other securities convertible into
additional shares of common stock.
Pursuant to the terms of the 2007 Warrants, we shall not effect the
exercise of any Warrants, and no person who is a holder of any 2007 Warrant
shall have the right to exercise his/her 2007 Warrants, to the extent that after
giving effect to such exercise, such person would beneficially own in excess of
9.99% of the then outstanding shares of our common stock. However, the holder is
entitled to waive this cap upon 61 days notice to us.
No fractional shares of common stock issuable upon exercise of the 2007
Warrants will be issued in connection with any exercise, but in lieu of such
fractional shares, we shall round the number of shares to be issued upon
exercise up to the nearest whole number of shares.
The 2007 Warrants expire at the close of business on the sixth
anniversary of the date of issuance.
2007 Series J Warrants
Each 2007 J Warrant allows its holder to purchase one share of common
stock for $1.30, subject to adjustment, until one year after the date of
issuance. As of April 16, 2007 there were 1,800,087 2007 J Warrants outstanding.
The exercise price of the 2007 J Warrants and the number of shares of
common stock purchasable upon exercise of such warrants are subject to
adjustment upon the occurrence of certain events. Such events include
recapitalizations or consolidations, combinations of our common stock, dividends
payable in our common stock, and the issuance of rights to purchase additional
shares of our common stock or to receive other securities convertible into
additional shares of common stock.
Pursuant to the terms of the 2007 J Warrants, we shall not effect the
exercise of any Warrants, and no person who is a holder of any 2007 J Warrant
shall have the right to exercise his/her 2007 J Warrants, to the extent that
after giving effect to such exercise, such person would beneficially own in
excess of 9.99% of the then outstanding shares of our common stock. However, the
holder is entitled to waive this cap upon 61 days notice to us.
No fractional shares of common stock issuable upon exercise of the 2007
J Warrants will be issued in connection with any exercise, but in lieu of such
51
fractional shares, we shall round the number of shares to be issued upon
exercise up to the nearest whole number of shares.
The 2007 J Warrants expire at the close of business on the first
anniversary of the date of issuance.
DIVIDEND POLICY
It is the policy of our Board of Directors to retain our earnings for
use in our day-to-day operations and expansion of our operations. We have not
declared any dividends on our common stock, nor do we intend to declare any
dividends in the foreseeable future. The description of our Series A Preferred
Stock and Series B Preferred Stock above, describes the dividend policy
associated with such stock.
REGISTRATION RIGHTS
In connection with the issuance of the Series A Preferred Stock and
2006 Warrants issued on April 12, 2006, May 30, 2006, June 30, 2006 and July 11,
2006, we agreed to file the current registration statement with the Securities
and Exchange Commission to register for resale the shares of common stock
issuable upon the exercise of the 2006 Warrants and conversion of the Series A
Preferred Stock. We also agreed to register the shares of common stock
underlying the placement consultant warrants we issued pursuant to that same
financing.
In connection with the issuance of the Series B Preferred Stock and
2007 Warrants issued on January 16, 2007, we agreed to file a registration
statement with the Securities and Exchange Commission to register for resale the
shares of common stock issuable upon the exercise of the 2007 Warrants and
conversion of the Series B Preferred Stock by February 14, 2007. We also agreed
to register the shares of common stock underlying the placement consultant
warrants we issued pursuant to that same financing.
TRANSFER AGENT
The transfer agent for our common stock is Empire Stock Transfer Inc.
at 2470 Saint Rose Pkwy, Suite 304, Henderson, NV 89074, 702.818.5898, Fax
702.974.1444.
MARKET FOR COMMON EQUITY
AND RELATED SHAREHOLDER MATTERS
The common stock is currently quoted on the over-the-counter Bulletin
Board under the symbol "EDWT."
The following table sets forth the quarterly high and low bid prices
for the common stock since the quarter ended December 31, 2004. The prices set
forth below represent inter-dealer quotations, without retail markup, markdown
or commission and may not be reflective of actual transactions.
52
HIGH LOW
---- ---
Quarter ended December 31, 2004 $0.25 $0.25
Quarter ended March 31, 2005 $0.30 $0.25
Quarter ended June 30, 2005 $0.55 $0.30
Quarter ended August 31, 2005 $1.95 $0.52
Quarter ended November 30, 2005 $2.00 $1.35
Quarter ended February 28, 2006 $1.64 $1.10
Quarter ended May 31, 2006 $1.45 $0.80
Quarter ended August 31, 2006 $1.70 $1.20
Quarter ended November 30, 2006 $1.85 $1.01
Quarter ended February 28, 2007 $1.70 $1.01
At April 16, 2007, the closing bid price of the common stock was $1.05
and we had approximately 55 record holders of our common stock, 14 record
holders of our Series A Preferred Stock and 2 record holders of our Series B
Preferred Stock. This number excludes any estimate by us of the number of
beneficial owners of shares held in street name, the accuracy of which cannot be
guaranteed.
We have not paid cash dividends on any class of common equity since
formation and we do not anticipate paying any dividends on our outstanding
common stock in the foreseeable future.
SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS
The following table provides information as of August 31, 2006 with
respect to compensation plans (including individual compensation arrangements)
under which our securities are authorized for issuance:
- ------------------------------- ---------------------------- ---------------------------- ----------------------------
Plan Category Number of securities to be Weighted average exercise Number of securities
issued upon exercise of price of outstanding remaining available for
outstanding options, options, warrants and future issuance under
warrants and rights rights equity compensation plans
(excluding securities
reflected in column (a))
(a) (b) (c)
- ------------------------------- ---------------------------- ---------------------------- ----------------------------
Equity Compensation plans 282,000 $1.50 5,718,000*
approved by security holders
- ------------------------------- ---------------------------- ---------------------------- ----------------------------
Equity compensation plans not N/A N/A N/A
approved by security holders
- ------------------------------- ---------------------------- ---------------------------- ----------------------------
Total 282,000 $1.50 5,718,000
- ------------------------------- ---------------------------- ---------------------------- ----------------------------
53
*As of January 1 of each year, commencing with the year 2006 and ending
with the year 2008, the aggregate number of shares available for granting Awards
under the Equity Plan shall automatically increase by a number of Shares equal
to the lesser of (x) 5% of the total number of Shares then outstanding or (y)
1,000,000.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion should be read in conjunction with our
financial statements and the notes thereto which appear elsewhere in this
report. The results shown herein are not necessarily indicative of the results
to be expected in any future periods. This discussion contains forward-looking
statements based on current expectations, which involve uncertainties. Actual
results and the timing of events could differ materially from the
forward-looking statements as a result of a number of factors. Readers should
also carefully review factors set forth in other reports or documents that we
file from time to time with the Securities and Exchange Commission.
OVERVIEW
In the first quarter of our 2007 fiscal year, we started harvesting the
remaining balance of our 2004 year class of scallops and completed transferring
our 2005 year-class scallops that were still maturing in our tenured growing
sites and joint venture locations, to final stage large grow-out nets on our
farm sites. We refer to the year-class of scallops based on when the scallops
were spawned. Generally, the harvest occurs approximately 22 to 24 months after
spawning of the scallops. Originally, we planned to ear-hang our entire 2005
scallop crop and subsequent year-classes, but after inspection of growth rates
of the 2004 ear-hung crops and an analysis of the labor costs of ear-hanging
versus lantern-style netting, we decided to use nets for the final grow-out
stage of the 2005 crop and subsequent classes.
The harvest of the remaining 2004 scallop-class started slower than expected as
we worked to develop improved processing and handling facilities and because the
handling and harvesting of these ear-hung scallops (on our farm sites) proved to
be tougher and more time consuming than originally expected. The combination of
these two factors resulted in slower than anticipated harvest rates in the first
quarter. Management believes that the improved processing facility that was
completed in the second quarter of 2007 will provide us with several important
advantages that will lead to expedited sale processes in the upcoming months.
Such advantages, which include a large onshore handling area that enables us to
bring product indoors (when needed) for line-removal and mass sorting (versus
having to do the same onboard boats) and provides a significantly larger
inventory holding and handling area, will help prevent future weather related
harvest delays to our sales. Starting with the 2005 scallop class, future
scallops will be grown in nets and hung from our new and improved longline
system thereby eliminating most of the problems that we experienced harvesting
(and handling) the ear-hung product. Despite the slower than expected start to
the 2004 year-class harvest and handling problems with our remaining ear hung
product, we anticipate bringing a significant number scallops to market before
the end of 2007 fiscal year. We began harvesting our 2005 scallop class in March
of 2007 and expect to bring between 3 and 4 million scallops to market over the
54
next twelve months. Additionally, we plan on generating additional near term
revenues via the sale of scallop and possibly other shellfish seed.
The use of DNA based family analysis that started in early 2000 and will
continue through 2007, with the goal of breeding high meat yield scallops, began
showing results in the harvest of our 2004 scallop class. Average weight per
scallop increased from 150-180 grams to over 225-250 grams -- representing an
increase of over 20% from the previous year. Management believes that the
improved meat yield will allow us to continue to demand higher scallop prices
per animal. Also, the Pacific scallop, farmed by us, continues to prove itself
highly disease resistant, with up to a 95% survival rate during the grow-out
phase.
During the first and second quarter of our 2007 fiscal year, we continued moving
the 2006 scallop crop from the onshore ponds at our harvest facility into
grow-out nets at our tenure sites. We anticipate that of the over 350 million
larvae that were spawned during the 2006 spawning season, at least 5 to 10
million scallops could reach full maturity and thus be harvested. We expect to
begin harvesting the 2006 year-class scallops during the Spring of 2008,
however, we could begin harvesting portions of the class sooner if mortality
rates (at various points of the growth cycle) are significantly better than our
current projection or if growth rates are substantially higher. In addition, we
expect our new longline and anchor systems, scallop nets and improved processing
facility will continue to improve harvesting rates as our scallop classes
increase in size.
As a result of the above, we believe that the 2005 scallop-class will produce at
least $5.5 million of gross revenue over a twelve month period beginning in
April of 2007. We anticipate that the harvest of our 2006 scallop class will
eventually result in total gross revenue of at least $14.0 million over the
twelve month period beginning in April 2008. If our mortality rates are better
than our current projections, our revenues from the 2005 and 2006 scallop class
could be higher, however, conversely, if our mortality rates are worse than we
anticipate our revenues for this period could be lower than we anticipate. In
addition, changes in the anticipated growth rates, projected harvesting cycles
and large fluctuations in the price of scallops or the US-Canadian exchange rate
could impact our current projections.
LIQUIDITY AND CASH RESOURCES
At August 31, 2006, we had a cash balance of approximately $1,817,000. We expect
to achieve operating positive cash flow in 2007. During the year ending August
31, 2006 we completed four private equity financings that resulted in net
proceeds of approximately $5,140,000. These financings contain warrants which if
fully exercised could raise approximately an additional $34,350,000. The
exercise of the warrants is, however, to a large extent dependent upon the price
of our stock in the public market. As a result, we cannot guarantee when any of
the warrants will be exercised, if at all and, as a result, the proceeds from
the exercise of the warrants may not be available to us should we require
additional financing or ever. Prior to the three months third quarter of 2006,
our recent expansion had been largely funded by a short term note with a maximum
limit of approximately $1,451,000. Previously, we have also relied on short term
loans from certain shareholders to assist with our working capital needs and to
meet short term cash requirements. We used a portion of our recent private
equity financing to repay these short term loans and as a result we have been
able to deploy the bulk of the proceeds from our financing toward our business
strategy.
55
SIGNIFICANT ACCOUNTING POLICIES
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of the
acquired entities since their respective dates of acquisition. All significant
inter-company amounts have been eliminated.
Cash and equivalents
Cash and equivalents include cash, bank indebtedness, and highly liquid short
term market investments with terms to maturity of three months or less. The
Company considers all highly liquid investments with original maturities of 90
days or less to be cash equivalents. The Company maintains its cash balances
primarily in on financial institution, which exceeded federally insured limits
by $1,653,378 at August 31, 2006. The Company has not experienced any losses, in
such accounts and believes it is not exposed to any significant credit risk on
cash and cash equivalents.
Accounts receivable
Accounts receivable is presented net of allowance for doubtful accounts. The
allowance for doubtful accounts reflects estimates of probable losses in
accounts receivable. The allowance is determined based on balances outstanding
for over 90 days at the period end date, historical experience and other current
information.
Loans receivable
Loans receivable is presented net of an allowance for loan losses, as necessary.
The loans are written off when collectibility becomes uncertain.
Inventory
We maintain inventories of raw materials for our aquaculture products, of
biomass (inventory of live aquaculture product being actively cultivated), and
of finished goods (aquaculture product ready for sale).
Inventories are reported at the lesser of cost or estimated net realizable
value. Biomass and finished goods includes direct and reasonably attributable
indirect production costs related to hatchery, cultivation, harvesting, and
processing activities. Carrying costs per unit are determined on a weighted
average basis.
Long term investments
Long term investments are recorded at cost. We review our investments
periodically to assess whether there is an "other than temporary" decline in the
carrying value of the investment. We consider whether there is an absence of an
ability to recover the carrying value of the investment by reference to
projected undiscounted future cash flows for the investment. If the projected
56
undiscounted future cash flow is less than the carrying amount of the asset, the
asset is deemed impaired. The amount of the impairment is measured as the
difference between the carrying value and the fair value of the asset.
Property, plant, and equipment
Property, plant, and equipment are recorded at cost less accumulated
amortization and are amortized on a straight-line basis over their estimated
useful lives:
Buildings 20-25 years
Seawater piping and tanks Over 15 years
Boats 6-7 years
Field equipment 5 years
Office equipment 5 years
Vehicles 3 years
Computer equipment 3 years
Impairment of long-lived assets
We monitor the recoverability of long-lived assets, including property and
equipment and intangible assets, based upon estimates using factors such as
expected future asset utilization, business climate, and undiscounted cash flows
resulting from the use of the related assets or to be realized on sale. Our
policy is to write down assets to the estimated net recoverable amount, in the
period in which it is determined likely that the carrying amount of the asset
will not be recoverable.
Government assistance
Government assistance we receive, such as grants, subsidies, and tax credits, is
recorded as a recovery of the appropriate related expenditure in the period that
the assistance is received.
We have received government assistance in the form of loans, for which repayment
is may not be required if we fail to meet sufficient future revenue levels to
repay these loans based on a percentage of gross sales for certain products over
a defined period of time. If we receive any such assistance, it is initially
recorded as a liability, until such time as all conditions for forgiveness are
met, and is then recognized as other income in that period.
Farm license costs
We must pay annual license costs in respect to government-granted tenures that
it holds, which give us the right to use certain offshore ocean waters for the
purpose of aquaculture farming. Such license costs are recognized as an expense
when incurred.
Research and development costs
Development costs include costs of materials, wages, and reasonably attributable
indirect costs incurred by us which are directly attributable to the development
57
of hatchery techniques for sablefish and shellfish, these costs are expensed
when incurred.
Research costs are expensed when incurred.
Income taxes
We calculate our provision for income taxes in accordance with Statement of
Financial Accounting Standards No. 109 (Accounting for Income Taxes) ("SPAS
109"), which requires an asset and liability approach to financial accounting
for income taxes. This approach recognizes the amount of taxes payable or
refundable for the current year, as well as deferred tax assets and liabilities
attributable to the future tax consequences of events recognized in the
financial statements and tax returns. Deferred income taxes are adjusted to
reflect the effects of enacted changes in tax laws or tax rates. Deferred income
tax assets are recorded in the financial statements if realization is considered
more likely than not.
Revenue recognition
We recognize revenue when it is realized or realizable, and earned. We consider
revenue realized or realizable and earned when there is persuasive evidence of a
contract, the product has been delivered or the services have been provided to
the customer, the sales price is fixed or determinable, and collectibility is
reasonably assured.
Our revenue is derived principally from the sale of scallops we produce or
purchase from third parties, and from the sale of seed and farm supplies to
other aquaculture farms.
Financial instruments
The carrying amount of our financial instruments, which include cash, accounts
receivable, loans receivable, bank indebtedness, accounts payable and accrued
liabilities, short term debt and long term debt approximate fair value. It is
management's opinion that the Company is not exposed to significant interest,
currency or credit risk arising from these financial instruments unless
otherwise noted.
Derivative financial instruments
In connection with the sale of debt or equity instruments, we may sell options
or warrants to purchase our common stock. In certain circumstances, these
options or warrants may be classified as derivative liabilities, rather than as
equity. Additionally, the debt or equity instruments may contain embedded
derivative instruments, such as embedded derivative features, which in certain
circumstances may be required to be bifurcated from the associated host
instrument and accounted for separately as a derivative instrument liability.
We account for all derivatives financial instruments in accordance with SFAS No.
133. Derivative financial instruments are recorded as liabilities in the
consolidated balance sheet, measured at fair value. When available, quoted
market prices are used in determining fair value. However, if quoted market
prices are not available, we estimate fair value using either quoted market
prices of financial instruments with similar characteristics or other valuation
techniques.
58
The identification of, and accounting for, derivative instruments is complex.
Our derivative instrument liabilities are re-valued at the end of each reporting
period, with changes in the fair value of the derivative liability recorded as
charges or credits to income, in the period in which the changes occur. For
options, warrants and bifurcated embedded derivative features that are accounted
for as derivative instrument liabilities, we estimate fair value using either
quoted market prices of financial instruments with similar characteristics or
other valuation techniques. The valuation techniques require assumptions related
to the remaining term of the instruments and risk-free rates of return, our
current common stock price and expected dividend yield, and the expected
volatility of our common stock price over the life of the option. The
identification of, and accounting for, derivative instruments and the
assumptions used to value them can significantly affect our financial
statements.
Derivative financial instruments that are not designated as hedges or that do
not meet the criteria for hedge accounting under SFAS No. 133 are recorded at
fair value, with gains or losses reported currently in earnings. All derivative
financial instruments held by us at August 31, 2006 were not designated as
hedges.
Foreign exchange
The functional currency of our foreign subsidiaries is the local foreign
currency. All assets and liabilities denominated in foreign currencies are
translated into U.S. dollars at the exchange rate prevailing on the balance
sheet date. Revenues, costs and expenses are translated at average rates of
exchange prevailing during the period. Translation adjustments resulting from
translation of the subsidiaries' accounts are accumulated as a separate
component of shareholders' equity. Gains and losses resulting from foreign
currency transactions are included in the consolidated statements of operations
and have not been significant.
Use of estimates
The preparation of financial statements in conformity with U.S. generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets, liabilities, revenues,
expenses and disclosure of contingent assets and liabilities. Such estimates
include providing for amortization of property, plant, and equipment, and
valuation of inventory. Actual results could differ from these estimates.
OFF-BALANCE SHEET ARRANGEMENTS
We do not have any off-balance sheet arrangements that have or are reasonably
likely to have a current or future effect on our financial condition, changes in
financial condition, revenues or expenses, results of operations, liquidity,
capital expenditures or capital resources that is material to our investors.
INVESTMENTS IN TENURES AS COMPARED TO ESTIMATED MARKET VALUE OF TENURES
We currently carry our investment in Island Scallops' tenures at $3,609. This
amount represents the initial carrying costs of certain tenures acquired by
Island Scallop's subsidiary. These tenures do not expire until various dates
ranging from 2021 - 2024, however, we believe that they have an indefinite
useful life because renewal on expiration is anticipated. The area available for
shellfish aquaculture within Baynes Sound is fully subscribed, and as a result
59
new tenures are not available through the Canadian Provincial application and
review process. The shellfish companies within the Sound are also well
established and sales of tenures are quite rare, making the assessment of the
market value for the Island Scallops tenures difficult. Historical sales and
government auction of tenures have received as much as $300,000 (CDN) for a
small beach tenure (less than 4 acres) and $65,000 CDN) for a small deepwater
tenure without infrastructure. The few tenures on the market over the previous
12 months suggest that the current market value is approximately $10,000 to
$25,000 (CDN) per acre. Based on listings of tenures on the coast of British
Columbia, discussions with local shellfish growers and individuals from the BC
Assets and Land Corporation, and an independent appraisal (commissioned by
Island Scallops) that recently estimated the value of our roughly 1018 acres of
tenures, the value is estimated to be approximately $8,600,000. If the proposed
expansion of two of our tenures is approved, the estimated market value of our
overall tenures would increase to roughly $10,600,000. The estimated market
value is based on the size, location and whether they are beach or deepwater in
nature. However, given the variable nature of the shellfish tenures market, the
actual value that we receive from the sale of a tenure or a partial tenure could
vary significantly from these estimated values.
Although we cannot determine the exact amount we would ultimately receive from
the sale of our tenure(s), based upon the information stated above we expect to
receive more than the carrying cost ($3,609) from such sale. Accordingly, the
carrying cost of our tenures is not indicative of their actual value. This
analysis indicates our cash generating capabilities after considering
investments in capital assets necessary to maintain and enhance existing
operations.
COMPARISON OF RESULTS FOR THE FISCAL YEAR ENDED AUGUST 31, 2006, TO THE FISCAL
YEAR ENDED AUGUST 31, 2005.
Revenues. Revenues for the fiscal year ended August 31, 2006, were approximately
$528,000. We had revenues of approximately $316,000 for the fiscal year ended
August 31, 2005. This is an increase of approximately $212,000 or 67%. The
increase in our revenue was mainly the result an increase in oyster seed and
scallop seed sales. As was the case in 2005, management continued its emphasis
on the development and production of larger 2005 and 2006 scallop crops.
Management believes that our emphasis on expansion of future crops will yield a
significant increase in revenues starting in 2007 and beyond.
Gross profit (loss). Gross loss for the year ended August 31, 2006, was
approximately $48,000, a decrease of approximately $3,000 as compared to gross
loss of roughly $51,000, for the year ended August 31, 2005. The slight decrease
in the amount of gross loss for 2006 (as compared to 2005) was mainly
attributable to management's continued focus on the expansion and development of
larger scallop crops and larger scallop yields for the crop year 2005 and 2006.
We continued to focus resources on the maintaining, developing and tending our
scallop crops in 2005 and 2006 and believe that we will begin seeing benefits
from our efforts in developing larger crops as early as the first quarter of
2007.
General and administrative. General and administrative expenses for the fiscal
year ended August 31, 2006, were approximately $653,000. Our general and
administrative expenses were approximately $221,000 for the fiscal year ended
August 31, 2005. This is an increase of approximately $432,000 or 195%. Our
increase in general and administrative expenses for the year ended August 31,
2006 were attributable to costs associated with establishing, building, and
supporting our infrastructure and included various consulting costs, legal and
60
accounting fees compensation paid as result of our recent financing, overhead,
realized stock compensation and salaries. We anticipate that these costs may
continue to rise as we continue to expand our operations.
Stock compensation expense. During the year ended August 31, 2006, we had stock
compensation expense of approximately $183,000. The expense was for two
consulting groups who would provide services to us. As such, we incurred a stock
compensation expense of approximately $183,000 for year ended August 31, 2006.
During the year ended August 31, 2005, our Board of Directors authorized the
issuance of shares of our restricted common stock to an individual who would
provide services to Edgewater. Based upon the common stock trading price at the
times of issuance, and FASB rules, we were required to incur non-cash expenses
for the issuance of stock of approximately $10. Since these shares were issued
by Edgewater in June 2005 prior to the share exchange, these shares were valued
based on the par value, $0.0001 of the stock at time of issuance and we recorded
a $10 stock compensation expense for the issuance of these shares during the
year ended August 31, 2005.
Other income (expense), net. Interest expense for the year ended August 31, 2006
was approximately $696,000. Interest expense for the year ending August 31, 2005
was approximately $81,000. The increase in interest expense was due to the
issuance of common stock for the extension of the due date of debt. Other income
for the year ended August 31, 2006 was approximately $45,000 as opposed to other
income of approximately $2,600 for the year ending August 31, 2005. We
recognized a loss of approximately $2,666,000 which was related to the change in
the fair value of warrants issued to 10 institutional and accredited investors
in conjunction with preferred stock financings on April 12, May 30, June 30 and
July 11 and the market price of the common stock underlying such warrants at
August 31, 2006. No such loss was recorded for the year ended August 31, 2005.
As a result, other expense for the year ended August 31, 2006 was approximately
$3,316,000 as compared to other expense of approximately $78,000 for the year
ended August 31, 2005. This increase was primarily attributed to loss associated
with the change in fair value of the recently issued warrants and interest
expense related to the extension of a former bridge financing loan.
Net profit (loss). As a result of the above, the net loss for the year ended
August 31, 2006, was approximately $4,200,000 as compared to a net loss of
approximately $350,000 for the year ended August 31, 2005.
COMPARISON OF RESULTS FOR THE THREE MONTHS AND SIX MONTHS ENDED FEBRUARY 28,
2007 TO THE THREE AND SIX MONTHS ENDED FEBRUARY 28, 2006.
Revenues. Revenues for the three months ended February 28, 2007, were
approximately $182,000. We had revenues of approximately $143,000 for the three
months ended February 28, 2006. This is an increase of approximately $39,000 or
27%. Revenues for the six months ended February 28, 2007, was approximately
$305,000 as compared to $304,000 for the six months ended February 28, 2006. The
slower than expected increase in our revenues was mainly the result of a slower
than anticipated start to the 2004 harvest and an unexpected early season winter
storm that forced us to curtail harvesting operations during at least one week
in November. Handling and harvesting of our 2004 ear-hung scallops also proved
to be tougher and more time consuming than originally expected, thereby slowing
61
our anticipated harvest rates. In addition, revenue for the six months ended
February 28, 2006, was also bolstered by a one-time sale on inventory equipment
and large scallop seed sales. As such, scallop-only sales were higher for the
six months ending February 28, 2007, as opposed to the six months ending
February 28, 2006. As in the previous year, management continued its emphasis on
the development and production of larger future (2005 and 2006) scallop crops.
Management believes that our emphasis on expansion of future crops coupled with
the recently completed new processing facility will yield a significant increase
in revenue starting as early as our next quarter and continuing thereafter.
Gross profit (loss). Gross loss for the three months ended February 28, 2007,
was approximately $92,000, an increase of approximately $102,000 as compared to
gross profit of roughly $10,000, for the three months ended February 28, 2006.
For the six months ended February 28, 2007, gross loss was approximately
$160,000. For the six months ended February 28, 2006 gross loss was roughly
$2,000. The increase in the amount of gross loss for this quarter (as compared
to the same periods in our 2006 fiscal year) was mainly attributable to the
slower than anticipated start to our 2004 class of scallops' harvest as we
worked to develop improved processing and handling facilities. Additionally,
because of an unusually large winter storm in November, we experienced some
minor weather related sale delays as harvesting operations were under way during
November. Aside from the slower than expected first quarter scallop sales, part
of the increase in gross loss was attributable to an increase in costs related
to a ramp-up of our processing personnel in preparation for increased future
harvests and sales.
General and administrative. General and administrative expenses for the three
months ended February 28, 2007, were approximately $245,000. Our general and
administrative expenses were approximately $63,000 for the three months ended
February 28, 2006. This is an increase of approximately $182,000 or 289%.
General and administrative expenses for the six months ended February 28, 2007,
were approximately $421,000. Our general and administrative expenses were
approximately $106,000 for the six months ended February 28, 2006. This is an
increase of approximately $315,000 or 297%. Our increase in general and
administrative expenses for the three and six months ended February 28, 2007
were attributable to costs associated with establishing, building, and
supporting our infrastructure and included various consulting costs, legal and
accounting fees, compensation paid as result of our recent financing, overhead,
and salaries. We anticipate that these costs may continue to rise as we continue
to expand our operations.
Stock compensation expense. During the three and six months ended February 28,
2007, our Board of Directors did not authorize the issuance of shares of our
restricted common stock for compensation. As a result, we did not incur any
stock compensation expense for the three months ended February 28, 2007. During
the six months ended February 28, 2006, our Board of Directors authorized the
issuance of shares of our restricted common stock to two consulting groups who
would provide services to us. Based upon the common stock trading price at the
times of issuance, and FASB rules, we were required to incur non-cash expenses
for the issuance of stock of approximately $183,000.
Other income (expense), net. Interest expense for the three months ended
February 28, 2007, was approximately $5,000. Interest expense for the three
months ending February 28, 2006, was approximately $53,000. The decrease in
interest expense was mainly due to repayment of a large short term note in the
third quarter of 2006. Other income for the three months ended February 28,
2007, was approximately $159,000 as opposed to other expense of approximately
62
$517,000 for the three months ended February 28, 2006. This increase was mainly
due to a one time gain of approximately $159,000 related to the forgiveness of a
third party short-term debt. We recognized a gain of approximately $8,595,000
which was related to a reclassification of certain liabilities related to
warrants issued to 10 institutional and accredited investors in conjunction with
preferred stock financings on April 12, May 30, June 30, July 11, 2006 and
January 16, 2007 and a resultant change in the fair value of such warrants as a
result of the reclassification as well as the market price of the common stock
underlying such warrants at November 30, 2006. No such gain or loss was recorded
for the period ended February 28, 2006. Interest expense for the six months
ended February 28, 2007 was approximately $12,000 as compared to interest
expense of roughly $106,000 for the six months ending February 28, 2006. Other
income for the six months ended February 28, 2007 was approximately $161,000.
For the six months ended February 28, 2006, other expense was roughly $513,000.
This increase in other income was mainly due to issuance of 520,000 share of
restricted stock to one group in consideration for the extension of the due date
on a share term loan to Island Scallops and a one time gain of approximately
$158,000 related to the forgiveness of a third party short-term debt in 2007. We
recognized a gain of approximately $5,827,000 which was related to the change in
the fair value of warrants issued to 10 institutional and accredited investors
in conjunction with preferred stock financings on April 12, May 30, June 30,
July 11, 2006 and January 16, 2007 and the market price of the common stock
underlying such warrants for the six months ended February 28, 2007. No such
gain or loss was recorded for the period six months ended February 28, 2006.
As a result, other income for the three and six months ended February 28, 2007,
was approximately $8,749,000 and $5,976,000 as compared to other expense of
approximately $570,000 and $619,000 for the three and six months ended February
28, 2006. This increase was primarily attributed to gain associated with the
reclassification of certain liabilities associated with warrants issued to
investors in our Series A and B Preferred Stock financings and the resultant
change in fair value of the warrants following the reclassification (See Foot
Note 12 to our Financial Statements "Reclassification of Warrant Liabilities
Associated with Series A and Series B Preferred Financings.").
Net profit (loss). As a result of the above, the net profit for three and six
months ended February 28, 2007, was approximately $8,339,000 and $5,235,000 as
compared to a net loss of approximately $659,000 and $989,000 for the three and
six months ended February 28, 2006.
Liquidity and Cash Resources. At February 28, 2007, we had a cash balance of
approximately $2,225,000. Between April 2006 and January 2007, we completed five
private equity financings that resulted in net proceeds of approximately
$7,004,000. These financings contain warrants which if fully exercised could
raise approximately an additional $49,350,000. In February, 2007, one investor
exercised warrants that net us an additional $276,000. The exercise of the any
additional warrants is, however, to a large extent dependent upon the price of
our stock in the public market. As a result, we cannot guarantee when any of the
warrants will be exercised, if at all and, as a result, the proceeds from the
exercise of the warrants may not be available to us at a time when we require
additional financing or ever. Prior to the completion of the Preferred Stock
Financing in the third quarter of 2006, our working capital had been primarily
financed with various forms of debt. Previously, we also relied on short term
loans from certain shareholders to assist with our working capital needs and to
meet short term cash requirements. We used a portion of our recent private
equity financing to repay these short term loans and as a result we have been
able to deploy the bulk of the proceeds from our financing toward our business
63
strategy. In addition to the foregoing, we are currently conducting due
diligence regarding the possible acquisition of a clam farming operation in
Morocco. Although to date we have not entered into any definitive agreements, in
the event that we determine to go ahead with such an acquisition it will result
in commitment of up to $1,000,000 in capital to such acquisition over a period
of approximately six months to one year. We anticipate that if we decide to move
forward with such acquisition it would occur sometime in the third or fourth
fiscal quarter of 2007.
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
ACCOUNTING AND FINANCIAL DISCLOSURE
We have had no disagreements with our certified public accountants with
respect to accounting practices or procedures or financial disclosure.
LEGAL PROCEEDINGS
In 1998 Island Scallops entered into an agreement with two purchasers,
pursuant to which Island Scallops was to produce and sell geoduck seed to the
two purchasers. Island Scallops received advance payments from each of the two
purchasers in 2002 totaling approximately $64,140. As a result of breaches of
the purchase agreements by the purchasers, it is our position that we may retain
any unused portion of these advance payments.
As of August 31, 2006, one of the two purchasers had claimed that
Island Scallops owed it amounts totaling $88,925. Since it is our position that
the purchasers breached their agreements with Island Scallops, we have no
intention of seeking a settlement of this matter at this time. We are unaware of
any formal proceedings that may have been commenced by either of these two
purchasers in regard to any claims that they may have.
Other than as set forth herein, we are not a party to any material
legal proceeding and to our knowledge, no such proceeding is currently
contemplated or pending.
EXPERTS
The financial statements included in the Prospectus have been audited
by LBB & Associates, Ltd., LPP, independent certified public accountants to the
extent and for the periods set forth in their report appearing elsewhere herein
and are included in reliance upon such report given upon the authority of said
firm as experts in auditing and accounting.
LEGAL MATTERS
Law Offices of Louis E. Taubman, P.C., has passed upon the validity of
the securities being offered hereby.
64
DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR
SECURITIES ACT LIABILITIES
Our Articles of Incorporation include provisions, which limit the
liability of our directors. As permitted by applicable provisions of the Nevada
Law, directors will not be liable to us for monetary damages arising from a
breach of their fiduciary duty as directors in certain circumstances. This
limitation does not affect liability for any breach of a director's duty to us
or our shareholders (i) with respect to approval by the director of any
transaction from which he or she derives an improper personal benefit, (ii) with
respect to acts or omissions involving an absence of good faith, that the
director believes to be contrary to our best interests or our shareholders, that
involve intentional misconduct or a knowing and culpable violation of law, that
constitute an unexcused pattern or inattention that amounts to an abdication of
his or her duty to us or our shareholders, or that show a reckless disregard for
duty to us or our shareholders in circumstances in which he or she was, or
should have been aware, in the ordinary course of performing his or her duties,
of a risk of serious injury to us or our shareholders, or (iii) based on
transactions between us and our directors or another corporation with
interrelated directors or based on improper distributions, loans or guarantees
under applicable sections of Nevada Law. This limitation of directors' liability
also does not affect the availability of equitable remedies, such as injunctive
relief or rescission.
Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to directors, officers and controlling persons of
the small business issuer pursuant to the foregoing provisions, or otherwise, we
have been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Act and is,
therefore, unenforceable.
WHERE YOU CAN FIND MORE INFORMATION
We have filed a registration statement on Form SB-2 with the SEC
covering the securities that may be sold under this prospectus. This prospectus
does not contain all of the information set forth in the registration statement,
and we strongly urge you to read the registration statement in its entirety.
We also file annual, quarterly and special reports, proxy statements
and other information with the SEC. You may read or obtain a copy of the
registration statement or any other information we file with the SEC at the
SEC's Public Reference Room at 100 F. Street, N.E., Washington, D.C. 20549. You
may obtain information regarding the operation of the Public Reference Room by
calling the SEC at 1-800-SEC-0330. Our SEC filings are also available to the
public from the SEC web site at www.sec.gov, which contains our reports, proxy
and information statements, and other information we file electronically with
the SEC.
65
FINANCIAL STATEMENTS
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors
Edgewater Foods International, Inc.
Qualicum Beach, British Columbia, Canada
We have audited the accompanying consolidated balance sheet of Edgewater Foods
International, Inc. as of August 31, 2006, and the related statements of
operations, stockholders' deficit, and cash flows for each of the two years then
ended. These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion of these financial
statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standard require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the financial statement referred to above present fairly, in all
material respects, the financial position of Edgewater Foods International, Inc.
as of August 31, 2006, and the results of its operations and its cash flows for
each of the two years then ended, in conformity with the accounting principles
generally accepted in the United States of America.
The accompanying financial statements have been prepared assuming that Edgewater
will continue as a going concern. As discussed in Note 16 to the financial
statements, Edgewater has incurred losses from operations for the year ended
August 31, 2006 and has suffered operating losses since its inception in its
efforts to establish and execute our business strategy. Edgewater will require
additional working capital to develop its business until Edgewater either (1)
achieves a level of revenues adequate to generate sufficient cash flows from
operations; or (2) obtains additional financing necessary to support its working
capital requirements. These conditions raise substantial doubt about Edgewater's
ability to continue as a going concern. Management's plans with regard to this
matter are described in Note 16. The accompanying financial statements do not
include any adjustments that might results from the outcome of these
uncertainties.
/s/ LBB & Associates Ltd., LLP
- ------------------------------
LBB & Associates Ltd., LLP
Houston, Texas
October 26, 2006
EDGEWATER FOODS INTERNATIONAL
CONSOLIDATED BALANCE SHEET
AUGUST 31, 2006
ASSETS
Current assets:
Cash $ 1,816,742
Accounts receivable, net of allowance for
doubtful accounts of $386 38,850
Inventory 1,252,051
Other current assets 67,596
------------
Total current assets 3,175,239
Property, plant and equipment, net 1,824,394
Investments in other assets 3,609
------------
Total assets $ 5,003,242
============
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current Liabilities:
Bank indebtedness $ 689
Short term debt 462,249
Current portion of warrant liabilities 1,743,996
Current portion of long term debt 948,732
Accounts payable and accrued liabilities 687,405
------------
Total current liabilities 3,843,071
Warrant liabilites, net of current portion 20,415,454
Long term debt, net of current portion 40,217
------------
Total liabilities 24,298,742
------------
Stockholders' Deficit
Series A preferred stock, par $0.001, 10,000,000
authorized, 7,887,999 issued and outstanding 7,888
Common stock, par $0.001, 100,000,000 authorized,
20,983,260 issued and outstanding 2,098
Additional paid in capital --
Accumulated deficit (19,049,166)
Accumulated other comprehensive income -
foreign exchange adjustment (256,320)
------------
Total stockholders' deficit (19,295,500)
------------
Total Liabilities and Stockholders' Deficit $ 5,003,242
============
See accompanying summary of accounting policies and notes to financial
statements
F-2
EDGEWATER FOODS INTERNATIONAL
CONSOLIDATED STATEMENTS OF OPERATIONS
YEARS ENDING AUGUST 31, 2006 and 2005
2006 2005
------------ ------------
Revenue $ 527,623 $ 315,869
Cost of goods sold 576,069 366,724
------------ ------------
Gross profit (loss) (48,446) (50,855)
------------ ------------
Operating Expenses:
General and administrative expenses (329,870) (137,337)
Salaries and benefits (323,186) (83,653)
Stock compensation expense (182,500) --
------------ ------------
Total operating expense (835,556) (220,990)
------------ ------------
Loss from operations (884,002) (271,845)
------------ ------------
Other income (expense):
Interest expense, net (695,889) (80,868)
Change in fair value of warrants (2,665,571) --
Other income (expense) 45,185 2,637
------------ ------------
Other income (expense), net (3,316,275) (78,231)
------------ ------------
Net loss (4,200,277) (350,076)
Dividend on preferred stock (34,709) --
------------ ------------
Net loss applicable to common shareholders $ (4,234,986) $ (350,076)
============ ============
Net loss per share
Basic and diluted $ (0.20) $ (0.03)
============ ============
Weighted average shares outstanding
Basic and diluted 20,794,784 11,899,320
============ ============
See accompanying summary of accounting policies and notes to financial
statements
F-3
EDGEWATER FOODS INTERNATIONAL
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT
YEARS ENDED AUGUST 31, 2006
Other
Accumulated Comprehensive
Paid Income
Preferred Stock Common Stock in Foreign Exchange
Number Value Number Value Capital Adjustment
------------ ------------ ------------ ------------ ------------ ------------
Balance at August 31, 2004 -- $ -- 10,300,000 $ 1,030 $ (1,029) $ 144,012
Comprehensive loss
Net loss
Foreign exchange adjustment (314,415)
Total comprehensive loss
Common stock issued for services -- -- 100,000 10 --
Common stock issued in
connection Island Scallops, Ltd.
with -- -- 8,600,000 860 (860)
Forgiveness of shareholder debt 3,153,848
Common stock issued in
connection with Heritage
Management recapitalization -- -- 1,585,400 159 (159)
------------ ------------ ------------ ------------ ------------ ------------
Balance at August 31, 2005 -- -- 20,585,400 2,059 3,151,800 (170,403)
Comprehensive loss
Net loss
Foreign (85,917)
Total comprehensive loss
Common stock cancelled -- -- (150,000) (15) 15
Common stock issued for services -- -- 525,000 52 702,448
Common stock issued for dividends 22,860 2 34,707
Preferred Series A stock issued in
connection with financing 7,887,999 7,888 -- -- 5,132,136
Warrants liability incurred in
connection with financings (9,021,106)
------------ ------------ ------------ ------------ ------------ ------------
Balance at August 31, 2006 7,887,999 $ 7,888 20,983,260 $ 2,098 $ 0 $ (256,320)
============ ============ ============ ============ ============ ============
Accumulated
Deficit Total
------------ ------------
Balance at August 31, 2004 $ (3,991,330) $ (3,847,317)
Comprehensive loss
Net loss (350,076) (350,076)
Foreign exchange adjustment (314,415)
------------
Total comprehensive loss
(664,491)
10
Common stock issued for services
Common stock issued in
connection Island Scallops, Ltd.
with --
Forgiveness of shareholder debt 3,153,848
Common stock issued in
connection with Heritage
Management recapitalization --
------------ ------------
Balance at August 31, 2005 (4,341,406) (1,357,950)
Comprehensive loss
Net loss (4,200,277) (4,200,277)
Foreign (85,917)
------------
Total comprehensive loss (4,286,194)
Common stock cancelled --
Common stock issued for services 702,500
Common stock issued for dividends (34,709) --
Preferred Series A stock issued in
connection with financing 5,140,024
Warrants liability incurred in
connection with financings (10,472,774) (19,493,880)
------------ ------------
Balance at August 31, 2006 $(19,049,166) $(19,295,500)
============ ============
See accompanying summary of accounting policies and notes to financial
statements
F-4
EDGEWATER FOODS INTERNATIONAL
CONSOLIDATED STATEMENTS OF CASHFLOWS
YEARS ENDED AUGUST 31, 2006 and 2005
2006 2005
------------ ------------
Cash flows from operating activities:
Net income (loss) $ (4,200,277) $ (350,076)
Adjustments to reconcile net loss to net
cash used in operating
activities:
Depreciation and amortization 123,008 80,435
Changes in fair value of warrants 2,665,570 --
Common stock issued for services 702,500 10
Bad debt expense -- 347
Changes in current assets and liabilities:
Accounts receivable (38,850) 25,069
Prepaid expenses (16,061) --
Other current assets (2,628) (22,338)
Inventory (711,925) (540,126)
Accounts payable 197,681 221,644
Bank overdrafts (38,538) 38,538
------------ ------------
Net cash used in operating activities (1,319,520) (546,497)
------------ ------------
Cash flows from investing activities:
Purchase of property, plant and equipment (784,291) (493,018)
------------ ------------
Net cash provided by (used in) investing activities (784,291) (493,018)
------------ ------------
Cash flows from financing activities:
Line of credit, net (64,675) 6,591
Proceeds from short term debt 862,451 1,125,247
Payment of short term debt (1,609,901) (38,128)
Proceeds from long term debt 62,112 --
Payment of long term debt (382,456) (25,408)
Proceeds from the sale of common stock -- 860
Proceeds from sale of preferred stock 5,140,024 --
------------ ------------
Net cash provided by financing activities 4,007,555 1,069,162
------------ ------------
Foreign currency translation effect (87,562) (41,997)
Net increase in cash 1,816,182 (12,350)
Cash, beginning of period 560 12,910
------------ ------------
Cash, end of period $ 1,816,742 $ 560
============ ============
Supplemental cash flow information:
Interest $ -- $ --
============ ============
Income taxes $ -- $ --
Supplement disclosure of non-cash transactions:
Issuance of common stock for dividends $ 34,709 $ --
Warrant liability incurred in connection with financing $ 19,493,880 $ --
F-5
See accompanying summary of accounting policies and notes to financial
statements
Edgewater Foods International, Inc.
Notes to Consolidated Financial Statements
NOTE 1. BASIS OF PRESENTATION, ORGANIZATION AND NATURE OF OPERATIONS
Edgewater Foods International Inc., a Nevada Corporation, is the parent company
of Island Scallops Ltd., a Vancouver Island aquaculture company. Island Scallops
was established in 1989 and for over 15 years has successfully operated a
scallop farming and marine hatchery business. Island Scallops is dedicated to
the farming, processing and marketing of high quality, high value marine
species: scallops and sablefish.
On June 29, 2005, Edgewater Foods International, Inc. ("Edgewater"), a holding
private company established under the laws of Nevada in order to acquire assets
in the aquaculture industry, issued 10,300,000 shares of common stock in
exchange for a 100% equity interest in Island Scallops, Ltd. As a result of the
share exchange, Island Scallops, Ltd. become the wholly own subsidiary of
Edgewater Foods International, Inc. As a result, the shareholders of Island
Scallops owned a majority (54.21%) of the voting stock of Edgewater Foods
International, Inc. The transaction was regarded as a reverse merger whereby
Island Scallops was considered to be the accounting acquirer as its shareholders
retained control of Edgewater Foods after the exchange, although Edgewater is
the legal parent company. The share exchange was treated as a recapitalization
of Edgewater Foods. As such, Island Scallops, Ltd. (and its historical financial
statements) is the continuing entity for financial reporting purposes.
On August 15, 2005, we completed a reverse acquisition of Heritage Management
Corporation, a public shell company, as that term is defined in Rule 12b-2 of
the Exchange Act, established under the laws of Nevada on June 12, 2000. To
accomplish the share exchange we issued 19,000,000 shares of common stock on a
one to one ratio for a 100% equity interest in Edgewater Foods. Per the terms of
the Share Exchange and Bill of Sale of Heritage Funding Corporation and E. Lee
Murdoch, Heritage was delivered with zero assets and zero liabilities at time of
closing. Following the reverse acquisition, we changed the name of Heritage
Management Corporation to "Edgewater Foods International, Inc." The transaction
was regarded as a reverse merger whereby Edgewater was considered to be the
accounting acquirer as it retained control of Heritage after the exchange.
Although the Company is the legal parent company, the share exchange was treated
as a recapitalization of Edgewater. Edgewater is the continuing entity for
financial reporting purposes. The Financial Statements have been prepared as if
Edgewater had always been the reporting company and then on the share exchange
date, had changed its name and reorganized its capital stock.
NOTE 2. SIGNIFICANT ACCOUNTING POLICIES
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of the
acquired entities since their respective dates of acquisition. All significant
inter-company amounts have been eliminated.
F-6
Cash and equivalents
Cash and equivalents include cash, bank indebtedness, and highly liquid short
term market investments with terms to maturity of three months or less. The
Company considers all highly liquid investments with original maturities of 90
days or less to be cash equivalents. The Company maintains its cash balances
primarily in on financial institution, which exceeded federally insured limits
by $1,653,378 at August 31, 2006. The Company has not experienced any losses, in
such accounts and believes it is not exposed to any significant credit risk on
cash and cash equivalents.
Accounts receivable
Accounts receivable is presented net of allowance for doubtful accounts. The
allowance for doubtful accounts reflects estimates of probable losses in
accounts receivable. The allowance is determined based on balances outstanding
for over 90 days at the period end date, historical experience and other current
information.
Loans receivable
Loans receivable is presented net of an allowance for loan losses, as necessary.
The loans are written off when collectibility becomes uncertain.
Inventory
The Company maintains inventories of raw materials for its aquaculture products,
of biomass (inventory of live aquaculture product being actively cultivated),
and of finished goods (aquaculture product ready for sale).
Inventories are reported at the lesser of cost or estimated net realizable
value. Biomass and finished goods includes direct and reasonably attributable
indirect production costs related to hatchery, cultivation, harvesting, and
processing activities. Carrying costs per unit are determined on a weighted
average basis.
At August 31, 2006, inventory consisted of the following:
Biomass (Scallops): $1,252,051
Reclassification
Certain amounts in the 2005 financial statements have been reclassified to
conform to the 2006 financial statement presentation.
Long term investments
Long term investments are recorded at cost. The Company reviews its investments
periodically to assess whether there is an "other than temporary" decline in the
carrying value of the investment. The Company considers whether there is an
absence of an ability to recover the carrying value of the investment by
reference to projected undiscounted future cash flows for the investment. If the
projected undiscounted future cash flow is less than the carrying amount of the
asset, the asset is deemed impaired. The amount of the impairment is measured as
the difference between the carrying value and the fair value of the asset.
F-7
Property, plant, and equipment
Property, plant, and equipment are recorded at cost less accumulated
amortization and are amortized in the following manner based on estimated useful
lives:
Buildings 4% - 5% declining balance
Seawater piping and tanks 6% declining balance
Boats 15% declining balance
Field equipment 20% declining balance
Office equipment 20% declining balance
Vehicles 30% declining balance
Computer equipment 30% declining balance
Impairment of long-lived assets
The Company monitors the recoverability of long-lived assets, including property
and equipment and intangible assets, based upon estimates using factors such as
expected future asset utilization, business climate, and undiscounted cash flows
resulting from the use of the related assets or to be realized on sale. The
Company's policy is to write down assets to the estimated net recoverable
amount, in the period in which it is determined likely that the carrying amount
of the asset will not be recoverable. At August 31, 2006 no indication of
impairment were present.
Government assistance
Government assistance received by the Company, such as grants, subsidies, and
tax credits, is recorded as a recovery of the appropriate related expenditure in
the period that the assistance is received.
The Company has received government assistance in the form of loans, for which
repayment may not be required if the Company fails to meet sufficient future
revenue levels to repay these loans based on a percentage of gross sales for
certain products over a defined period of time., Such assistance received by the
Company is initially recorded as a liability, until such time as all conditions
for forgiveness are met, and is then recognized as other income in that period.
Farm license costs
The Company must pay annual license costs in respect to government-granted
tenures that it holds, which give the Company the right to use certain offshore
ocean waters for the purpose of aquaculture farming. Such license costs are
recognized as an expense when incurred.
Research and development costs
Development costs include costs of materials, wages, and reasonably attributable
indirect costs incurred by the Company which are directly attributable to the
development of hatchery techniques for sablefish and shellfish. These costs are
expensed when incurred.
F-8
Research costs are expensed when incurred.
Income taxes
The Company calculates its provision for income taxes in accordance with
Statement of Financial Accounting Standards No. 109 (Accounting for Income
Taxes) ("SFAS 109"), which requires an asset and liability approach to financial
accounting for income taxes. This approach recognizes the amount of taxes
payable or refundable for the current year, as well as deferred tax assets and
liabilities attributable to the future tax consequences of events recognized in
the financial statements and tax returns. Deferred income taxes are adjusted to
reflect the effects of enacted changes in tax laws or tax rates. Deferred income
tax assets are recorded in the financial statements if realization is considered
more likely than not.
Revenue recognition
The Company recognizes revenue when it is realized or realizable, and earned.
The Company considers revenue realized or realizable and earned when it has
persuasive evidence of a contract, the product has been delivered or the
services have been provided to the customer, the sales price is fixed or
determinable, and collectibility is reasonably assured.
Revenue of the Company is derived principally from the sale of scallops produced
by the Company or purchased from third parties, and from the sale of seed and
farm supplies to other aquaculture farms.
Financial instruments
The carrying amount of the Company's financial instruments, which include cash,
accounts receivable, loans receivable, bank indebtedness, accounts payable and
accrued liabilities, short term debt, shareholder debt, and long term debt,
approximate fair value. It is management's opinion that the Company is not
exposed to significant interest, currency or credit risk arising from these
financial instruments unless otherwise noted.
Derivative Financial Instruments
In connection with the sale of debt or equity instruments, we may sell options
or warrants to purchase our common stock. In certain circumstances, these
options or warrants may be classified as derivative liabilities, rather than as
equity. Additionally, the debt or equity instruments may contain embedded
derivative instruments, such as embedded derivative features, which in certain
circumstances may be required to be bifurcated from the associated host
instrument and accounted for separately as a derivative instrument liability.
The Company accounts for all derivatives financial instruments in accordance
with SFAS No. 133. Derivative financial instruments are recorded as liabilities
in the consolidated balance sheet, measured at fair value. When available,
quoted market prices are used in determining fair value. However, if quoted
market prices are not available, the Company estimates fair value using either
quoted market prices of financial instruments with similar characteristics or
other valuation techniques.
The identification of, and accounting for, derivative instruments is complex.
Our derivative instrument liabilities are re-valued at the end of each reporting
F-9
period, with changes in the fair value of the derivative liability recorded as
charges or credits to income, in the period in which the changes occur. For
options, warrants and bifurcated embedded derivative features that are accounted
for as derivative instrument liabilities, we estimate fair value using either
quoted market prices of financial instruments with similar characteristics or
other valuation techniques. The valuation techniques require assumptions related
to the remaining term of the instruments and risk-free rates of return, our
current common stock price and expected dividend yield, and the expected
volatility of our common stock price over the life of the option. The
identification of, and accounting for, derivative instruments and the
assumptions used to value them can significantly affect our financial
statements.
Derivative financial instruments that are not designated as hedges or that do
not meet the criteria for hedge accounting under SFAS No. 133 are recorded at
fair value, with gains or losses reported currently in earnings. All derivative
financial instruments held by the Company as August 31, 2006 were not designated
as hedges.
Foreign exchange
The functional currency of the Company's foreign subsidiary is the local foreign
currency (Canadian dollars). All assets and liabilities denominated in foreign
currencies are translated into U.S. dollars at the exchange rate prevailing on
the balance sheet date. Revenues, costs and expenses are translated at average
rates of exchange prevailing during the period. Translation adjustments
resulting from translation of the subsidiaries' accounts are accumulated as a
separate component of shareholders' equity. Gains and losses resulting from
foreign currency transactions are included in the consolidated statements of
operations and have not been significant.
Use of estimates
The preparation of financial statements in conformity with U.S. generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets, liabilities, revenues,
expenses and disclosure of contingent assets and liabilities. Such estimates
include providing for amortization of property, plant, and equipment, and
valuation of inventory. Actual results could differ from these estimates.
Concentration of risk
The Company operates in the regulated aquaculture industry. Material changes in
this industry or the applicable regulations could have a significant impact on
the Company.
The quality and quantity of the aquaculture products cultivated, harvested and
processed by the Company could be impacted by biological and environmental risks
such as contamination, parasites, predators, disease and pollution. These
factors could severely restrict the ability of the Company to successfully
market its products.
During the year ended August 31, 2006, three customers, Summer Breeze, TriStar
and Sea World, individually accounted for 30%, 15% and 13% or our revenues
respectively, and we therefore are materially dependent upon such customers. The
Company's ongoing operations are dependent on continued business from these
customers.
F-10
Stock-based compensation
The Company accounts for stock-based employee compensation arrangements using
the intrinsic value method in accordance with the provisions of Accounting
Principles Board (APB) Opinion No. 25, "Accounting for Stock Issued to
Employees," and complies with the disclosure provisions of SFAS No. 123
"Accounting for Stock-Based Compensation," as amended by SFAS No. 148. Under APB
Opinion No. 25, compensation cost is generally recognized based on the
difference, if any, on the date of grant between the fair value of the Company's
common stock and the amount an employee must pay to acquire the stock.
The Company periodically issues common stock for acquisitions and services
rendered. Common stock issued is valued at the estimated fair market value, as
determined by management and the board of directors of the Company. Management
and the board of directors consider market price quotations, recent stock
offering prices and other factors in determining fair market value for purposes
of valuing the common stock.
The following table illustrated the effect on net income and earnings per share
if Edgewater had applied the fair value recognition provisions of FASB Statement
No. 123, Accounting for Stock-Based Compensation, to stock-based employee
compensation.
Year Ended
August 31,
2006 2005
----------------------------
Net loss, as reported $ (4,200,277) $(350,076)
Add: Stock based intrinsic value included
in report loss -- --
Less: Total stock-based employee compensation
expense determined under the fair value based
method for all awards -- (370,565)
---------------------------
Pro-forma net loss $ (4,200,277) $(720,641)
---------------------------
Basis and diluted net loss per share
As reported $ (0.20) $ (0.03)
Pro-forma $ (0.20) $ (0.06)
The fair value of each option granted is estimated on the date of grant using
the Black-Scholes option-pricing model with the following weighted average
assumptions: dividend yield $0, expected volatility of 93%, average risk-free
F-11
interest rate of 4.15%, and expected lives of 10 and 5 years (for 2006) and
dividend yield $0, expected volatility of 100%, average risk-free interest rate
of 4.70% and 4.71%, and expected lives of 10 and 5 years (for 2005).
Basic and diluted net loss per share
Basic income or loss per share includes no dilution and is computed by dividing
net income or loss by the weighted-average number of common shares outstanding
for the period. Diluted income or loss per share includes the potential dilution
that could occur if securities or other contracts to issue common stock were
exercised or converted into common stock. For all periods presented, diluted
loss per share equaled the basic loss per share as all convertible instruments
were anti-dilutive.
Recent accounting pronouncements
In December of 2004, the FASB issued Statement of Financial Accounting Standards
No, 123 (revised 2004) (Share-Based Payment) ("SFAS 123R"). SFAS 123R is a
revision of SFAS 123 (Accounting for Stock-Based Compensation), and supersedes
Accounting Principles Beard ("APB") Opinion No. 25 (Accounting for Stock Issued
to Employees). SFAS 123R requires that the fair value of employees awards
issued, modified, repurchased or cancelled after implementation, under
share-based payment arrangements, be measured as of the date the award is
issued, modified, repurchased or cancelled. The resulting cost is then
recognized in the statement of earnings over the service period. SFAS 123R is
required to be adopted by the Company not later than for the 2007 fiscal year.
In the opinion of Management, the adoption of this statement will not have a
significant impact on the Company's consolidated financial statements.
In December of 2004, the FASB issued Statement of Financial Accounting Standards
No. 153 (Exchanges of Nonmonetary Assets - An Amendment of APB Opinion No. 29,
Accounting for Nonmonetary transactions) ("SFAS 153"). SFAS 153 eliminates the
exception from fair value measurement for nonmonetary exchanges of similar
productive assets in paragraph 21(b) of APB Opinion No. 29 and replaces it with
an exception for exchanges that do not have commercial substance, SFAS 153
specifies that a nonmonetary exchange has commercial substance if the future
cash flows of the entity are expected to change significantly as a result of the
exchange. SFAS 153 is effective for fiscal periods beginning after June 15,
2005, and is required to be adopted by the Company in the second quarter of the
2006 fiscal year. We do not currently believe that the adoption of SFAS No. 153
will have a material impact on its consolidated financial statements.
In May 2005, SFAS No. 154, "Accounting Changes and Error Corrections" (a
replacement of APB Opinion No. 20 and SFAS No. 3) was issued. Statement 154
requires that all voluntary changes in accounting principles and changes
required by a new accounting pronouncement that do not include specific
transition provisions be applied retrospectively to prior periods' financial
statements, unless it is impracticable to do so. APB Opinion 20 required that
most voluntary changes in accounting principle be recognized by including the
cumulative effect of changing to the new accounting principle as a component of
net income in the period of change. Statement 154 is effective prospectively for
accounting changes and corrections of errors made in fiscal years beginning
after December 15, 2005, with earlier application encouraged. Earlier
application is permitted for accounting changes and corrections of errors made
in fiscal years beginning after the date the Statement was issued (May 2005).
SFAS 154 does not change the transition provisions of any existing accounting
pronouncements, including those that are in a transition phase as of the
effective date of the Statement. Accordingly, the Company will implement the
provisions of this accounting pronouncement in the fiscal reporting period
ending August 31, 2007. We do not currently believe that the adoption of SFAS
145 No. 154 will have a material impact on our consolidated financial
statements.
In June 2006, the FASB issued FASB Interpretation No. 48, Accounting for
Uncertainty in Income Taxes - An Interpretation of FASB Statement No. 109 ("FIN
48"). FIN 48 clarifies the accounting for uncertainty in income taxes recognized
F-12
in a company's financial statements and prescribes a recognition threshold and
measurement attribute for the financial statement recognition and measurement of
a tax position expected to be taken in a tax return. The Interpretation also
provides guidance on de-recognition, classification, interest and penalties,
accounting in interim periods, disclosure and transition. FIN 48 is effective
for fiscal years beginning after December 15, 2006. Currently, there would be no
effect of this interpretation on the company's financial position and results of
operations.
NOTE 3. PROPERTY, PLANT AND EQUIPMENT
Property, Plant and Equipment at August 31, 2006 consisted of the following:
Accumulated Net Book
Cost Amortization Value
------------------------------------
Land $ 227,355 $ -- $ 227,355
Buildings 451,445 230,302 221,143
Seawater piping and tanks 473,376 268,965 204,411
Boats and Barge 286,489 118,063 168,426
Field equipment 1,701,247 716,419 984,828
Office equipment 13,673 12,373 1,300
Vehicles 38,168 33,283 4,885
Computer equipment 17,149 5,103 12,046
------------------------------------
$3,208,902 $1,384,508 $1,824,394
Accumulated amortization was $1,384,508 year ended August 31, 2006. Depreciation
expenses are $123,000 and $10,195 for the year ended August 31, 2006 and 2005
respectively.
NOTE 4. RELATED PARTY TRANSACTIONS
The Company has two secured notes receivable from RKS Laboratories, Inc.
("RKS"), a Vancouver research and development that is working towards developing
superior strains of scallops with beneficial traits such as higher meat yield
and rapid growth. (Robert Saunders owns 100% of RKS.) The first non-interest
bearing note in the amount of $18,044 is secured by all assets of RKS is due on
or before June 15, 2007. The second non-interest bearing note in the amount of
$4,971 is also secured by all assets of RKS is due on or before August 31, 2007.
These amounts are included in other current assets.
F-13
NOTE 5. INVESTMENTS IN TENURES
The Company carries its Investment in Tenures at $3,609 at August 31, 2006. This
amount represent the carrying costs of certain shellfish tenures acquired by the
subsidiary of the Company's wholly-owned subsidiary Island Scallops Ltd., 377332
B.C. Ltd. Shellfish tenures are government-granted rights allowing limited use
of offshore waters for the purposes of cultivation of shellfish. The granting of
shellfish tenure rights are the responsibility of the Provincial (British
Columbia) Government and not the Canadian Federal Government. As such, the
government assistance that we receive via loan agreement with various Federal
Agencies has no effect on our ability to renew and/or modify these tenure
agreements. The tenure held by 377332 B.C. Ltd. has an expiration date of July
10, 2021. Other shellfish tenures held by the Company and its subsidiaries have
expiration dates ranging from 2021 to 2024.
These tenures are considered to have an indefinite useful life because renewal
on expiration is anticipated, and therefore are not subject to amortization.
NOTE 6. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
Included in accounts payable and accrued liabilities are balances outstanding
related to credit cards held in the name of the shareholder totaling $13,325 at
August 31, 2006. The Company used these credit cards as a means of short term
financing and incurs interest charges on such unpaid balances.
Included in accounts payable and accrued liabilities at August 31, 2006 is an
amount of $118,963 in respect to an agreement to purchase geoduck seed from the
Company (for additional information see Note 10 - Contingent Liabilities).
Included in accounts payable and accrued liabilities at August 31, 2006 is an
amount of $59,856 payments due and interest accrued in respect to the loan from
the National Research Council of Canada Industrial Research Assistance Program
(see Note 8 - Long Term Debt for additional information).
NOTE 7. SHORT TERM DEBT
These consolidated financial statements include Island Scallop's mortgage loan
repayable at $2,030 per month including interest calculated at the greater of
10% and (Canadian) prime plus 6% (12% as of August 31, 2006). The loan, which is
due on April 1, 2007, is secured by a second charge on the real property of
Island Scallops. At August 31, 2006, the principal due is $192,690.
These consolidated financial statements include a non-interest bearing loan to
Island Scallops from Industry Science and Technology Canada requiring repayment
equal to 0.5% of gross scallop sales of the Company's wholly owned subsidiary
(Island Scallops) for each preceding year, which is due January 1, 2007. If at
the due date the Company has not generated sufficient revenues to be required to
repay the original amount of $164,254, the remaining portion of the loan is to
be forgiven. Amounts currently due bear interest based on the published rates of
90 day (Canadian) treasury bills.
Included in short-term debt at August 31, 2006 is estimated royalties of $60,045
payable to a third party from who the former sole shareholder of Island Scallops
Ltd. originally acquired the shares of Island Scallops Ltd. The 1992 share
purchase agreement (for Island Scallops) provided that the third party was to
F-14
receive from the Company 3% of revenues of the Company as earned, on a quarterly
basis, throughout the period from December 1, 1992 to November 30, 2002. The
third party holds a first charge (or first lien) over inventory of the Company
(including broodstock) in the amount of $315,770 in support of its royalty
entitlement. The third party has not taken further action to enforce payment of
the arrears liability. To date, we have accrued the entire balance of $60,045 as
a current liability and we plan to pay it with available funds in the near
future.
Included in short-term notes payable at August 31, 2006 is an unsecured
non-interest bearing demand loan from an individual with a face value of $45,260
and no specific terms of repayment. However, the lender has informally requested
that the loan be repaid in full by October 6, 2008.
NOTE 8. LONG TERM DEBT
These consolidated financial statements include a Western Diversification
Program non-interest bearing loan to Island Scallops that requires repayment
equal to 12% of gross revenues from scallop sales of the Company, payable
semi-annually, with no specified due date. At August 31, 2006 as Island Scallops
is in arrears in respect to the payment of these amounts, the full principal
balance of $611,055 is reflected as a current liability. Our management of the
Company is seeking to renegotiate terms of repayment of this debt (for
additional information see Note 15 - Subsequent Events).
These consolidated financial statements include the Company's wholly owned
subsidiary's (Island Scallops) unsecured non-interest bearing loan from the
National Research Council of Canada Industrial Research Assistance Program which
requires quarterly payments commencing March 1, 2003 equal to 3% of gross black
cod revenues of the Island Scallops until the earlier of full repayment or
December 1, 2012. The amount repayable is up to 150% of the original advance of
$397,532, if repayment is before December 1, 2007. If at December 1, 2012,
Island Scallops has not earned sufficient revenues to be required to repay the
original loan amount, the remaining portion of the loan is to be forgiven.
Amounts currently due at August 31, 2006, bear interest at a rate of 1% per
month. At August 31, 2006, Island Scallops is in arrears in respect to the
payment of these amounts. The National Council of Canada Industrial Research
Assistance Program has requested payment of the $59,856 that they claim is owed
under this loan agreement. As such, at August 31, 2006, $59,856 is included in
accounts payable and accrued liabilities and remaining full principal balance of
$337,676 is reflected as a current liability. The Company is seeking to
renegotiate the repayment terms.
These consolidated financial statements include two bank loans for Island
Scallops. The first bank loan is repayable at $1,128 per month, plus interest
calculated at the floating base rate of the Business Development Bank of Canada
plus 1.5% annum (7.5% as of August 31, 2006), is due February 23, 2009, and is
secured by a General Security Agreement over the assets of the Company's wholly
owned subsidiary (Island Scallops), a mortgage charge on Island Scallop's real
property and a personal guarantee of $45,110 by our Chairman, President and CEO,
and former sole shareholder of Island Scallops. At August 31, 2006, the
principal due is $33,833. The second bank loan is repayable at $470 per month
plus interest calculated at (Canadian) prime plus 3% per annum (9% as of August
31, 2006), is unsecured and is due October 23, 2007. At August 31, 2006, the
principal due is $6,384.
F-15
As a result, at August 31, 2006, the Company had $988,949 of long-term debt less
a current portion of $948,732 for a balance of $40,217. Principal payments due
within each of the next five fiscal years and subsequently, in respect to long
term debt are approximately as follows:
2007 $948,732
2008 $6,384
2009 $33,833
-------------------
$988,949
===================
NOTE 9. WARRANT LIABILITIES
The warrants that each investor received as a result of our April 12, May 30,
June 30 and July 11 Preferred Stock Financing (see Note 13 - Preferred Stock
Financing for additional details) contained a cashless exercise provision that
becomes effective if our registration statement (that we are required to file
under the registration rights agreement) is not declared effective one-year
after the initial issue date of each warrant. As such and in accordance with the
accounting guidelines under SFAS No. 133, we valued the warrants as a derivative
financial instrument and the corresponding liabilities were entered onto our
consolidated balance sheet, measured at fair value. The Company determined the
fair value of the warrants as follows as of April 12, 2006, May 30, 2006, June
30, 2006 and July 11, 2006 (the issuance date):
The Company used the Black Scholes option-pricing model with the following
assumptions: an expected life equal to the contractual term of the warrants
(one, three or five), underlying stock price of $1.10 (at April 12), $1.40 (at
May 30), $1.35 (at June 30) and $1.40 (July 11) no dividends; a risk free rate
of 4.91%, 4.90% and 4.91%, which equals the one, three and five-year yield on
Treasury bonds at constant (or fixed) maturity (for those warrants issued on
April 12), a risk free rate of 4.99%, which equals three and five-year yield on
Treasury bonds at constant (or fixed) maturity (for those warrants issued on May
30), a risk free rate of 4.71% and 4.70%, which equals the three and five-year
yield on Treasury bonds at constant (or fixed) maturity (for those warrants
issued on June 30) and a risk free rate of 4.71% and 4.70%, which equals the
three and five-year yield on Treasury bonds at constant (or fixed) maturity (for
those warrants issued on July 11); and volatility of 93%. Under the assumptions,
the Black-Scholes option pricing model yielded an aggregate value of
approximately $19,494,000 with a current portion of approximately $1,225,000.
The Company performed the same calculations as of August 31, 2006, to revalue
the warrants as of that date. In using the Black Scholes option-pricing model,
the Company used an underlying stock price of $1.40 per share; no dividends; a
risk free rate of 5.00%, 4.71% and 5.70%, which equals the one, three and
five-year yield on Treasury bonds at constant (or fixed); and maturity
volatility of 97%. The resulting aggregate allocated value of the warrants as of
August 31 2006 equaled approximately $22,160,000. The change in fair value of
approximately $2,666,000 (with a current portion of roughly $519,000) was
recorded for the period ended August, 2006.
Upon the earlier of the warrant exercise or the expiration date, the warrant
liability will be reclassified into shareholders' equity. Until that time, the
warrant liability will be recorded at fair value based on the methodology
described above. Liquidated damages under the registration rights agreement will
be expensed as incurred and will be included in operating expenses.
F-16
NOTE 10. CONTINGENT LIABILITIES
The Company's wholly owned subsidiary, Island Scallops, entered into an
Agreement in the 1998 year with two parties, under which Island Scallops was to
produce and sell geoduck seed to the two parties. Island Scallops received
advance payments from each of the two parties in the 2002 year of approximately
$64,140 and recognized related revenue of $43,705 in respect to seed delivered
in the 2002 year. The balance of the deposits received (advance payments), net
of sales, totaling $118,963, is included in accounts payable and accrued
liabilities.
Management's position is that the two parties violated the terms of the
agreement, such that the Company is entitled to retain the balance of the
deposits. Per the terms of the original agreement, Island Scallop was entitled
to make up any shortfall in the product produced in the following year. Although
product was available and offered by Island Scallops in the following year, the
two parties refused to honor the terms of the agreement and would not accept the
product (to make up the shortfall) in the following YEAR.
As of August 31, 2004, one of the two parties had made claims that the Company
owed to it amounts totaling $88,925. This particular party believed that the
agreement required Island Scallops to deliver the product in year one and did
not allow Island Scallop to make up any shortfall with product produced in the
following year. The balance included in accounts payable and accrued liabilities
related to this party is $34,708.
Any additional liability to the Company, or any reduction of the currently
recognized liability, in respect to these deposits will be recorded at the time
a conclusion to this matter can be determined.
Neither the Company nor its wholly owned subsidiary maintain insurance in
respect to replacement of its inventory. Consequently, the Company is exposed to
financial losses or failure as a result of this risk.
NOTE 11. INCOME TAXES
The Company did not provide any current or deferred United States federal, state
or foreign income tax provision or benefit for the period presented because it
has experienced operation losses since inception. The Company has provided a
full valuation allowance on the deferred tax asset, consisting primarily
unclaimed research and development expenditures, because of uncertainty
regarding the Company's ability to realize the benefit.
Deferred income taxes reflect the net tax effect of temporary differences
between the carrying amounts of assets and liabilities for financial reporting
purposes and the amounts used for income tax purposes. Significant components of
the net deferred taxes at August 31, 2006 are as follows:
August 31,
2006
---------------
Deferred tax asset attributable to:
Net operating loss carryover $ 884,219
Less, valuation allowance (884,219)
---------------
Total net deferred tax asset $ -
===============
F-17
Edgewater follows Statement of Financial Accounting Standards Number 109 (SFAS
109), "Accounting for Income Taxes." SFAS No. 109 requires a valuation
allowance, if any, to reduce the deferred tax assets reported if, based on the
weight of the evidence, it is more likely than not that some portion or all of
the deferred tax assets will not be realized. Management has determined that a
valuation allowance of $884,219 at August 31, 2006 is necessary to reduce the
deferred tax assets to the amount that will more than likely than not be
realized. The change in valuation allowance for 2006 was approximately $438,661.
At August 31, 2006 Edgewater had net operating loss carryforwards amounting to
approximately $524,000 for U.S. and Canadian tax purposes, respectively, that
expires in various amounts beginning in 2009 and 2009 in the U.S. and Canada,
respectively.
The federal statutory tax rate reconciled to the effective tax rate for 2006 is
as follows:
2006 2005
--------------------
Tax at U.S. statutory rate 34.0% 34%
State tax rate, net of federal benefits 0.0 0.0
Foreign tax rate in excess of U.S. statutory rate 17.6% 17.6%
Change in valuation allowance 51.6% 51.6%
--------------------
Effective tax rate 0.0% 0.0%
====================
NOTE 12. STOCK-COMPENSATION EXPENSE
In October 2005, we engaged Aurelius Consulting to provide marketing and
investor relations services. The initial term of the agreement is one year.
Aurelius is entitled to receive 100,000 shares of our restricted common stock
during the term of its agreement (25,000 per quarter), in consideration for
their services. The shares were valued at $1.45 per share, the closing bid price
for shares of our common stock on the date of the contract. Therefore, the total
aggregate value of the transaction recognized by the Company in the first
quarter of 2006 was $145,000.
At October 21, 2005 and November 11, 2005, our board approved the issuing a
total of 25,000 shares of the Company's common stock to The Shemano Group, LLC
for preparing a research report for the Company. The shares were valued at $1.50
per share, the closing market bid of our common stock on the date of the
resolution. Therefore, the total aggregate value of the transaction recognized
by the Company in the first quarter of 2006 was $37,500.
On January 31, 2006, we issued 400,000 shares of our restricted common stock to
World Wide Mortgage as consideration for agreeing to extend the due date to
April 15, 2006 for us to repay our CDN $1,500,000 loan pursuant to the bridge
loan agreement dated November 9, 2004 and amended on April 15, 2005 between us
and World Wide. The shares have piggy-back registration rights that require us
to register the shares in our next registration statement. The shares were
valued at $1.30 per share, the closing bid price for shares of our common stock
on the date we issued the shares. Therefore, the total aggregate value of the
transaction is $520,000 which was recorded as interest expense.
F-18
On June 30, 2006, we issued 22,860 shares of common stock to the two accredited
investors of our April 12 and May 30, 2006 financings as payment of the
semi-annual dividend (8% per annum) per the terms of the Certificate of
Designation of the Relative Rights and Preferences of the Series A Convertible
Preferred Stock (see Note 13 - Preferred Shares Financing for additional
information on the Series A Convertible Preferred Stock). The number of shares
issued was based on the Dividend Payment at a rate of 8% per annum (subject to a
pro rata adjustment) of the Liquidation Preference Amount ($1,416,000 for the
April 12 financing and $1,500,000 for the May 30 financing) payable in shares
equal to 90% of the quotient of (i) the Dividend Payment divided by (ii) the
average of the VWAP for the twenty (20) trading days immediately preceding the
date the Dividend Payment is due, but in no event less than $0.65. As such, the
shares were valued at approximately $34,700 and the total aggregate value of the
transaction was recorded as a preferred stock dividend.
Stock Options
In August 2005, our Board of Directors approved the "Edgewater Foods
International 2005 Equity Incentive Plan." The Board of Directors reserved
5,000,000 shares of our common stock to be issued in the form of incentive
and/or non-qualified stock options for employees, directors and consultants to
Edgewater. As of August 31, 2006, our Board of Directors had authorized the
issuance of 282,000 options to employees.
Stock option activity during the year ending August 31, 2006 was as follows:
Weighted Average
Number of Exercise Price
Shares
-----------------------------------
Outstanding, August 31, 2005 282,000 $ 1.50
Granted -- --
Exercised -- --
Forfeited -- --
Expired -- --
-----------------------------------
Outstanding, August 31, 2006 282,000 $
1.50
===================================
Exercisable, August 31, 2006 282,000 $ 1.50
===================================
At August 31, 2006, 62,000 of the outstanding options expire in August 2010 with
the remaining balance of 220,000 having an expiration date of August 2015.
NOTE 13. PREFERRED STOCK FINANCING
On April 12, 2006, we completed a private equity financing of $1,062,000 with
two accredited investors. Net proceeds from the financing were approximately
$952,000. We issued 1,888,000 shares of our Series A Preferred Stock, par value
$0.001 per share and stated value of $0.75 per share, at a purchase price of
$0.5625 per share. Each investor also received one of each of the following
warrants: (i) Series A Warrant, (ii) Series B Warrant, (iii) Series C Warrant,
(iv) Series D Warrant, (v) Series J Warrant, (vi) Series E Warrant, (vii) Series
F Warrant, (viii) Series G Warrant, and (ix) Series H Warrant, each to purchase
a number of shares of common stock equal to 50% of the number of Series A
Preferred Stock purchased, except for the Series J Warrants, which entitled the
investor to purchase a number of shares of common stock equal to 100% of the
number of shares of Series A Preferred Stock purchased. We issued a total of
9,440,000 Warrants. Each of the Warrants has a term of 5 years, except for the
Series J Warrants, which have a term of 1 year.
F-19
In connection with the April 12, 2006 financing, we paid cash compensation to a
placement consultant in the amount of $84,960 and issued him 188,800 warrants.
Each of the placement consultant's warrants allow him to purchase one share of
our Series A Preferred Stock, and one half of each of the Series A-I Warrants
and one Series J warrant. Each of the placement consultant's warrants to
purchase the securities described above is exercisable at a price of $0.5625 per
warrant, for a period of three years. The fees were recorded as a cost of
capital.
On May 30, 2006, we completed another round of private equity financing of
$1,500,000 with one accredited investor pursuant to a Series A Convertible
Preferred Stock Purchase Agreement. Net proceeds from this financing were
approximately $1,380,000. We issued 2,000,000 shares of our Series A Preferred
Stock, stated value of $0.75 per share, at a purchase price of $0.75 per share
and the investor also received one of each of the following warrants: (i) Series
A Warrant, (ii) Series B Warrant, (iii) Series C Warrant, and (iv) Series D
Warrant, each to purchase a 1,000,000 shares of Common Stock; therefore, we
issued a total of 4,000,000 Warrants. Each of the Warrants has a term of 5 years
and is identical to the Series A-D Warrants we issued to investors pursuant to
the financing we closed on April 12, 2006 as disclosed in our Current Report on
Form 8-K filed on April 14, 2006. Each share of the Series A Preferred Stock is
convertible into one fully paid and nonassessable share of our common stock.
In connection with the May 30, 2006 financing, we paid cash compensation to a
placement consultant in the amount of $120,000 and issued him 200,000 warrants.
Each of the placement consultant's warrants allow him to purchase one share of
our Series A preferred stock, and one half of each of the Series A-D Warrants.
Each of the placement consultant's warrants to purchase the securities described
above is exercisable at a price of $0.75 per warrant, for a period of 3 years.
The fees were recorded as a cost of capital.
On June 30, 2006 and July 11, 2006, we completed two final rounds of private
equity financing, accepting subscriptions in the aggregate amount of $2,840,000
from nine institutional and accredited investors pursuant to the May 30, 2006
Series A Convertible Preferred Stock Purchase. On June 30, 2006 and July 11,
2006, we entered into separate Joinder Agreements to each of the Series A
Convertible Preferred Stock Purchase Agreement and the Registration Rights
Agreement, each dated as of May 30, 2006, with each of the new investors which
added such investors as additional parties to the May 30, 2006 financing
documents. Net cash proceeds from these two rounds were approximately
$2,808,000. Pursuant to these round two final financings, we issued a total of
3,786,666 shares of our Series A Preferred Stock, stated value of $0.75 per
share, at a purchase price of $0.75 per share and each investor also received
one of each of the following warrants: (i) Series A Warrant, (ii) Series B
Warrant, (iii) Series C Warrant, and (iv) Series D Warrant, each to purchase
1,893,338 shares of Common Stock ; therefore, we issued a total of 7,573,352
Warrants in these two final rounds of financing. Each of the Warrants has a term
of 5 years and is identical to the Series A-D Warrants we issued to investors
pursuant to the financings we closed on April 12, 2006 and May 30, 2006. Each
share of the Series A Preferred Stock is convertible into one fully paid and
nonassessable share of our common stock.
In connection with the June 30, 2006 and July 11, 2006 financing, we paid a
total placement consultant fee of $217,000. The placement consultant received
$160,000 of his fee in securities (as described below) and $57,000 in cash. As a
result, we issued the placement consultant 213,333 shares of our Series A
Preferred Stock, and one of each of the A-D Warrants, each to purchase 106,667
shares of our Common Stock. The A-D Warrants issued to the placement consultant
are identical to the Series A-D Warrants we issued to the investors as described
above. The fees were recorded as a cost of capital.
F-20
We used a portion of the proceeds of the above referenced private equity
financings to repay the entire balance of short-term loan with an authorized
limit of $1,451,510 secured by our assets, including a mortgage charge in the
amount of $1,451,510 on land and building of the Company, and by a personal
guarantee of Robert Saunders, our Chairman, President and CEO, and former sole
shareholder of Island Scallops. (For additional information on this note, please
see Note 7 - Short Term Debt above)
Series A Preferred Stock
Our Board of Directors of has designated 10,000,000 shares of our
authorized preferred stock as Series A Convertible Preferred Stock. The
principal terms of the preferred stock are as follows:
Voting. Except with respect to specified transactions that may affect
the rights, preferences, privileges or voting power of the Series A Preferred
Stock and except as otherwise required by Nevada law, the Series A Preferred
Stock has no voting rights. We shall not affect such specified transactions,
which include authorizing, creating, issuing or increasing the authorized or
issued amount of any class or series of stock, ranking pari passu or senior to
the Series A Preferred Stock, with respect to the distribution of assets on
liquidation, dissolution or winding up, without the affirmative vote or consent
of the holders of at least 75% of the shares of the Series A Preferred Stock
outstanding at the time, given in person or by proxy, either in writing or at a
meeting, in which the holders of the Series A Preferred Stock vote separately as
a class. The common stock into which the Series A Preferred Stock is convertible
shall, upon issuance, have all of the same voting rights as other issued and
outstanding common stock and none of the rights of the Series A Preferred Stock.
Dividends. The holders of record of shares of Series A Preferred Stock
are entitled to receive, out of any assets at the time legally available
therefor and when and as declared by the Board of Directors, dividends at the
rate of 8% per annum in shares of our common stock. The number of shares of
common stock to be issued to the holder shall be an amount equal to 90% of the
quotient of (i) the dividend payment divided by (ii) the average of the daily
volume weighted average price (VWAP) of our common stock for such date on the
OTC Bulletin Board for the 20 trading days immediately preceding the date the
dividend payment is due, but in no event less than $0.65. Dividends on the
Series A Preferred Stock are cumulative, accrue and are payable semi-annually.
Dividends on the Series A Preferred Stock are prior and in preference to any
declaration or payment of any distribution on any outstanding shares of junior
stock. So long as any shares of Series A Preferred Stock are outstanding, we
will not declare, pay or set apart for payment any dividend or make any
distribution on any junior stock (other than dividends or distributions payable
in additional shares of junior stock), unless at the time of such dividend or
distribution we shall have paid all accrued and unpaid dividends on the
outstanding shares of Series A Preferred Stock.
Conversion. At any time on or after the issuance date, the holder of
any such shares of Series A Preferred Stock may, at the holder's option, elect
to convert all or any portion of the shares of the Series A Preferred Stock held
by such person into a number of fully paid and nonassessable shares of common
stock equal to the quotient of (i) the liquidation preference amount ($0.75) of
the shares of Series A Preferred Stock being converted plus any accrued but
unpaid dividends divided by (ii) the conversion price, which initially is $0.75
per share, subject to certain adjustments.
F-21
If within 3 business days of our receipt of an executed copy of a
conversion notice the transfer agent shall fail to issue and deliver to a holder
the number of shares of common stock to which such holder is entitled upon such
holder's conversion of the Series A Preferred Stock or to issue a new preferred
stock certificate representing the number of shares of Series A Preferred Stock
to which such holder is entitled, we shall pay additional damages to such holder
on each business day after such 3rd business day that such conversion is not
timely effected in an amount equal 0.5% of the product of (A) the sum of the
number of shares of common stock not issued to the holder on a timely basis and
to which such holder is entitled and, in the event we failed to deliver a
preferred stock certificate to the holder on a timely basis, the number of
shares of common stock issuable upon conversion of the shares of Series A
Preferred Stock represented by such certificate, as of the last possible date
which we could have issued such certificate to such holder timely and (B) the
closing bid price of our common stock on the last possible date which we could
have issued such common stock and such certificate, as the case may be, to such
holder timely. If we fail to pay those additional damages within 5 business days
of the date incurred, then such payment shall bear interest at the rate of 2.0%
per month (pro rated for partial months) until such payments are made.
The conversion price of the Series A Preferred Stock may be adjusted in
the event of (i) combination, stock split, or reclassification of the common
stock; (ii) capital reorganization; (iii) distribution of dividends; or (iv) the
issuance or sale of additional shares of common stock or common stock
equivalents.
Liquidation. In the event of the liquidation, dissolution or winding up
of our affairs, whether voluntary or involuntary, the holders of shares of
Series A Preferred Stock then outstanding shall be entitled to receive, out of
our assets available for distribution to its stockholders, an amount equal to
$0.75 per share or the liquidation preference amount, of the Series A Preferred
Stock plus any accrued and unpaid dividends before any payment shall be made or
any assets distributed to the holders of the common stock or any other junior
stock. If our assets are not sufficient to pay in full the liquidation
preference amount plus any accrued and unpaid dividends payable to the holders
of outstanding shares of the Series A Preferred Stock and any series of
preferred stock or any other class of stock ranking pari passu, as to rights on
liquidation, dissolution or winding up, with the Series A Preferred Stock, then
all of said assets will be distributed among the holders of the Series A
Preferred Stock and the other classes of stock ranking pari passu with the
Series A Preferred Stock, if any, ratably in accordance with the respective
amounts that would be payable on such shares if all amounts payable thereon were
paid in full. The liquidation payment with respect to each outstanding
fractional share of Series A Preferred Stock shall be equal to a ratably
proportionate amount of the liquidation payment with respect to each outstanding
share of Series A Preferred Stock. All payments pursuant thereto, shall be in
cash, property (valued at its fair market value as determined by an independent
appraiser reasonably acceptable to the holders of a majority of the Series A
Preferred Stock) or a combination thereof; provided, however, that no cash shall
be paid to holders of junior stock unless each holder of the outstanding shares
of Series A Preferred Stock has been paid in cash the full Liquidation
Preference Amount plus any accrued and unpaid dividends to which such holder is
entitled as provided herein. After payment of the full liquidation preference
amount plus any accrued and unpaid dividends to which each holder is entitled,
such holders of shares of Series A Preferred Stock will not be entitled to any
further participation as such in any distribution of our assets.
F-22
NOTE 14. COMMITMENTS AND CONTINGENCIES
Corporate Offices
For the fiscal year ended August 31, 2006, our U.S. corporate office was located
at 400 Professional Drive, Suite 310, Gaithersburg, Maryland 20878. This space
was provided on a rent free basis by one of our shareholders. As a result, the
Company did not recognize rental expense in the fiscal year.
Employment Agreements
We entered into an employment agreement with Mr. Robert Saunders as our Chairman
and President effective on June 29, 2005. Subsequently in August 2005, Mr.
Saunders was appointed CEO by our Board of Directors. Mr. Saunders will serve at
the pleasure of the Board of Director's. For serving as President, Mr. Saunders'
compensation will be US $60,000 per annum. Additionally, we agreed to grant Mr.
Saunders a signing bonus of US $150,000 to be paid on closing of at least US
$3,500,000 in third party financing and increase his compensation to $120,000
per annum if we receive at least US $5,000,000 in outside funding. After the
completion of our Preferred Stock Financing (see Note 13 - Preferred Shares
Financing for additional information on the Series A Convertible Preferred
Stock), Mr. Saunders was due the signing bonus of $150,000 and a monthly salary
of $10,000 per month beginning in August 2006. However, Mr. Saunders agreed to
reduce his monthly salary to $5,000 per month until such time that we become
significantly cash flow positive for its operations. Additionally, we are
currently discussing possible restructuring/payment terms of the $150,000 bonus
and the accrued salary of $70,000 as of August 31, 2006 until such time that we
become significantly cash flow positive for its operations.
NOTE 15. SUBSEQUENT EVENTS (UNAUDITED)
In September 2006, the Company entered into a Settlement Agreement with the
Minister of Western Economic Diversification to amend the repayment terms of the
Company non-interest bearing loan of $611,055 (to Island Scallops) with the
Western Diversification Program. The Company agreed to repay the $174,976 due as
of August 31, 2006 in accordance with a payment schedule beginning with a
payment of $64,202 in September 2006 and continuing with monthly payment of
roughly $10,070 until August 15, 2007. The parties agreed that the remaining
balance of the $436,079 shall be repaid via quarterly payment equal to the
greater of $31,577 or 4% of the gross scallop sales starting the quarter
beginning on June 1, 2007 and subsequent quarters until the balance is repaid.
Under the terms of this agreement, the first quarter payment will be due on
September 30, 2007.
In September 2006, we engaged PR Global Concept GBR to provide international
investor relations services. The initial term of the agreement is two years.
Pursuant to the consulting agreement, we will pay PR Global $5,000 per month for
the term of the agreement. As additional compensation, we will also issue a
total of 500,000 options to purchase our common stock in quarter installments,
the first of which vested immediately upon signing the agreement and the
remainder of which will vest 3 months, 12 months and the final installment, 15
months after the date of signing; the options are exercisable at strike prices
ranging from $1.40 to $2.25.
F-23
NOTE 16. GOING CONCERN
Prior to the completion of our Preferred Stock Financing (see Note 13 for
additional details), our working capital had been primarily financed with
various forms of debt. We have suffered operating losses since inception in our
efforts to establish and execute our business strategy. As of August 31, 2006 we
had a cash balance of approximately $1,800,000. Although management believes
that we have adequate funds to maintain our business operations into the next
fiscal year and until we become cash flow positive, we are likely to continue to
suffer operational losses until the first quarter of our 2007 fiscal year. Until
our operations are able to demonstrate and maintain positive cash flows, we may
require additional working capital to fund our ongoing operations and execute
our business strategy. Based on these factors, there is substantial doubt about
our ability to continue as a going concern.
The financial statements do not include any adjustments relating to the
recoverability and classification of liabilities that might be necessary should
we be unable to continue as a going concern. Our ability to continue as a going
concern is dependent upon our ability to generate sufficient cash flows to meet
our obligations on a timely basis and ultimately to attain profitability. Our
Management intends to obtain working capital through operations and to seek
additional funding through debt and equity offerings to help fund our operations
as we expand. There is no assurance that we will be successful in our efforts to
raise additional working capital or achieve profitable operations. The financial
statements do not include any adjustments that might result from the outcome of
this uncertainty.
NOTE 17. FOREIGN OPERATIONS
The Company's share of the net assets held outside of the United States totaled
approximately $3,250,000 at August 31, 2006.
F-24
Interim Financial Statements
EDGEWATER FOODS INTERNATIONAL, INC.
CONSOLIDATED BALANCE SHEET
FEBRUARY 28, 2007
(unaudited)
2007
----
ASSETS
Current assets:
Cash $ 2,225,647
Accounts receivable, net 53,586
Inventory 1,416,432
Loans receivable, related party 56,684
Other current assets 82,988
------------
Total current assets 3,835,337
Property, plant and equipment, net 2,287,545
Investments in other assets 3,444
------------
Total assets $ 6,126,326
============
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Short term debt $ 287,692
Current portion of long term debt 428,752
Accounts payable and accrued liabilities 648,378
------------
Total current liabilities 1,364,822
Long term debt, net of current portion 383,074
------------
Total liabilities 1,747,896
------------
Commitments and contingencies
Stockholders' equity
Series A Preferred stock, par $0.001, 9,999,780
authorized, 7,821,333 issued and outstanding 7,821
Series B Preferred stock, par $0.001, 220
authorized, 207 issued and outstanding --
Common stock, par $0.0001, 100,000,000
authorized, 21,721,824 issued and outstanding 2,172
Additional paid in capital 20,782,333
Accumulated deficit (16,066,813)
Accumulated other comprehensive income -
foreign currency translation (347,083)
------------
3
Total stockholders' equity 4,378,430
------------
Total liabilities and stockholders' equity $ 6,126,326
============
See accompanying notes to consolidated financial statements
4
EDGEWATER FOODS INTERNATIONAL, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
THREE AND SIX MONTH PERIOD ENDING FEBRUARY 28
(unaudited)
THREE MONTHS ENDED SIX MONTHS ENDED
FEBRUARY 28, FEBRUARY 28,
---------------------------- ----------------------------
2007 2006 2007 2006
------------ ------------ ------------ ------------
Revenue $ 182,212 $ 143,372 $ 305,399 $ 303,551
Cost of goods sold 274,699 133,466 465,768 305,547
------------ ------------ ------------ ------------
Gross profit (loss) (92,487) 9,906 (160,369) (1,996)
------------ ------------ ------------ ------------
Expenses:
General and administrative expenses 244,795 62,804 420,726 105,867
Salaries and benefits 72,229 35,571 160,610 79,666
Stock compensation expense -- -- -- 182,500
------------ ------------ ------------ ------------
Total expenses 317,024 98,375 581,336 368,033
------------ ------------ ------------ ------------
Loss from operations (409,511) (88,469) (741,705) (370,029)
------------ ------------ ------------ ------------
Other income (expense):
Interest (expense), net (4,876) (52,573) (11,636) (106,096)
Change in fair value of warrants 8,595,107 -- 5,826,630 --
Other income (expense) 158,948 (517,468) 161,256 (513,350)
------------ ------------ ------------ ------------
Total other income (expense), net 8,749,179 (570,041) 5,976,250 (619,446)
------------ ------------ ------------ ------------
Net income (loss) 8,339,668 (658,510) 5,234,545 (989,475)
Dividend on preferred stock (234,497) -- (234,497) --
------------ ------------ ------------ ------------
Net income (loss) applicable to common
shareholders 8,105,171 (658,510) 5,000,048 (989,475)
Foreign currency translation (46,731) (28,205) (90,763) (221,553)
------------ ------------ ------------ ------------
Accumulated other comprehensive
income (loss) $ 8,058,440 $ (686,715) $ 4,909,285 $ (1,211,028)
============ ============ ============ ============
Net income (loss) per Share
Basic and diluted $ 0.38 $ (0.03) $ 0.25 $ (0.05)
Weighted average shares outstanding
Basic and diluted 21,782,245 20,689,289 21,091,042 20,626,422
See accompanying notes to consolidated financial statements
5
EDGEWATER FOODS INTERNATIONAL, INC.
CONSOLIDATED STATEMENTS OF CASHFLOWS
SIX MONTHS ENDED FEBRUARY 28
(unaudited)
2007 2006
------------ ------------
Cash flows from operating activities:
Net income (loss) $ 5,234,545 $ (989,475)
Adjustments to reconcile net income (loss) to net cash
used in operating activities:
Depreciation and amortization 147,017 135,923
Changes in fair value of warrants (5,826,630) --
Stock option expense 56,827 --
Common stock issued for services -- 702,500
Gain on disposal of debt (158,211) --
Changes in current assets and liabilities:
Accounts receivable (14,736) (27,320)
Prepaid expenses (38,407) 11,307
Loan receivable (33,669) 5,405
Inventory (164,381) (280,142)
Accounts payable (39,705) 120,808
Bank overdrafts -- (12,610)
------------ ------------
Net cash used in operating activities (837,350) (333,604)
------------ ------------
Cash flows from investing activities:
Purchase of property, plant and equipment (697,602) (18,113)
------------ ------------
Net cash used in investing activities (697,602) (18,113)
------------ ------------
Cash flows from financing activities:
Net proceeds from line of credit -- 4,623
Proceeds from short term debt -- 405,036
Payment of short term debt (3,232) --
Proceeds of long term debt -- 2,178
Payment of long term debt (127,647) (13,292)
Proceeds from exercise of warrants 276,000 --
Proceeds from sale of preferred stock 1,864,501 --
------------ ------------
6
Net cash provided by financing activities 2,009,622 398,545
------------ ------------
Foreign currency translation effect (65,765) (47,265)
------------ ------------
Net increase (decrease) in cash 408,905 (437)
Cash, beginning of period 1,816,742 560
------------ ------------
Cash, end of period $ 2,225,647 $ 123
============ ============
Supplemental disclosure of cash flow information
Net cash paid during year ended
Interest $ -- $ --
============ ============
Income taxes $ -- $ --
============ ============
Supplemental disclosure of non-cash flow information
Issuance of stock for dividends $ 234,497 $ --
============ ============
Warrant liability incurred in connection with financing $ 4,116,739 $ --
============ ============
Reclassification of warrant liability $(20,449,559) $ --
============ ============
See accompanying notes consolidated to financial statements
7
EDGEWATER FOODS INTERNATIONAL , INC.
NOTES TO CONSOLIDATED Financial Statements
(unaudited)
NOTE 1. BASIS OF PRESENTATION, ORGANIZATION AND NATURE OF OPERATIONS
Edgewater Foods International Inc., a Nevada Corporation, is the parent company
of Island Scallops Ltd., a Vancouver Island aquaculture company. Island Scallops
was established in 1989 and for over 15 years has successfully operated a
scallop farming and marine hatchery business. Island Scallops is dedicated to
the farming, processing and marketing of high quality, high value marine
species: scallops and sablefish.
On June 29, 2005, Edgewater Foods International, Inc. ("Edgewater"), a holding
private company established under the laws of Nevada in order to acquire assets
in the aquaculture industry, issued 10,300,000 shares of common stock in
exchange for a 100% equity interest in Island Scallops, Ltd. As a result of the
share exchange, Island Scallops, Ltd. become the wholly own subsidiary of
Edgewater. As a result, the shareholders of Island Scallops owned a majority
(54.21%) of the voting stock of Edgewater. The transaction was regarded as a
reverse merger whereby Island Scallops was considered to be the accounting
acquirer as its shareholders retained control of Edgewater after the exchange,
although Edgewater is the legal parent company. The share exchange was treated
as a recapitalization of Edgewater. As such, Island Scallops (and its historical
financial statements) is the continuing entity for financial reporting purposes.
On August 15, 2005, we completed a reverse acquisition of Heritage Management
Corporation, a public shell company, as that term is defined in Rule 12b-2 of
the Exchange Act, established under the laws of Nevada on June 12, 2000. To
accomplish the share exchange we issued 19,000,000 shares of common stock on a
one to one ratio for a 100% equity interest in Edgewater. Per the terms of the
Share Exchange and Bill of Sale of Heritage Funding Corporation and E. Lee
Murdoch, Heritage was delivered with zero assets and zero liabilities at time of
closing. Following the reverse acquisition, we changed the name of Heritage
Management Corporation to "Edgewater Foods International, Inc." The transaction
was regarded as a reverse merger whereby Edgewater was considered to be the
accounting acquirer as it retained control of Heritage after the exchange.
Although Edgewater is the legal parent company, the share exchange was treated
as a recapitalization of Edgewater. Edgewater is the continuing entity for
financial reporting purposes. The Financial Statements contained herein have
been prepared as if Edgewater had always been the reporting company and then on
the share exchange date, had changed its name and reorganized its capital stock.
NOTE 2. SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
Our unaudited consolidated financial statements are prepared in conformity with
accounting principles generally accepted in the United States of America for
8
reporting interim financial information and the rules and regulations of the
Securities and Exchange Commission. In the opinion of management, all
adjustments necessary for a fair presentation of the financial position and
results of operations for the periods presented have been included. All such
adjustments are of a normal recurring nature. These unaudited consolidated
financial statements should be read in conjunction with the audited consolidated
financial statements included in our Annual Report on Form 10-KSB for the year
ended August 31, 2006. Results of operations for the three and six months ended
February 28, 2007, are not necessarily indicative of the operating results for
the full accounting year or any future period.
Inventory
Edgewater maintains inventories of raw materials for its aquaculture products,
of biomass (inventory of live aquaculture product being actively cultivated),
and of finished goods (aquaculture product ready for sale).
Inventories are reported at the lesser of cost or estimated net realizable
value. Biomass and finished goods includes direct and reasonably attributable
indirect production costs related to hatchery, cultivation, harvesting, and
processing activities. Carrying costs per unit are determined on a weighted
average basis.
At February 28, 2007, inventory consisted of the following:
Biomass (Scallops): $1,416,432
Derivative Financial Instruments
In connection with the sale of debt or equity instruments, we may sell options
or warrants to purchase our common stock. In certain circumstances, these
options or warrants may be classified as derivative liabilities, rather than as
equity. Additionally, the debt or equity instruments may contain embedded
derivative instruments, such as embedded derivative features, which in certain
circumstances may be required to be bifurcated from the associated host
instrument and accounted for separately as a derivative instrument liability.
Edgewater accounts for all derivatives financial instruments in accordance with
SFAS No. 133. Derivative financial instruments are recorded as liabilities in
the consolidated balance sheet, measured at fair value. When available, quoted
market prices are used in determining fair value. However, if quoted market
prices are not available, Edgewater estimates fair value using either quoted
market prices of financial instruments with similar characteristics or other
valuation techniques.
The identification of, and accounting for, derivative instruments is complex.
Our derivative instrument liabilities are re-valued at the end of each reporting
period, with changes in the fair value of the derivative liability recorded as
charges or credits to income, in the period in which the changes occur. For
options, warrants and bifurcated embedded derivative features that are accounted
for as derivative instrument liabilities, we estimate fair value using either
9
quoted market prices of financial instruments with similar characteristics or
other valuation techniques. The valuation techniques require assumptions related
to the remaining term of the instruments and risk-free rates of return, our
current common stock price and expected dividend yield, and the expected
volatility of our common stock price over the life of the option. The
identification of, and accounting for, derivative instruments and the
assumptions used to value them can significantly affect our financial
statements.
Derivative financial instruments that are not designated as hedges or that do
not meet the criteria for hedge accounting under SFAS No. 133 are recorded at
fair value, with gains or losses reported currently in earnings. None of
Edgewater's derivative financial instruments held as of February 28, 2007 were
designated as hedges.
Change in Depreciation Method
Effective September 1, 2006, as a result of management's evaluation of
long-lived depreciable assets, we adopted the straight-line method of
depreciation for all property, plant and equipment. Under the new provisions of
SFAS No. 154 "Accounting Changes and Error Corrections, a replacement of APB
Opinion No. 20 and FASB Statement No. 3," which becomes effective as of
September 1, 2006, a change in depreciation method is treated as a change in
estimate. The effect of the change in depreciation method will be reflected on a
prospective basis beginning September 1, 2006, and prior period results will not
be restated. As the results of management's evaluation indicated the current
estimated useful lives of our assets were appropriate, the depreciable lives of
property, plant and equipment will not be changed. We believe that the change
from the declining balance depreciation method to the straight-line method will
better reflect the pattern of consumption of the future benefits to be derived
from those assets being deprecated and will provide a better matching of costs
and revenues over the assets' estimated useful lives.
Reclassifications
Certain 2006 amounts have been reclassified to conform to 2007 presentation.
Recent accounting pronouncements
In June 2006, the FASB issued FASB Interpretation No. 48, Accounting for
Uncertainty in Income Taxes - An Interpretation of FASB Statement No. 109 ("FIN
48"). FIN 48 clarifies the accounting for uncertainty in income taxes recognized
in a company's financial statements and prescribes a recognition threshold and
measurement attribute for the financial statement recognition and measurement of
a tax position expected to be taken in a tax return. The Interpretation also
provides guidance on de-recognition, classification, interest and penalties,
accounting in interim periods, disclosure and transition. FIN 48 is effective
for fiscal years beginning after December 15, 2006. Currently, there would be no
effect of this Interpretation on our financial position and results of
operations.
During September 2006, the FASB issued Statement of Financial Accounting
Standards ("SFAS") No. 157, Fair Value Measurements ("FAS 157"). FAS 157
10
establishes a standard definition for fair value, establishes a framework under
generally accepted accounting principles for measuring fair value and requires
enhanced disclosures about fair value measurements. This standard is effective
for financial statements issued for fiscal years beginning after November 15,
2007. We are currently evaluating the impact, if any, the adoption of FAS 157
will have on its financial position and results of operations.
During September 2006, the Securities and Exchange Commission issued Staff
Accounting Bulletin No. 108 ("SAB 108"), Considering the Effects of Prior Year
Misstatements when Quantifying Misstatements in Current Year Financial
Statement. This SAB provides guidance on how the effects of the carryover or
reversal of prior year misstatements should be considered in quantifying a
current year misstatement. This interpretation is effective for the first fiscal
year ending after November 15, 2006. We do not expect the adoption of this
interpretation to have an impact on our financial position or results of
operations.
In December 2006, the FASB issued FASB Staff Position EITF 00-19-2, Accounting
for Registration Payment Arrangements ("FSP EITF 00-19-2"). FSP EITF 00-19-2
specifies that the contingent obligation to make future payments or otherwise
transfer consideration under a registration payment arrangement, whether issued
as a separate agreement or included as a provision of a financial instrument or
other agreement, should be separately recognized and measured in accordance with
FASB Statement No. 5, Accounting for Contingencies. A registration payment
arrangement is defined in FSP EITF 00-19-2 as an arrangement with both of the
following characteristics: (1) the arrangement specifies that the issuer will
endeavor (a) to file a registration statement for the resale of specified
financial instruments and/or for the resale of equity shares that are issuable
upon exercise or conversion of specified financial instruments and for that
registration statement to be declared effective by the US SEC within a specified
grace period, and/or (b) to maintain the effectiveness of the registration
statement for a specified period of time (or in perpetuity); and (2) the
arrangement requires the issuer to transfer consideration to the counterparty if
the registration statement for the resale of the financial instrument or
instruments subject to the arrangement is not declared effective or if
effectiveness of the registration statement is not maintained. FSP EITF 00-19-2
is effective for registration payment arrangements and the financial instruments
subject to those arrangements that are entered into or modified subsequent to
December 21, 2006. For registration payment arrangements and financial
instruments subject to those arrangements that were entered into prior to the
issuance of FSP EITF 00-19-2, this guidance is effective for financial
statements issued for fiscal years beginning after December 15, 2006, and
interim periods within those fiscal years. We do not expect the adoption of FSP
EITF 00-19-2 to have a material impact on our consolidated financial statements.
In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for
Financial Assets and Financial Liabilities ("SFAS 159") which permits entities
to choose to measure many financial instruments and certain other items at fair
value that are not currently required to be measured at fair value. SFAS 159
will be effective for us on January 1, 2008. We are currently evaluating the
impact of adopting SFAS 159 on our financial position, cash flows, and results
of operations.
11
NOTE 3. PROPERTY, PLANT AND EQUIPMENT
Property, Plant and Equipment at February 28, 2007 consisted of the following:
Accumulated Net Book
Cost Amortization Value
-------------------------------------
Land $ 216,998 $ -- $ 216,998
Buildings 738,236 220,338 517,898
Seawater piping and tanks 537,720 268,105 269,615
Boats and Barge 333,939 124,047 209,892
Field equipment 1,853,843 799,349 1,054,494
Office equipment 14,406 12,654 1,752
Vehicles 36,430 34,938 1,492
Computer equipment 24,352 8,948 15,404
---------- ---------- ----------
$3,755,924 $1,468,379 $2,287,545
========== ========== ==========
Depreciation expenses for the six month ended February 28, 2007 and 2006 was
$147,017 and $135,923.
NOTE 4. RELATED PARTY TRANSACTIONS
We have six secured notes receivable from RKS Laboratories, Inc. ("RKS"), a
Vancouver research and development company that is working towards developing
superior strains of scallops with beneficial traits such as higher meat yield
and rapid growth. (Robert Saunders, our President and CEO, owns 100% of RKS.)
The first non-interest bearing note in the amount of $17,222 is secured by all
assets of RKS is due on or before June 15, 2007. The second non-interest bearing
note in the amount of $4,745 is also secured by all assets of RKS is due on or
before August 31, 2007. The third non-interest bearing note in the amount of
$17,222 is also secured by all assets of RKS is due on or before September 15,
2007. The fourth non-interest bearing note in the amount of $12,916 is also
secured by all assets of RKS is due on or before September 21, 2007. The fifth
non-interest bearing note in the amount of $2,324 is also secured by all assets
of RKS is due on or before November 30, 2007. The sixth non-interest bearing
note in the amount of $2,255 is also secured by all assets of RKS is due on or
before February 28, 2008. These amounts are included in current assets as loans
receivable.
NOTE 5. INVESTMENTS IN TENURES
Edgewater carries its Investment in Tenures at $3,444 at February 28, 2007. This
amount represents the carrying costs of certain shellfish tenures acquired by
Island Scallops' subsidiary, 377332 B.C. Ltd. Shellfish tenures are
12
government-granted rights allowing limited use of offshore waters for the
purposes of cultivation of shellfish. The granting of shellfish tenure rights
are the responsibility of the Provincial (British Columbia) Government and not
the Canadian Federal Government. As such, the government assistance that we
receive via loan agreement with various Federal Agencies has no effect on our
ability to renew and/or modify these tenure agreements. The tenure held by
377332 B.C. Ltd. has an expiration date of July 10, 2021. Other shellfish
tenures held by Edgewater and our subsidiaries have expiration dates ranging
from 2021 to 2024.
These tenures are considered to have an indefinite useful life because renewal
on expiration is anticipated, and therefore are not subject to amortization.
NOTE 6. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
Included in accounts payable and accrued liabilities are balances outstanding
related to credit cards held in the name of one of our shareholders totaling
$17,240 at February 28, 2007. We used these credit cards as a means of short
term financing and incur interest charges on such unpaid balances.
Included in accounts payable and accrued liabilities at February 28, 2007, is an
amount of $113,544 in respect to an agreement to purchase geoduck seed from us
(for additional information see Note 13 - Contingent Liabilities).
Included in accounts payable and accrued liabilities at February 28, 2007 is an
amount of $69,947 payments due and interest accrued in respect to the loan from
the National Research Council of Canada Industrial Research Assistance Program
(see Note 8 - Long Term Debt for additional information).
NOTE 7. SHORT TERM DEBT
These consolidated financial statements include Island Scallop's mortgage loan
repayable at $1,937 per month including interest calculated at the greater of
10% and (Canadian) prime plus 6% (11.5% as of February 28, 2007). The loan,
which was due on April 1, 2007, is secured by a second charge on the real
property of Island Scallops. The company is currently finalizing the terms of a
new loan for this mortgage payable and the current due date has been extended by
the lender until the new loan in completed. At February 28, 2007, the principal
due is $183,771.
Included in short-term debt at February 28, 2007, is estimated royalties of
$57,310 payable to a third party from whom the former sole shareholder of Island
Scallops originally acquired the shares of Island Scallops. The 1992 share
purchase agreement (for Island Scallops) provided that the third party was to
receive 3% of revenues from Island Scallops as earned, on a quarterly basis,
throughout the period from December 1, 1992 to November 30, 2002. The third
party holds a first charge (or first lien) over our inventory (including
broodstock) in the amount of $301,360 in support of its royalty entitlement. The
third party has not taken further action to enforce payment of the arrears
liability. To date, we have accrued the entire balance of $57,310 as a current
liability and we plan to pay it with available funds in the near future.
13
Included in short-term notes payable at February 28, 2007, is an unsecured
non-interest bearing demand loan from an individual with a face value of $43,198
and no specific terms of repayment. However, the lender has informally requested
that the loan be repaid in full by October 6, 2008.
Included in short-term debt is a bank loan repayable at $448 per month plus
interest calculated at (Canadian) prime plus 3% per annum (9% as of February 28,
2007), that is unsecured and is due October 23, 2007. At February 28, 2007, the
principal due is $3,413.
These consolidated financial statements formerly included a non-interest bearing
loan to Island Scallops from Industry Science and Technology Canada requiring
repayment equal to 0.5% of Island Scallops' gross scallop sales for each
preceding year. Per the terms of the loan, if we were unable to generate
sufficient revenues to repay the original amount of the loan by January 1, 2007,
the remaining balance would be forgiven. As such, the remaining balance of
approximately $159,000 was forgiven on January 1, 2007.
NOTE 8. LONG TERM DEBT
These consolidated financial statements include a Western Diversification
Program non-interest bearing loan to Island Scallops that requires repayment
equal to 12% of gross revenues from our scallop sales, payable semi-annually,
with no specified due date. In September 2006, we entered into a Settlement
Agreement with the Minister of Western Economic Diversification to amend the
repayment terms of our non-interest bearing loan of $597,103 (to Island
Scallops) with the Western Diversification Program. We agreed to repay the
$170,981 due as of August 31, 2006, in accordance with a payment schedule
beginning with a payment of $62,736 in September 2006 and continuing with
monthly payments of roughly $9,840 until August 15, 2007. The parties agreed
that the remaining balance of the $426,122 shall be repaid via quarterly
payments equal to the greater of $30,856 or 4% of the gross scallop sales
starting the quarter beginning on June 1, 2007 and subsequent quarters until the
balance is repaid. Under the terms of this agreement, the first quarter payment
will be due on September 30, 2007. At February 28, 2007, the balance due is
$473,884, of which $116,643 is reflected in the current portion of long term
debt and the remaining balance of $357,241 is reflected as long term debt.
These consolidated financial statements include Island Scallops' unsecured
non-interest bearing loan from the National Research Council of Canada
Industrial Research Assistance Program which requires quarterly payments
commencing March 1, 2003 equal to 3% of gross revenues of Island Scallops until
the earlier of full repayment or December 1, 2012. The amount repayable is up to
150% of the original advance of $379,424, if repayment is before December 1,
2007. If at December 1, 2012, Island Scallops has not earned sufficient revenues
to be required to repay the original loan amount, the remaining portion of the
loan is to be forgiven. Amounts currently due at February 28, 2007, bear
interest at a rate of 1% per month. At February 28, 2007, Island Scallops is in
arrears in respect to the payment of these amounts. The National Council of
Canada Industrial Research Assistance Program has requested payment of the
14
$69,947 that they claim is owed under this loan agreement. As such, at February
28, 2007, $69,947 is included in accounts payable and accrued liabilities and
the remaining full principal balance of $312,109 is reflected in the current
portion of long term debt. We are seeking to renegotiate the repayment terms.
Included in long-term debt is one bank loan to Island Scallops. The bank loan is
repayable at $1,076 per month, plus interest calculated at the floating base
rate of the Business Development Bank of Canada plus 1.5% annum (9.5% as of
February 28, 2007), is due February 23, 2009 and is secured by a General
Security Agreement over the assets of Island Scallops, a mortgage charge on
Island Scallops' real property and a personal guarantee of $43,055 by our
Chairman, President and CEO, and former sole shareholder of Island Scallops. At
February 28, 2007, the principal due is $25,833.
NOTE 9. SERIES B PREFERRED STOCK FINANCING
We completed a private equity financing of $2,070,000 on January 16, 2007, with
two accredited investors. Net proceeds from the offering are approximately
$1,864,500. We issued 207 shares of our Series B Preferred Stock, par value
$0.001 per share and stated value of $10,000 per share and each investor also
received one of each of the following warrants: (i) Series A Warrant, (ii)
Series B Warrant, (iii) Series C Warrant, (iv) Series J Warrant, (v) Series D
Warrant, (vi) Series E Warrant, and (vii) Series F Warrant, each to purchase a
number of shares of common stock equal to fifty percent (50%) of the number of
shares of common stock issuable upon conversion of the purchaser's preferred
stock, except for the Series J Warrants, which shall entitle the investor to
purchase a number of shares of our common stock equal to one hundred percent
(100%) of the number of shares of common stock issuable upon conversion of the
purchaser's preferred stock. Each of the Warrants has a term of 6 years, except
for the Series J Warrants, which have a term of 1 year. Each share of the
preferred stock is convertible into a number of fully paid and nonassessable
shares of our common stock equal to the quotient of the liquidation preference
amount per share ($10,000) divided by the conversion price, which initially is
$1.15 per share, subject to certain adjustments, or approximately 8,696 shares
of common for each share of converted preferred stock. We issued a total of
7,200,345 Warrants.
In connection with this financing, we paid cash compensation to a placement
consultant in the amount of $165,600 and issued him placement consultant
warrants, exercisable for a period of three years from the date of issue. The
placement consultant's warrants allow him to purchase up to (i) 20 shares of
Series B Preferred Stock, and each of the following warrants, which are
identical to the warrants issued to the investors of the financing: (i) Series A
Warrant, (ii) Series B Warrant, (iii) Series C Warrant, (iv) Series D Warrant,
(v) Series J Warrant, (vi) Series E Warrant, and (vii) Series F Warrant, each to
purchase 90,004 shares of common stock, except for the Series J Warrants, which
shall entitle the Consultant to purchase 180,008 shares of common stock. The
placement consultant warrant is exercisable at a price of $1.15, for a period of
three years. The fees were recorded as a cost of capital.
The net proceeds from the January 16, 2007 financing are to be used for capital
expenditures necessary to expand our operations into clam farming in Morocco
(any remaining proceeds may be used for working capital and general corporate
15
purposes). We are currently conducting due diligence on a North African based
aquaculture company that farms shellfish products in Morocco and pending the
successful completion of such inquiry, may acquire a majority ownership interest
in the company. At the date of this filing, we have not entered into any binding
agreements for the purchase of such company and may or may not do so depending
on the results of our due diligence investigation.
NOTE 10. SERIES A PREFERRED STOCK WARRANT LIABILITIES
The warrants that each investor received as a result of our April 12, May 30,
June 30 and July 11 Preferred Stock Financing contained a cashless exercise
provision that becomes effective one year after the original issuance date of
such warrants if our registration statement (that we are required to file under
the Series A Preferred Stock Financing's corresponding registration rights
agreement) is not then in effect by the date such registration statement was
required to be effective pursuant to the Registration Rights Agreement of the
Preferred Stock Financing or not effective at any time during the Effectiveness
Period (as defined in the Registration Rights Agreement) in accordance with the
terms of the Registration Rights Agreement. As such and in accordance with the
accounting guidelines under SFAS No. 133, we valued the warrants as a derivative
financial instrument and the corresponding liabilities were entered onto our
consolidated balance sheet, measured at fair value. We determined the fair value
of the warrants as follows as of April 12, 2006, May 30, 2006, June 30, 2006 and
July 11, 2006 (the issuance dates).
We used the Black Scholes option-pricing model with the following assumptions:
an expected life equal to the contractual term of the warrants (one, three or
five), underlying stock price of $1.10 (at April 12), $1.40 (at May 30), $1.35
(at June 30) and $1.40 (July 11) no dividends; a risk free rate of 4.91%, 4.90%
and 4.91%, which equals the one, three and five-year yield on Treasury bonds at
constant (or fixed) maturity (for those warrants issued on April 12), a risk
free rate of 4.99%, which equals three and five-year yield on Treasury bonds at
constant (or fixed) maturity (for those warrants issued on May 30), a risk free
rate of 4.71% and 4.70%, which equals the three and five-year yield on Treasury
bonds at constant (or fixed) maturity (for those warrants issued on June 30) and
a risk free rate of 4.71% and 4.70%, which equals the three and five-year yield
on Treasury bonds at constant (or fixed) maturity (for those warrants issued on
July 11); and volatility of 93%. Under the assumptions, the Black-Scholes option
pricing model yielded an aggregate value of approximately $19,494,000 with a
current portion of approximately $1,225,000.
We performed the same calculations as of August 31, 2006, to revalue the
warrants as of that date. In using the Black Scholes option-pricing model, we
used an underlying stock price of $1.40 per share; no dividends; a risk free
rate of 5.01%, 4.71% and 4.70%, which equals the one, three and five-year yield
on Treasury bonds at constant (or fixed); and maturity volatility of 93%. The
resulting aggregate allocated value of the warrants as of August 31 2006 equaled
approximately $22,160,000. The change in fair value of approximately $2,666,000
(with a current portion of roughly $519,000) was recorded for the period ended
August 31, 2006.
We performed the same calculations as of November 30, 2006, to revalue the
warrants as of that date. In using the Black Scholes option-pricing model, we
16
used an underlying stock price of $1.50 per share; no dividends; a risk free
rate of 4.94%, 4.52% and 4.45%, which equals the one, three and five-year yield
on Treasury bonds at constant (or fixed); and maturity volatility of 100%. The
resulting aggregate allocated value of the warrants as of November 30, 2006
equaled approximately $24,928,000. The change in fair value of approximately
$2,768,000 (with a current portion of roughly $198,000) was recorded for the
period ended November 30, 2006.
We performed the same calculations as of February 21, 2007 (date of
reclassification of warrant liability, see Note 12 for additional information),
to revalue the warrants as of that date. In using the Black Scholes
option-pricing model, we used an underlying stock price of $1.15 per share; no
dividends; a risk free rate of 5.05%, 4.74% and 4.68%, which equals the one,
three and five-year yield on Treasury bonds at constant (or fixed); and maturity
volatility of 96%. The resulting aggregate allocated value of the warrants as of
February 21, 2007 equaled approximately $17,365,000. The change in fair value
(gain) of approximately $7,563,000 (with a current portion of roughly $994,000)
was recorded for the period ended February 21, 2007.
Upon the earlier of the warrant exercise or the expiration date, the warrant
liability will be reclassified into shareholders' equity. Until that time, the
warrant liability will be recorded at fair value based on the methodology
described above. Liquidated damages under the registration rights agreement will
be expensed as incurred and will be included in operating expenses.
NOTE 11. SERIES B PREFERRED STOCK WARRANT LIABILITIES
The warrants that each investor received as a result of our January 16, 2007
Series B Preferred Stock Financing contained a cashless exercise provision that
becomes effective one year after the original issuance date of such warrants if
our registration statement (that we are required to file under the Series B
Preferred Stock Financing's corresponding registration rights agreement) is then
in effect by the required date or not effective at any time during the
Effectiveness Period (as defined in the Registration Rights Agreement). As such
and in accordance with the accounting guidelines under SFAS No. 133, we valued
the warrants as a derivative financial instrument and the corresponding
liabilities were entered onto our consolidated balance sheet, measured at fair
value. We determined the fair value of the warrants as follows as of January 16,
2007 (the issuance date):
We used the Black Scholes option-pricing model with the following assumptions:
an expected life equal to the contractual term of the warrants (one, three or
six), underlying stock price of $1.40 (at January 16), no dividends; a risk free
rate of 5.06%, 4.79% and 4.74%, which equals the one, three and six-year yield
on Treasury bonds at constant (or fixed) maturity and volatility of 93%. Under
the assumptions, the Black-Scholes option pricing model yielded an aggregate
value of approximately $4,117,000 with a current portion of approximately
$1,058,000.
We performed the same calculations as of February 2, 2007 (date of
reclassification of warrant liability, see Note 12 for additional information),
to revalue the warrants as of that date. In using the Black Scholes
option-pricing model, we used an underlying stock price of $1.15 per share; no
dividends; a risk free rate of 5.05%, 4.74% and 4.68%, which equals the one,
three and six-year yield on Treasury bonds at constant (or fixed); and maturity
17
volatility of 96%. The resulting aggregate allocated value of the warrants as of
February 21, 2007 equaled approximately $3,085,000. The change in fair value
(gain) of approximately $1,033,000 (with a current portion of roughly $342,000)
was recorded for the period ended February 21, 2007.
Upon the earlier of the warrant exercise or the expiration date, the warrant
liability will be reclassified into shareholders' equity. Until that time, the
warrant liability will be recorded at fair value based on the methodology
described above. Liquidated damages under the registration rights agreement will
be expensed as incurred and will be included in operating expenses.
NOTE 12. RECLASSIFICATION OF WARRANT LIABILITIES ASSOCIATED WITH SERIES A AND
SERIES B PREFERRED FINANCINGS
The warrants that each investor received as a result of our April 12, May 30,
June 30 and July 11, 2006 Series A Preferred Stock Financing and our January 16,
2007 Series B Preferred Stock Financing contained a cashless exercise provision
that becomes effective one year after the original issuance date of such
warrants if our registration statements (that we are required to file under the
registration rights agreement for both financings) are not then in effect by the
date such registration statement was required to be effective pursuant to the
each Registration Rights Agreement of the Preferred Stock Financings or not
effective at any time during the Effectiveness Period (as defined in each of the
Registration Rights Agreements) in accordance with the terms of each of the
Registration Rights Agreement. As such and in accordance with the accounting
guidelines under SFAS No. 133 and ETIF Issue No. 00-19 (Accounting for
Derivative Financial Instruments Indexed to, and Potentially Settled in a,
Company's Own Stock), we classified the warrants as a liability because the
cashless exercise provision did not specify whether the contract could be
settled via the delivery of unregistered shares of our common stock. As such and
per the terms of paragraph 14 of ETIF 00-19 (see below), we assumed net-cash
settlement and the warrants were classified as a derivative financial instrument
and the corresponding liabilities were entered onto our consolidated balance
sheet, measured at fair value. We determined the fair value of the warrants as
follows as of April 12, 2006, May 30, 2006, June 30, 2006, July 11, 2006 and
January 16, 2007 (the issuance dates) and we preformed the same calculation as
of May 31, August 31, November 30 and February 28 to revalue the warrants at the
end of each period (as described above in Notes 9 and 10). The change in fair
value was then recorded for each period.
On February 28, 2007, the cashless exercise provision for all warrants issued in
conjunction with both the Series A and Series B Preferred Stock financings was
modified to clarify that any shares issued in connection with the cashless
exercise will be "restricted." As a result, we determined that (per the
accounting guidelines under SFAS No. 133 and ETIF Issue No. 00-19) we are now
able to net-share settle the contract by delivery of unregistered shares and
that the warrant liability should be reclassified as permanent equity.
The initial fair value of the Series A warrant liability was determined to be
approximately $19,494,000 (with a current portion of approximately $1,225,000).
Since this value exceeded our additional paid in capital ("APIC") balance,
approximately $9,021,000 of the liability was allocated to APIC and the
18
remaining $10,472,000 was allocated to retained deficit. We made this decision
because the changes in the fair value of the warrants are marked through our
profit and loss.
The initial fair value of the Series B warrant liability was determined to be
approximately $4,117,000 (with a current portion of approximately $1,058,000).
Since this value exceeded our additional paid in capital ("APIC"), approximately
$2,099,000 of the liability was allocated to APIC and the remaining $2,018,000
was allocated to retained deficit. We made this decision because the changes in
the fair value of the warrants are marked through our profit and loss.
As described above, a portion of the fair value of the warrant liability was
allocated to APIC and the remaining balance was allocated to retained deficit.
Subsequent changes in the fair value of the warrants (at May 31, August 28,
November 30, and February 28), were marked through our profit and loss. Since
the terms of the cashless provision have been clarified and the warrants were
reclassified as equity, we reversed the liabilities and allocated approximately
$20,450,000 to APIC ($17,365,000 from the Series A financing warrants and
$3,085,000 from the Series B financing warrants).
NOTE 13. CONTINGENT LIABILITIES
Our wholly owned subsidiary, Island Scallops, entered into an agreement in 1998
with two parties, under which Island Scallops was to produce and sell geoduck
seed to the two parties. Island Scallops received advance payments from each of
the two parties in the 2002 of approximately $64,140 and recognized related
revenue of $43,705 in respect to seed delivered in the 2002 year. The balance of
the deposits received (advance payments), net of sales, totaling $113,544, is
included in accounts payable and accrued liabilities.
Management's position is that the two parties violated the terms of the
agreement and we are therefore entitled to retain the balance of the deposits.
Per the terms of the original agreement, Island Scallops was entitled to make up
any shortfall in the product produced in the following year. Although product
was available and offered by Island Scallops in the following year, the two
parties refused to honor the terms of the agreement and would not accept the
product (to make up the shortfall) in the following year.
As of August 31, 2004, one of the two parties made claims that Island Scallops
owed it an amount totaling $88,925. This particular party believed that the
agreement required Island Scallops to deliver the product in year one and did
not allow Island Scallops to make up any shortfall with product produced in the
following year. The balance included in accounts payable and accrued liabilities
related to this party is $33,126.
Any additional liability to us, or any reduction of the currently recognized
liability, in respect to these deposits will be recorded at the time a
conclusion to this matter can be determined.
Neither we nor our wholly owned subsidiary maintain insurance covering the
replacement of our inventory. Consequently, we are exposed to financial losses
or failure as a result of this risk.
19
NOTE 14. STOCK-COMPENSATION EXPENSE
On December 31, 2006, we issued 138,565 shares of common stock to the Series A
Convertible Preferred Stock holders. The number of shares issued was based on
the Dividend Payment at a rate of 8% per annum (subject to a pro rata
adjustment) of the Liquidation Preference Amount ($1,416,000 for the April 12
financing, $1,500,000 for the May 30 financing, $1,550,000 for the June 30
financing and $1,450,000 for the July 11 financing) payable in shares equal to
90% of the quotient of (i) the Dividend Payment divided by (ii) the average of
the VWAP for the twenty (20) trading days immediately preceding the date the
Dividend Payment is due, but in no event less than $0.65. As such, the shares
were valued at approximately $234,000 and the total aggregate value of the
transaction was recorded as a preferred stock dividend.
Stock Options
In August 2005, our Board of Directors approved the "Edgewater Foods
International 2005 Equity Incentive Plan." The Board of Directors reserved
5,000,000 shares of our common stock to be issued in the form of incentive
and/or non-qualified stock options for employees, directors and consultants to
Edgewater. As of August 31, 2006, our Board of Directors had authorized the
issuance of 282,000 options to employees.
In September 2006, we engaged PR Global Concept GBR to provide international
investor relations services. The initial term of the agreement was for two
years. Pursuant to the consulting agreement, we were to pay PR Global $5,000 per
month for the term of the agreement. As additional compensation, we originally
agreed to issue a total of 500,000 options to purchase our common stock in
quarter installments, the first 125,000 of which was to vest immediately upon
signing of the agreement and the remainder of which was to vest in three equal
amounts of 125,000 after 3 months, 12 months and the final installment, 15
months after the date of signing; the options are exercisable at strike prices
ranging from $1.40 to $2.25. The options were to be exercisable for a period of
three years from the date of the vesting.
In December 2006, we entered into an Amended and Restated Agreement with PR
Global Concept GBR. Under the terms of the amended agreement, PR Global was only
eligible to receive a total of 350,000 (as opposed to 500,000 in the original
agreement) options to purchase our common stock in the following installments:
25,000 options every 3 months after the date of the Amended Agreement for a
total of four installments; one installment of 125,000 options 18 months from
the date of the Amended Agreement; and, one installment of 125,000 options 24
months from the date of the Amended Agreement. The options issued in the first
four installments were to be exercisable at a strike price of $1.52 and the last
two installments were to be exercisable at a strike price of $2.25. The options
were to be exercisable for a period of three years from the date of the vesting.
Additionally, PR Global would no longer receive the $5,000 monthly payment; we
did however pay the one month owed to PR Global under the original agreement
when the Amended Agreement was signed. The Amended Agreement was otherwise
unchanged from the originally entered into agreement with PR Global. On January
20
12, 2007, however, we terminated our Amended and Restated Agreement with PR
Global and ended our relationship with the firm. As such, we rescinded the
350,000 options that were to be issued under the amended agreement and PR Global
is to receive no additional compensation.
On February 1, 2007 we issued Kitsilano Capital Corp. four 100,000 options to
purchase our common stock, pursuant to our Consulting Agreement with them. The
first option vests on May 1, 2007, the second on August 1, 2007, the third on
February 1, 2008 and the fourth on June 1, 2008, so long as Kitsilano continues
to provide services to us under the Consulting Agreement. Each option is
exercisable for a period of three years from the vesting date and has an
exercise price of $1.20, $1.40, $1.60 and $1.80 respectively. The shares
underlying the options have piggy-back registration rights that required us to
register the shares in our last registration statement. The options and the
shares underlying the options were issued in accordance with the exemption from
the registration provisions of the Securities Act of 1933, as amended, provided
by Section 4(2) of such Act for issuances not involving any public offering.
Stock option activity during the period ending February 28, 2007 was as follows:
Weighted
Number of Average
Shares Exercise Price
---------------------------------
Outstanding, September 1, 2006 282,000 $
1.50
Granted 400,000 1.50
Exercised -- --
Forfeited -- --
Expired -- --
---------------------------------
Outstanding, February 28, 2007 682,000 $
1.50
=================================
Exercisable, February 28, 2007 282,000 $
1.50
=================================
At February 28, 2007, 62,000 of the exercisable options expire in August 2010
with the remaining balance of 220,000 having an expiration date of August 2015.
NOTE 15. SERIES A PREFERRED STOCK CONVERSION AND WARRANT EXERCISE
On November 7, 2006, a holder of our series A preferred stock exercised their
right to covert 66,666 shares of our series A preferred stock into 66,666 share
of common stock. As such, we issued 66,666 shares of common stock and canceled
66,666 shares of our series A.
On February 22, 2007, we issued 533,333 shares of common stock to an investor of
our April 12, 2006 financing in connection with the exercise of 533,333 Series J
warrants received by such investor as part of the financing. We received net
proceeds of approximately $276,000 pursuant to the exercise of these warrants.
NOTE 16. GOING CONCERN
21
Prior to the completion of our Preferred Stock Financing working capital had
been primarily financed with various forms of debt. We have suffered operating
losses since inception in our efforts to establish and execute our business
strategy. As of February 28, 2007, we had a cash balance of approximately
$2,226,000. Although management believes that we have adequate funds to maintain
our business operations into the third and fourth quarter and/or until we become
cash flow positive, we continued to suffer operational losses in the first half
of our 2007 fiscal year. Until our operations are able to demonstrate and
maintain positive cash flows, we may require additional working capital to fund
our ongoing operations and execute our business strategy. Based on these
factors, there is substantial doubt about our ability to continue as a going
concern.
The financial statements do not include any adjustments relating to the
recoverability and classification of liabilities that might be necessary should
we be unable to continue as a going concern. Our ability to continue as a going
concern is dependent upon our ability to generate sufficient cash flows to meet
our obligations on a timely basis and ultimately to attain profitability. Our
management intends to obtain working capital through operations and to seek
additional funding through debt and equity offerings to help fund our operations
as we expand. There is no assurance that we will be successful in our efforts to
raise additional working capital or achieve profitable operations. The financial
statements do not include any adjustments that might result from the outcome of
this uncertainty.
NOTE 17. SUBSEQUENT EVENTS
On April 5 2007, we issued 88,000 shares of common stock to an investor of our
April 12th financing in connection with the exercise of 88,000 Series J warrants
received by such investor as part of the financing. We received net proceeds of
approximately $45,600 pursuant to the exercise of these warrants.
On April 12, 2007 we issued 1,266,667 shares of common stock to an investor of
our April 12th financing in connection with such investor's exercise of
1,266,667 Series J warrants he received as part of the April 12th financing. We
received net proceeds of approximately $655,500 pursuant to the exercise of
these warrants.
On April 12, 2007, we issued 188,800 shares of our Series A Preferred Stock and
the followings warrants: (i) Series A Warrant, (ii) Series B Warrant, (iii)
Series C Warrant, (iv) Series D Warrant, (v) Series J Warrant, (vi) Series E
Warrant, (vii) Series F Warrant, (viii) Series G Warrant, and (ix) Series H
Warrant, each to purchase a number of shares of Common Stock equal to 50% of the
number of shares of Series A Preferred Stock purchased, except for the Series J
Warrants, which entitled the investor to purchase a number of shares of our
common stock equal to 100% of the number of shares of Series A Preferred Stock
purchased. We issued a total of 944,000 Warrants. Each of the Warrants has a
term of 5 years, except for the Series J Warrants, which have a term of 1 year.
Each share of the Series A Preferred Stock is convertible into one fully paid
and nonassessable share of our common stock. These shares and warrants were
issued as a result of the exercise of 188,800 placement consultant warrants
received as a result of our April 12, 2006 financing. We received net proceeds
of approximately $106,000 pursuant to the exercise of these warrants.
On April 12, 2007, we issued 188,800 shares of common stock to the placement
consultant of our April 12, 2006 financing in connection with the exercise of
188,800 Series J warrants, which the placement consultant received from his
exercise of his placement consultant warrant. We received net proceeds of
approximately $106,000 pursuant to the exercise of these warrants.
22
EDGEWATER FOODS INTERNATIONAL, INC.
--------------------------------
PROSPECTUS
--------------------------------
i
PART II
ITEM 24. INDEMNIFICATION OF DIRECTORS AND OFFICERS
Our Articles of Incorporation include provisions, which limit the
liability of our directors. As permitted by applicable provisions of the Nevada
Law, directors will not be liable to Edgewater for monetary damages arising from
a breach of their fiduciary duty as directors in certain circumstances. This
limitation does not affect liability for any breach of a director's duty to
Edgewater or our shareholders (i) with respect to approval by the director of
any transaction from which he or she derives an improper personal benefit, (ii)
with respect to acts or omissions involving an absence of good faith, that the
director believes to be contrary to the best interests of Edgewater or our
shareholders, that involve intentional misconduct or a knowing and culpable
violation of law, that constitute an unexcused pattern or inattention that
amounts to an abdication of his or her duty to Edgewater or our shareholders, or
that show a reckless disregard for duty to Edgewater or our shareholders in
circumstances in which he or she was, or should have been aware, in the ordinary
course of performing his or her duties, of a risk of serious injury to Edgewater
or our shareholders, or (iii) based on transactions between Edgewater and our
directors or another corporation with interrelated directors or based on
improper distributions, loans or guarantees under applicable sections of Nevada
Law. This limitation of directors' liability also does not affect the
availability of equitable remedies, such as injunctive relief or rescission.
We have been advised that it is the position of the Commission that
insofar as the provision in Edgewater's Articles of Incorporation, as amended,
may be invoked for liabilities arising under the Securities Act, the provision
is against public policy and is therefore unenforceable.
ITEM 25. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION
We are issuing a new series of Preferred Stock under this Registration
Statement. All common stock registered pursuant to this Registration Statement
is being registered on behalf of selling shareholders. We have agreed to pay all
costs of this Registration Statement. The estimated expenses for the
distribution of the common stock registered hereby, other than underwriting
commissions, fees and Representative's nonaccountable expense allowance are set
forth in the following table:
ITEM AMOUNT
---- ------
SEC Registration Fee $5,156.45
Transfer Agent Fees $0.00
Legal Fees $32,500.00
Accounting Fees $10,000.00
Printing and Engraving Costs $0.00
Miscellaneous $5,000.00
-----------------------------
Total $52,656.45
=============================
ITEM 26. RECENT SALES OF UNREGISTERED SECURITIES
During the past three years, we effected the following transactions in
reliance upon exemptions from registration under the Securities Act as amended.
Unless stated otherwise; (i) that each of the persons who received these
unregistered securities had knowledge and experience in financial and business
matters which allowed them to evaluate the merits and risk of the receipt of
these securities, and that they were knowledgeable about our operations and
financial condition; (ii) no underwriter participated in, nor did we pay any
commissions or fees to any underwriter in connection with the transactions;
(iii) the transactions did not involve a public offerings; and (iv) each
certificate issued for these unregistered securities contained a legend stating
that the securities have not been registered under the Act and setting forth the
restrictions on the transferability and the sale of the securities.
ii
To accomplish the Share Exchange with Edgewater, we issued an aggregate
of 19,000,000 shares of common stock in exchange for all of the issued and
outstanding capital stock of Edgewater. The shares were issued to 17 accredited
investors pursuant to the exemption from registration provided by Section 4(2)
of the Securities Act for issuances not involving any public offering.
In October 2005, we engaged Aurelius Consulting to provide marketing
and investor relations services. The initial term of the agreement is one year.
Aurelius is entitled to receive 100,000 shares of our restricted common stock
during the term of its agreement (25,000 per quarter), in consideration for
their services. The shares were valued at $1.45 per share, the closing bid price
for shares of our common stock on the date of the contract. The shares were
issued in accordance with the exemption from the registration provisions of the
Securities Act of 1933, as amended, provided by Section 4(2) of such Act for
issuances not involving any public offering.
On October 21, 2005 and November 11, 2005, our board approved the
issuing a total of 25,000 shares of the Company's common stock to The Shemano
Group, LLC for preparing a research report for the Company. The shares were
valued at $1.50 per share, the closing market bid of our common stock on the
date of the resolution. The shares were issued in accordance with the exemption
from the registration provisions of the Securities Act of 1933, as amended,
provided by Section 4(2) of such Act for issuances not involving any public
offering.
On January 31, 2006, we issued 400,000 shares of our restricted common
stock to World Wide Mortgage as consideration for agreeing to extend the due
date for us to repay our CDN $1,500,000 loan pursuant to the bridge loan
agreement dated November 9, 2004 and amended on April 15, 2005 between us and
World Wide. The shares have piggy-back registration rights that require us to
register the shares in our next registration statement. The shares were valued
at $1.30 per share, the closing bid price for shares of our common stock on the
date we issued the shares. The shares were issued in accordance with the
exemption from the registration provisions of the Securities Act of 1933, as
amended, provided by Section 4(2) of such Act for issuances not involving any
public offering.
Pursuant to the financings we closed on April 12, May 30, June 30, 2006
and July 11, 2006, we issued an aggregate of 30,905,619 shares. The shares were
issued to 9 accredited investors pursuant to the exemption from registration
provided by Section 4(2) of the Securities Act for issuances not involving any
public offering.
On June 30, we issued 22,860 shares of common stock to the two
accredited investors of our April 12 and May 30, 2006 financings as payment of
the semi-annual dividend (8% per annum) per the terms of the Certificate of
Designation of the Relative Rights and Preferences of the Series A Convertible
Preferred Stock. The dividend shares were issued to these investors pursuant to
the exemption from registration provided by Section 4(2) of the Securities Act
for issuances not involving any public offering.
On December 31, 2006, we issued 138,565 shares of common stock to the
investors of our April 12, May 30, 2006, June 30, 2006 and July 11, 2006
financings as payment of the semi-annual dividend (8% per annum) per the terms
of the Certificate of Designation of the Relative Rights and Preferences of the
Series A Convertible Preferred Stock. The dividend shares were issued to these
investors pursuant to the exemption from registration provided by Section 4(2)
of the Securities Act for issuances not involving any public offering.
Pursuant to the financing we closed on January 16, 2007, we issued 207
shares of our series B preferred stock. The shares were issued to two accredited
investors pursuant to the exemption from registration provided by Section 4(2)
of the Securities Act for issuances not involving any public offering.
In connection with the January 16, 2007 financing, we issued the
placement consultant a placement consultant warrant, exercisable for a period of
three years from the date of issue with an exercise price of $1.15 per share.
The warrant allows the placement consultant to purchase up to (i) 20 shares of
Series B Preferred Stock, and each of the following warrants, which are
identical to the warrants issued to the investors of the financing: (i) Series A
Warrant, (ii) Series B Warrant, (iii) Series C Warrant, (iv) Series D Warrant,
(v) Series J Warrant, (vi) Series E Warrant, and (vii) Series F Warrant, each to
purchase 90,004 shares of common stock, except for the Series J Warrants, which
shall entitle the consultant to purchase 180,008 shares of common stock. The
iii
shares were issued in accordance with the exemption from the registration
provisions of the Securities Act of 1933, as amended, provided by Section 4(2)
of such Act for issuances not involving any public offering.
On February 1, 2007 we issued Kitsilano Capital Corp. four 100,000
options to purchase our common stock, pursuant to our Consulting Agreement with
them. The first option vests on May 1, 2007, the second on August 1, 2007, the
third on February 1, 2008 and the fourth on June 1, 2008, so long as Kitsilano
continues to provide services to us under the Consulting Agreement. Each option
is exercisable for a period of three years from the vesting date and has an
exercise price of $1.20, $1.40, $1.60 and $1.80 respectively. The shares
underlying the options have piggy-back registration rights that required us to
register the shares in our last registration statement. The options and the
shares underlying were issued in accordance with the exemption from the
registration provisions of the Securities Act of 1933, as amended, provided by
Section 4(2) of such Act for issuances not involving any public offering.
ITEM 27. EXHIBITS
EXHIBIT DESCRIPTION
NUMBER -----------
------
3.1 Articles of Incorporation.
3.2 Amended and Restated Bylaws.
3.3 Amendment to Articles of Incorporation (Incorporated by
reference to Exhibit 3.1 to the Company's Annual Report
on Form 10-KSB filed on November 28, 2006)
4.1 Securities Purchase Agreement dated as of April 12, 2006
(Incorporated by reference to Exhibit 10.0 to the
Company's Current Report on Form 8-K filed on April 14,
2006).
4.2 Registration Rights Agreement dated as of April 12, 2006
(Incorporated by reference to Exhibit 10.2 to the
Company's Current Report on Form 8-K filed on April 14,
2006).
4.3 Designation of Rights and Preferences of Series A
Preferred Stock dated as of April 12, 2006 (Incorporated
by reference to Exhibit 10.3 to the Company's Current
Report on Form 8-K filed on April 14, 2006).
4.4 Form of Warrant to Purchase Common Stock (Incorporated by
reference to Exhibits 10.6 through 10.14 to the Company's
Current Report on Form 8-K filed on April 14, 2006).
4.5 Amendment to Registration Rights Agreement dated as of
May 30, 2006 (Incorporated by reference to Exhibit 10.7
to the Company's Current Report on Form 8-K filed on May
30, 2006).
4.6 Form of Joinder Agreement to the Securities Purchase
Agreement dated as of June 30, 2006 and July 11, 2006
(Incorporate by reference to Exhibits 10.1 and 10.2 to
the Company's Current Report on Form 8-K filed on June
30, 2006).
4.7 Joinder Agreement to the Registration Rights Agreement
dated as of June 30, 2006 and July 11, 2006 (Incorporate
by reference to Exhibits 10.1 and 10.2 to the Company's
Current Report on Form 8-K filed on June 30, 2006).
4.8 Securities Purchase Agreement dated as of January 16,
2007 (Incorporated by reference to Exhibit 10.0 to the
Company's Current Report on Form 8-K filed on January 17,
2007).
4.9 Registration Rights Agreement dated as of January 16,
iv
2006 (Incorporated by reference to Exhibit 10.2 to the
Company's Current Report on Form 8-K filed on January 17,
2007).
4.10 Designation of Rights and Preferences of Series A
Preferred Stock dated as of January 16, 2006
(Incorporated by reference to Exhibit 10.3 to the
Company's Current Report on Form 8-K filed on January 17,
2007).
4.11 Form of Warrant to Purchase Common Stock (Incorporated by
reference to Exhibits 10.6 through 10.14 to the Company's
Current Report on Form 8-K filed on January 17, 2007).
5.1 Opinion and Consent of Law Offices of Louis E. Taubman,
P.C.
10.1 Employment Agreement of Robert Saunders (Incorporate by
reference to Exhibits 10.1 to the Company's Registration
Statement on Form SB-2 filed on July 14, 2006).
10.2 Consulting Agreement with TriPoint Capital Advisors, LLC
(Incorporated by reference to Exhibit 10.2 to the
Company's Registration Statement on Form SB-2 filed on
October 16, 2006)
10.5 Consulting Agreement with Aurelius Consulting Group, Inc.
(Incorporate by reference to Exhibits 10.5 Company's
Registration Statement on Form SB-2 filed on July 14,
2006).
10.6 Consulting Agreement with Gallatin Consulting, Inc.
(Incorporated by reference to Exhibits 10.6 Company's
Registration Statement on Form SB-2 filed on July 14,
2006).
10.7 Placement Consultant Agreement with Pai's International
Trade, Inc. dated March 9, 2006 (Incorporated by
reference to Exhibit 10.7 in the Company's Registration
Statement on Form SB-2 filed on October 10, 2006).
10.8 Excerpt from Board of Directors' Meeting summarizing
Robert Saunders' amended employment agreement
(Incorporated by reference to Exhibit 10.8 in the
Company's Registration Statement on Form SB-2 filed on
October 16, 2006).
23.1 Consent of LBB & Associates, Ltd., LLP
v
ITEM 28. UNDERTAKINGS.
a) The undersigned Registrant hereby undertakes:
1) To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:
(i) To include any prospectus required by Section 10(a)(3) of the
Securities Act of 1933, as amended (the "Securities Act");
(ii) To reflect in the prospectus any facts or events arising after
the effective date of this registration statement (or the most
recent post-effective amendment thereof) which, individually or
in the aggregate, represent a fundamental change in the
information set forth in the registration statement.
Notwithstanding the foregoing, any increase or decrease in the
volume of securities offered (if the total dollar value of
securities offered would not exceed that which was registered)
and any deviation from the low or high end of the estimated
maximum offering range may be reflected in the form of prospectus
filed with the SEC pursuant to Rule 424(b) if, in the aggregate,
the changes in volume and price represent no more than 20 percent
change in the maximum aggregate offering price set forth in the
"Calculation of Registration Fee" table in the effective
registration statement; and,
(iii)To include any material information with respect to the plan of
distribution not previously disclosed in this registration
statement or any material change to such information in this
registration statement; provided, however, that paragraphs (1)
(i), (1) (ii) and (1) (iii) do not apply if the information
required to be included in a post-effective amendment by those
paragraphs is contained in periodic reports filed with or
furnished to the SEC by the Registrant pursuant to Section 13 or
Section 15(d) of the Securities Exchange Act of 1934, as amended
(the "Exchange Act") that are incorporated by reference in this
registration statement
2) That, for the purposes of determining any liability under the Securities
Act, each post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of
such securities at the time shall be deemed to be the initial bona fide
offering thereof.
3) To remove from registration by means of a post-effective amendment any of
the securities being registered which remain unsold at the termination of
the offering.
4) Not applicable.
5) That for the purpose of determining liability under the Securities Act of
1933 to any purchaser:
(i) If the registrant is relying on Rule 430B:
(A) Each prospectus filed by the registrant pursuant to Rule 424
(b)(3) shall be deemed to be part of the registration statement
as of the date the filed prospectus was deemed part of and
included in the registration statement; and
(B) Each prospectus required to be filed pursuant to Rule 424(b)(2),
(b)(5), or (b)(7) as part of a registration statement in reliance
on Rule 430B relating to an offering made pursuant to Rule
415(a)(1)(i), (vii) or (x) for the purpose of providing the
information required by Section 10(a) of the Securities Act of
1933 shall be deemed to be part of and included in the
registration statement as of the earlier of the date such form of
prospectus is first used after effectiveness or the date of the
first contract of sale of securities in the offering described in
the prospectus. As provided in Rule 430B, for liability purposes
of the issuer and any person that is at that date an underwriter,
such date shall be deemed to be a new effective date of the
registration statement relating to the securities in the
vi
registration statement to which that prospectus relates, and the
offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof. Provided, however, that
no statement made in a registration statement or prospectus that
is part of the registration statement or made in a document
incorporated or deemed incorporated by reference into the
registration statement or prospectus that is part of the
registration statement will, as to a purchaser with a time of
contract of sale prior to such effective date, supersede or
modify any statement that was made in the registration statement
or prospectus that was part of the registration statement or made
in any such document immediately prior to such effective date; or
(ii) If the registrant is subject to Rule 430C, each prospectus filed
pursuant to Rule 424(b) as part of a registration statement relating
to an offering, other than registration statements relying on Rule
430B or other than prospectuses filed in reliance on Rule 430A, shall
be deemed to be part of and included in the registration statement as
of the date it is first used after effectiveness. Provided, however,
that no statement made in a registration statement or prospectus that
is part of the registration statement or made in a document
incorporated or deemed incorporated by reference into the registration
statement or prospectus that is part of the registration statement
will, as to a purchaser with a time of contract of sale prior to such
first use, supersede or modify any statement that was made in the
registration statement or prospectus that was part of the registration
statement or made in any such document immediately prior to such date
of first use.
(6) That, for the purpose of determining liability of the registrant under the
Securities Act of 1933 to any purchaser in the initial distribution of the
securities: The undersigned registrant undertakes that in a primary
offering of securities of the undersigned registrant pursuant to this
registration statement, regardless of the underwriting method used to sell
the securities to the purchaser, if the securities are offered or sold to
such purchaser by means of any of the following communications, the
undersigned registrant will be a seller to the purchaser and will be
considered to offer or sell such securities to such purchaser:
(i) Any preliminary prospectus or prospectus of the undersigned registrant
relating to the offering required to be filed pursuant to Rule 424;
(ii) Any free writing prospectus relating to the offering prepared by
or on behalf of the undersigned registrant or used or referred to
by the undersigned registrant;
(iii)The portion of any other free writing prospectus relating to the
offering containing material information about the undersigned
registrant or its securities provided by or on behalf of the
undersigned registrant; and
(iv) Any other communication that is an offer in the offering made by
the undersigned registrant to the purchaser.
(b) The undersigned Registrant undertakes that, for purposes of
determining any liability under the Securities Act of 1933, each
filing of the registrant's annual report pursuant to Section
13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where
applicable, each filing of an employee benefit plan's annual
report pursuant to Section 15(d) of the Securities Exchange Act
of 1934) that is incorporated by reference in the registration
statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of
such securities at that time shall be deemed to be the initial
bona fide offering thereof.
(c) Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers and
controlling persons of the Registrant pursuant to the
indemnification provisions herein, or otherwise, the Registrant
has been advised that in the opinion of the SEC such
indemnification is against public policy as expressed in the
Securities Act and is, therefore, unenforceable. In the event
that a claim for indemnification against such liabilities (other
than the payment by the Registrant of expenses incurred or paid
by a director, officer or controlling person of the Registrant in
the successful defense of any action, suit or proceeding) is
asserted by such director, officer, or controlling person in
connection with the securities being registered, the Registrant
will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of
vii
appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in
the Securities Act and will be governed by the final adjudication
of such issue.
viii
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended,
the Registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements of filing on Form SB-2 and authorized this registration
statement to be signed on its behalf by the undersigned, in the City of
Vancouver , State of British Colubmia, on April 17, 2007 and the City of
Gaithersburg, State of Maryland on April 17, 2007
Edgewater Foods International, Inc.
By: /s/ Robert Saunders
---------------
Name: Robert Saunders
Title: President & Chief Executive Officer
By: /s/ Michael Boswell
---------------
Name: Michael Boswell
Title: Acting Chief Financial Officer and
Acting Chief Accounting Officer
Dated: April 17, 2007
In accordance with the requirements of the Securities Act of 1933, this
registration statement was signed by the following persons in the capacities and
on the dates stated.
/s/ Robert Saunders Dated: April 17, 2007
---------------
Robert Saunders
President and Chief Executive Officer
/s/ Michael Boswell Dated: April 17, 2007
---------------
Michael Boswell
Director & Acting Chief Financial Officer &
Acting Chief Accounting Officer
/s/ Douglas C. MacLellan Dated: April 17, 2007
--------------------
Douglas C. MacLellan
Vice-chairman of the Board
/s/ Mark H. Elenowitz Dated: April 17, 2007
---------------------
Mark H. Elenowitz
Director
---------
Ian Fraser
Director
/s/ Victor Bolton Dated: April 17, 2007
-------------
Victor Bolton
Director
/s/ Darryl Horton Dated: April 17, 2007
-------------
Darryl Horton
Director
/s/ Robert Rooks Dated: April 17, 2007
------------
Robert Rooks
Director
ix